>GP267829.1 Sequence 9 from patent US 7504493
TACCACTCCT
>GP267828.1 Sequence 8 from patent US 7504493
AGACAAACTG
>GP267827.1 Sequence 7 from patent US 7504493
GGTGTTAACG
>GP245455.1 Sequence 107 from patent US 7504555
GCTCTAGAGC
>GP244695.1 Sequence 66 from patent US 7504259
MAMMATGNHS
>GP238014.1 Sequence 1 from patent US 7501552
CTAADTGGGG
>GP237951.1 Sequence 718 from patent US 7501502
GATCCTCGGC
>GP237390.1 Sequence 105 from patent US 7501400
GGAGGGAATG
>GP237374.1 Sequence 88 from patent US 7501400
AGGAAAAGGA
>GP236852.1 Sequence 330 from patent US 7501251
TTGGAACCGA
>GP235645.1 Sequence 12 from patent US 7498426
TCNAACNTTC
>GP235604.1 Sequence 12 from patent US 7498425
TCNAACNTTC
>GP233589.1 Sequence 38 from patent US 7498153
AGGACAAAAG
>GP229809.1 Sequence 68 from patent US 7495070
ATGACGTCAT
>GP229808.1 Sequence 67 from patent US 7495070
ATTGCGCAAT
>GP229675.1 Sequence 19 from patent US 7494806
CATGATCAAT
>GP229668.1 Sequence 3 from patent US 7494806
GTACTAGTTA
>GP224714.1 Sequence 72 from patent US 7494646
GATCCTCGGC
>GP210090.1 Sequence 12 from patent US 7491808
ACAAAACAAA
>GP210054.1 Sequence 42 from patent US 7491807
GGATGTAGGA
>GP206158.1 Sequence 1 from patent US 7491805
GCCGTTAGGC
>GP205857.1 Sequence 1 from patent US 7491539
MAGTCACTAT
>GP205801.1 Sequence 12 from patent US 7491532
TTAAGTCGAC
>GP205800.1 Sequence 11 from patent US 7491532
TTAAGTCGAC
>GP205000.1 Sequence 80 from patent US 7491494
AATTCGTACC
>GP204999.1 Sequence 79 from patent US 7491494
GTCGAATTCG
>GP204998.1 Sequence 78 from patent US 7491494
AGGTGGTATT
>GP204997.1 Sequence 77 from patent US 7491494
GGTGGTATTC
>GP204996.1 Sequence 76 from patent US 7491494
GTGGTATTCC
>GP204995.1 Sequence 75 from patent US 7491494
TGGTATTCCC
>GP204994.1 Sequence 74 from patent US 7491494
GGTATTCCCG
>GP204984.1 Sequence 64 from patent US 7491494
TCCCTGATCG
>GP204983.1 Sequence 63 from patent US 7491494
AAGGTGGTAT
>GP204982.1 Sequence 62 from patent US 7491494
TCCCGAGTCG
>GP204981.1 Sequence 61 from patent US 7491494
AATTCGTACC
>GP204976.1 Sequence 56 from patent US 7491494
TCGTATTCCA
>GP204975.1 Sequence 55 from patent US 7491494
AATTCGTACC
>GP204971.1 Sequence 51 from patent US 7491494
TCACCTAGCA
>GP204970.1 Sequence 50 from patent US 7491494
AATTCGTACC
>GP204969.1 Sequence 49 from patent US 7491494
TCCCGAGTCG
>GP204964.1 Sequence 44 from patent US 7491494
ATTCGTACCA
>GP204961.1 Sequence 41 from patent US 7491494
AATTCTTACC
>GP204960.1 Sequence 40 from patent US 7491494
AAATCTTCCC
>GP204933.1 Sequence 13 from patent US 7491494
CNNGNTNGNC
>GP204932.1 Sequence 12 from patent US 7491494
CACCCGTCAC
>GP204929.1 Sequence 9 from patent US 7491494
CCCGAGTCGA
>GP204925.1 Sequence 5 from patent US 7491494
AATTCGTACC
>GN336550.1 Sequence 14 from Patent WO2009037481
CATAGGGCAC
>GN336549.1 Sequence 13 from Patent WO2009037481
CAGAGCGCAT
>GN336548.1 Sequence 12 from Patent WO2009037481
TATTAGACAC
>GN336547.1 Sequence 11 from Patent WO2009037481
CGTTAGACAC
>GN336546.1 Sequence 10 from Patent WO2009037481
TATTAGATGC
>GN336545.1 Sequence 9 from Patent WO2009037481
CATAGGGCAC
>GN336544.1 Sequence 8 from Patent WO2009037481
CAGAGCGCAT
>GN336543.1 Sequence 7 from Patent WO2009037481
TATTAGATGC
>GN336536.1 Sequence 2 from Patent WO2009037511
TTCTTCTTCT
>GN117114.1 Sequence 10 from Patent WO2009037329
TTGCTCTTCG
>GN117113.1 Sequence 9 from Patent WO2009037329
TTGCTCTTCC
>GN115966.1 Sequence 54 from Patent EP2048237
CCRGCCATGG
>GN115364.1 Sequence 69 from Patent WO2009037183
GGGGGGGGGG
>GN115303.1 Sequence 8 from Patent WO2009037183
ATGACGTTCC
>GN114682.1 Sequence 402 from Patent WO2009036379
GACGAGCTTC
>GN114675.1 Sequence 395 from Patent WO2009036379
ATGCACAGTT
>GN095229.1 Sequence 10 from Patent WO2009037279
TTGCTCTTCG
>GN095228.1 Sequence 9 from Patent WO2009037279
TTGCTCTTCC
>GN113929.1 Sequence 16 from Patent WO2009036228
GCCRCCATGG
>DM068311.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
CAATGCGTCT
>DM068310.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
GTCCTCAACG
>DM068309.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
ACGGTACACT
>DM068308.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
TAGGCTCACG
>DM068307.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
GGTCTGAACC
>DM068306.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
AGGCATTCCC
>DM068305.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
AGCTTCAGGG
>DM068304.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
TACGGACACG
>DM068303.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
CAGGCCCTTC
>DM068302.1 DIAGNOSTIC SCREENS FOR ALZHEIMER'S DISEASE
CCGGCTACGG
>DM068000.1 Method and kit for detecting a target protein using a DNA aptamer
CACTGTGGTT
>DM067979.1 BIOMOLECULE SUBSTRATE, AND TEST AND DIAGNOSIS METHODS AND APPARATUSES USING THE SAME
ATGANNNNNN
>DM067978.1 BIOMOLECULE SUBSTRATE, AND TEST AND DIAGNOSIS METHODS AND APPARATUSES USING THE SAME
TACGACTNNN
>DM079713.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DM079356.1 COMPOSITION AND METHODS OF RNAI THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASES
TCAACGTTGA
>DM079046.1 METHODS FOR TREATING INFECTIOUS DISEASE EXACERBATED ASTHMA
GGGGGCCCCC
>DM079045.1 METHODS FOR TREATING INFECTIOUS DISEASE EXACERBATED ASTHMA
CCCCCGGGGG
>DM065726.1 A method of detecting a nucleic acid
TCTGTGCCCG
>DM065725.1 A method of detecting a nucleic acid
TTGCCTTGCT
>DM065722.1 A method of detecting a nucleic acid
CTGGTTTGCC
>DM065721.1 A method of detecting a nucleic acid
ACTGGGGCCT
>DM064145.1 Functional Molecules, Amidite for Synthesizing the Functional Molecules, and Method for Analyzing Target Substances
CTTCACCTTC
>DM077557.1 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics
AACGTTCGAG
>DM069286.1 Novel oligonucleotides and NF-kappa B decoys comprising the same
GGGACTTTCC
>DM069285.1 Novel oligonucleotides and NF-kappa B decoys comprising the same
GGGATTTCCC
>GN085230.1 Sequence 57 from Patent WO2009029293
CTTCGGAGTT
>GN085223.1 Sequence 50 from Patent WO2009029293
CTTCGGAGTT
>GN085215.1 Sequence 42 from Patent WO2009029293
GGATCTTATT
>GN085206.1 Sequence 33 from Patent WO2009029293
CTACACAAAT
>GN085201.1 Sequence 28 from Patent WO2009029293
AGCGATTTTT
>GN085194.1 Sequence 21 from Patent WO2009029293
GGATCTTATT
>GN085183.1 Sequence 10 from Patent WO2009029293
CTTCGGAGTT
>GN094099.1 Sequence 10 from Patent WO2008028535
GGATCCATGA
>GN086295.1 Sequence 1122 from Patent WO2009029293
CCTGAAACAC
>GN086291.1 Sequence 1118 from Patent WO2009029293
GCCGTTCAGG
>GN086284.1 Sequence 1111 from Patent WO2009029293
AGACCACCAC
>GN086265.1 Sequence 1092 from Patent WO2009029293
GGAAGAGAGG
>GN086264.1 Sequence 1091 from Patent WO2009029293
CTGGAGTGGT
>GN086237.1 Sequence 1064 from Patent WO2009029293
CTGCATTTGT
>GN086234.1 Sequence 1061 from Patent WO2009029293
ACATGGGCTG
>GN086225.1 Sequence 1052 from Patent WO2009029293
GCCCATACAG
>GN086220.1 Sequence 1047 from Patent WO2009029293
GGAAGAGGAC
>GN086219.1 Sequence 1046 from Patent WO2009029293
GGTGAGGTTA
>GN086180.1 Sequence 1007 from Patent WO2009029293
ATGTAGCCGC
>GN086173.1 Sequence 1000 from Patent WO2009029293
ATCCTCCTGA
>GN086170.1 Sequence 997 from Patent WO2009029293
CAGCCTAGAG
>GN086168.1 Sequence 995 from Patent WO2009029293
CTGCTGAACC
>GN086166.1 Sequence 993 from Patent WO2009029293
TCCTCAAGCA
>GN086165.1 Sequence 992 from Patent WO2009029293
ATGGCCCTGA
>GN086160.1 Sequence 987 from Patent WO2009029293
TCAGTTCTGC
>GN086144.1 Sequence 971 from Patent WO2009029293
GCTGACCTCA
>GN086134.1 Sequence 961 from Patent WO2009029293
TTACCTGCGA
>GN086133.1 Sequence 960 from Patent WO2009029293
ATGGGTTACC
>GN086121.1 Sequence 948 from Patent WO2009029293
CTACAATTGG
>GN086107.1 Sequence 934 from Patent WO2009029293
AAAGCTCCGG
>GN086104.1 Sequence 931 from Patent WO2009029293
CTTCAGCGGC
>GN086103.1 Sequence 930 from Patent WO2009029293
CCCTTCAGCG
>GN086100.1 Sequence 927 from Patent WO2009029293
TTCTCCCTGA
>GN086098.1 Sequence 925 from Patent WO2009029293
GGAAAGCCCT
>GN086091.1 Sequence 918 from Patent WO2009029293
CTGCGGGTTT
>GN086089.1 Sequence 916 from Patent WO2009029293
GTTCACGGCC
>GN086088.1 Sequence 915 from Patent WO2009029293
TCCCACTTGG
>GN086046.1 Sequence 873 from Patent WO2009029293
CATGAAGGCT
>GN086033.1 Sequence 860 from Patent WO2009029293
AGGGACCTGA
>GN079405.1 Sequence 8 from Patent WO2009027539
TTGCTCTTCG
>GN079404.1 Sequence 7 from Patent WO2009027539
TTGCTCTTCC
>GN086009.1 Sequence 836 from Patent WO2009029293
GTATACCTAC
>GN085950.1 Sequence 777 from Patent WO2009029293
GTTCAGCCCA
>GN085880.1 Sequence 707 from Patent WO2009029293
CAGGAAAGCC
>GN085875.1 Sequence 702 from Patent WO2009029293
ATCCAGTTTG
>GN085855.1 Sequence 682 from Patent WO2009029293
TCACCGCGGG
>GN085847.1 Sequence 674 from Patent WO2009029293
TCGGAACCCA
>GN085837.1 Sequence 664 from Patent WO2009029293
CTCTACAGCC
>GN079242.1 Sequence 1 from Patent EP2040187
ACACACACAC
>GN085820.1 Sequence 647 from Patent WO2009029293
GGAGTGATAT
>GN085803.1 Sequence 630 from Patent WO2009029293
GAAAGGGAAG
>GN085767.1 Sequence 594 from Patent WO2009029293
AGATTAGGTC
>GN085766.1 Sequence 593 from Patent WO2009029293
GCTCTTCTTA
>GN085756.1 Sequence 583 from Patent WO2009029293
ATGTGGGTAG
>GN085717.1 Sequence 544 from Patent WO2009029293
ACCACTGCCA
>GN085711.1 Sequence 538 from Patent WO2009029293
GGTCTGGTAC
>DL233273.1 CELLS FOR DRUG DISCOVERY
GCGGTGGCTC
>GN078477.1 Sequence 26 from Patent WO2009027978
GGGCTGTCCC
>GN078476.1 Sequence 25 from Patent WO2009027978
GGGACAGCCC
>GN078475.1 Sequence 24 from Patent WO2009027978
GGGATAGTCC
>GN078474.1 Sequence 23 from Patent WO2009027978
GGACTATCCC
>GN078473.1 Sequence 22 from Patent WO2009027978
GGACAGACCC
>GN078472.1 Sequence 21 from Patent WO2009027978
GGGTCTGTCC
>GN078471.1 Sequence 20 from Patent WO2009027978
GGGTGTTCCC
>GN078470.1 Sequence 19 from Patent WO2009027978
GGGAACACCC
>GN078469.1 Sequence 18 from Patent WO2009027978
GGGACTTTAC
>GN078468.1 Sequence 17 from Patent WO2009027978
GTAAAGTCCC
>GN077287.1 Sequence 21 from Patent WO2009026502
TCATGCCTGC
>DM059255.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGGCCAATCC
>DM059254.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGATTAGCCC
>DM059253.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CTACTGGTTT
>DM059252.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGACCAGCCC
>DM059251.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGACTGGTTT
>DM059250.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
GTACTGATCC
>DM059249.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGATCAACCC
>DM059248.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
GTGCTGATCC
>DM059247.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGATCAGCCC
>DM059246.1 MULTIPLEX ASSAYS FOR INFERRING ANCESTRY
CGATCGGCCC
>DM063409.1 Method for Preparing Polynucleotides for Analysis
AAGCGGTGCC
>DM063408.1 Method for Preparing Polynucleotides for Analysis
CCTGTTCATG
>DM063407.1 Method for Preparing Polynucleotides for Analysis
TGGAATGGTA
>DM063406.1 Method for Preparing Polynucleotides for Analysis
GCGTTCCCCT
>DM063405.1 Method for Preparing Polynucleotides for Analysis
ACGTGTATAG
>DM063404.1 Method for Preparing Polynucleotides for Analysis
AAGCTATGCC
>DM063403.1 Method for Preparing Polynucleotides for Analysis
CCTGCGCATG
>DM063402.1 Method for Preparing Polynucleotides for Analysis
TGGACCGGTA
>DM063401.1 Method for Preparing Polynucleotides for Analysis
GCGTAGCCCT
>DM063400.1 Method for Preparing Polynucleotides for Analysis
ACGTTGATAG
>DM063399.1 Method for Preparing Polynucleotides for Analysis
GTATGCGTCA
>DM063398.1 Method for Preparing Polynucleotides for Analysis
GACTTAACCG
>DM063397.1 Method for Preparing Polynucleotides for Analysis
GCATCATCGA
>DM063396.1 Method for Preparing Polynucleotides for Analysis
GTATACGTCA
>DM063395.1 Method for Preparing Polynucleotides for Analysis
GACTCAACCG
>DM063394.1 Method for Preparing Polynucleotides for Analysis
GCATTATCGA
>DM063393.1 Method for Preparing Polynucleotides for Analysis
GTATGTGTCA
>DM063392.1 Method for Preparing Polynucleotides for Analysis
GACTTGACCG
>DM063391.1 Method for Preparing Polynucleotides for Analysis
GCATCGTCGA
>DM042553.1 Circadian rhythm gene and clock motif
TGCACGAGGC
>DM042551.1 Circadian rhythm gene and clock motif
GGCGCGAGGC
>DM042549.1 Circadian rhythm gene and clock motif
GGCAGGAGGG
>DM042547.1 Circadian rhythm gene and clock motif
GGCACGCGGC
>DM042540.1 Circadian rhythm gene and clock motif
GCTCCCTCCC
>DM042538.1 Circadian rhythm gene and clock motif
GAAATCGGCT
>DM042533.1 Circadian rhythm gene and clock motif
GGCACGAGGC
>DM042530.1 Circadian rhythm gene and clock motif
CCCGTCGCCT
>DM041975.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
AGCCGTACCC
>DM041974.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
CTGCTACGGG
>DM041973.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
CCCTGAAGCA
>DM041972.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
CCCTAAAGCA
>DM041971.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
TGCTTAAGCA
>DM041970.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
CCCTTAAGGG
>DM041969.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
CCCTTAAGCA
>DM041968.1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for DNA hybridization detection using the polymer, and fabricating method of probe DNA
GGGAATTCGT
>DM041929.1 36P6D5: SECRETED TUMOR ANTIGEN
GATCCTCGGC
>DM049085.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TACGGAACGA
>DM049084.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TCGCCCCCGA
>DM049082.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
CGGAAGCCGA
>DM049081.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCGATGAT
>DM049080.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCGGGGGCT
>DM049078.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCCAAAGG
>DM049076.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCGGGGGCT
>DM049072.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TCGCCCCCGA
>DM049053.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCACTCTTC
>DM057034.1 miR-155 Assay
TGCTTCGTGG
>DM056992.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DM045349.1 Biomarkers which are specific to blood cells or specific to the differentiation of osteoclast
ATGGGGGGCT
>DM039461.1 A molecular sensor using a functional nucleic acid
TTTCCTTTTT
>DM055976.1 PHARMACEUTICAL LIPOSOMAL COMPOSITIONS
ACGGGTAACC
>DM055975.1 PHARMACEUTICAL LIPOSOMAL COMPOSITIONS
GGGGGCTCCA
>DM055974.1 PHARMACEUTICAL LIPOSOMAL COMPOSITIONS
TAACAAAGGC
>DM055973.1 PHARMACEUTICAL LIPOSOMAL COMPOSITIONS
GGGTAACCTT
>DM055889.1 Methods and Compositions for Increased Dynamic Range Detection of Nucleic Acid Molecules
CGCGCCGAGG
>DM044475.1 METHOD FOR AMPLIFYING DNA FRAGMENTS
CGAGCGGTGA
>DM044473.1 METHOD FOR AMPLIFYING DNA FRAGMENTS
CGTTCCCTCG
>DM055626.1 Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells
TTTTTTTTTT
>DM055625.1 Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells
CCCCCCCCCC
>DM055624.1 Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells
AAAAAAAAAA
>DM055623.1 Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells
GGGGGGGGGG
>GN068852.1 Sequence 23 from Patent EP2033970
ACCTGCCCGG
>GN062471.1 Sequence 14 from Patent EP2033968
NNNGNNNNNN
>GN062464.1 Sequence 7 from Patent EP2033968
CTAGGCNGAA
>GN054847.1 Sequence 1146 from Patent WO2008109465
CCTGAAACAC
>GN054843.1 Sequence 1142 from Patent WO2008109465
GCCGTTCAGG
>GN054836.1 Sequence 1135 from Patent WO2008109465
AGACCACCAC
>GN054817.1 Sequence 1116 from Patent WO2008109465
GGAAGAGAGG
>GN054816.1 Sequence 1115 from Patent WO2008109465
CTGGAGTGGT
>GN054789.1 Sequence 1088 from Patent WO2008109465
CTGCATTTGT
>GN054786.1 Sequence 1085 from Patent WO2008109465
ACATGGGCTG
>GN054777.1 Sequence 1076 from Patent WO2008109465
GCCCATACAG
>GN054772.1 Sequence 1071 from Patent WO2008109465
GGAAGAGGAC
>GN054771.1 Sequence 1070 from Patent WO2008109465
GGTGAGGTTA
>GN054732.1 Sequence 1031 from Patent WO2008109465
ATGTAGCCGC
>GN054725.1 Sequence 1024 from Patent WO2008109465
ATCCTCCTGA
>GN054722.1 Sequence 1021 from Patent WO2008109465
CAGCCTAGAG
>GN054720.1 Sequence 1019 from Patent WO2008109465
CTGCTGAACC
>GN054718.1 Sequence 1017 from Patent WO2008109465
TCCTCAAGCA
>GN054717.1 Sequence 1016 from Patent WO2008109465
ATGGCCCTGA
>GN054712.1 Sequence 1011 from Patent WO2008109465
TCAGTTCTGC
>GN054696.1 Sequence 995 from Patent WO2008109465
GCTGACCTCA
>GN054686.1 Sequence 985 from Patent WO2008109465
TTACCTGCGA
>GN054685.1 Sequence 984 from Patent WO2008109465
ATGGGTTACC
>GN054673.1 Sequence 972 from Patent WO2008109465
CTACAATTGG
>GN054659.1 Sequence 958 from Patent WO2008109465
AAAGCTCCGG
>GN054656.1 Sequence 955 from Patent WO2008109465
CTTCAGCGGC
>GN054655.1 Sequence 954 from Patent WO2008109465
CCCTTCAGCG
>GN054652.1 Sequence 951 from Patent WO2008109465
TTCTCCCTGA
>GN054650.1 Sequence 949 from Patent WO2008109465
GGAAAGCCCT
>GN054643.1 Sequence 942 from Patent WO2008109465
CTGCGGGTTT
>GN054641.1 Sequence 940 from Patent WO2008109465
GTTCACGGCC
>GN054640.1 Sequence 939 from Patent WO2008109465
TCCCACTTGG
>GN054598.1 Sequence 897 from Patent WO2008109465
CATGAAGGCT
>GN054585.1 Sequence 884 from Patent WO2008109465
AGGGACCTGA
>GN054561.1 Sequence 860 from Patent WO2008109465
GTATACCTAC
>GN054502.1 Sequence 801 from Patent WO2008109465
GTTCAGCCCA
>GN054432.1 Sequence 731 from Patent WO2008109465
CAGGAAAGCC
>GN054427.1 Sequence 726 from Patent WO2008109465
ATCCAGTTTG
>GN054407.1 Sequence 706 from Patent WO2008109465
TCACCGCGGG
>GN054399.1 Sequence 698 from Patent WO2008109465
TCGGAACCCA
>GN054389.1 Sequence 688 from Patent WO2008109465
CTCTACAGCC
>GN054372.1 Sequence 671 from Patent WO2008109465
GGAGTGATAT
>GN054355.1 Sequence 654 from Patent WO2008109465
GAAAGGGAAG
>GN054319.1 Sequence 618 from Patent WO2008109465
AGATTAGGTC
>GN054318.1 Sequence 617 from Patent WO2008109465
GCTCTTCTTA
>GN054308.1 Sequence 607 from Patent WO2008109465
ATGTGGGTAG
>GN054269.1 Sequence 568 from Patent WO2008109465
ACCACTGCCA
>GN054263.1 Sequence 562 from Patent WO2008109465
GGTCTGGTAC
>GN053758.1 Sequence 57 from Patent WO2008109465
CTTCGGAGTT
>GN053751.1 Sequence 50 from Patent WO2008109465
CTTCGGAGTT
>GN053743.1 Sequence 42 from Patent WO2008109465
GGATCTTATT
>GN053734.1 Sequence 33 from Patent WO2008109465
CTACACAAAT
>GN053729.1 Sequence 28 from Patent WO2008109465
AGCGATTTTT
>GN053722.1 Sequence 21 from Patent WO2008109465
GGATCTTATT
>GN053711.1 Sequence 10 from Patent WO2008109465
CTTCGGAGTT
>GN046651.1 Sequence 122 from Patent WO2009019007
RKSBTGSVGR
>GN046649.1 Sequence 120 from Patent WO2009019007
RKSBTSNVGR
>DM014268.1 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER
GATCCTCGGC
>DM014219.1 Evolving New Molecular Function
GCGNNNNCCG
>DM014218.1 Evolving New Molecular Function
CCGNNNNGCC
>DM014217.1 Evolving New Molecular Function
GCCNNNNCGC
>DM014205.1 Evolving New Molecular Function
CCCGAGTCGA
>DM014201.1 Evolving New Molecular Function
AATTCGTACC
>DM014197.1 Evolving New Molecular Function
TCGTATTCCA
>DM014196.1 Evolving New Molecular Function
AATTCGTACC
>DM014192.1 Evolving New Molecular Function
TCACCTAGCA
>DM014191.1 Evolving New Molecular Function
AATTCGTACC
>DM014190.1 Evolving New Molecular Function
TCCCGAGTCG
>DM014185.1 Evolving New Molecular Function
ATTCGTACCA
>DM014182.1 Evolving New Molecular Function
AATTCTTACC
>DM014181.1 Evolving New Molecular Function
AAATCTTCCC
>DM024316.1 USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA, VEGF, INTERLEUKIN-10, C-JUN, C-FOS OR PROSTAGLANDIN E2 GENES IN THE TREATMENT OF TUMORS
CCAAGAAGCC
>DM017679.1 Detection of human papilloma virus
AAAAAAATTC
>DM017678.1 Detection of human papilloma virus
AAATTTCCCC
>DM017677.1 Detection of human papilloma virus
GAATTTTTTT
>DM017676.1 Detection of human papilloma virus
GGGGAAATTT
>DM017675.1 Detection of human papilloma virus
GAATTTTTTT
>DM017674.1 Detection of human papilloma virus
GGGGAAATTT
>DM017673.1 Detection of human papilloma virus
GAATTTCCCC
>DM017672.1 Detection of human papilloma virus
GGGGAAATTC
>DM011110.1 The new protein expression system working-out and application which assume Actinomyces host
CGCCTATGAT
>DM038926.1 Immunostimulatory Combinations and Methods
CCCCCCCCCC
>DM033564.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
CGCAAGCTAA
>DM033563.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
CGGGCTTAAA
>DM033562.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
CGACTAGGAA
>DM033561.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
CGTTGCACAA
>DM033556.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
GGTACGAATT
>DM033554.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
AATACATCCC
>DM033553.1 Free Reactant Use in Nucleic Acid-Templated Synthesis
AATTCGTACC
>DM038811.1 MYD88 HOMODIMERIZATION INHIBITORS
GGGACTTTCC
>DM033341.1 METHODS FOR SEPARATING SHORT SINGLE-STRANDED NUCLEIC ACID FROM LONG SINGLE- AND DOUBLE-STRANDED NUCLEIC ACID, AND ASSOCIATED BIOMOLECULAR ASSAYS
CAGGAATTCC
>DM033176.1 Nucleic Acid Complex
TTCTTCTTTT
>DM021813.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GAAGAAGATA
>DM037951.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DM027123.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
CGCAGTCAAG
>DM027122.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
CACCGTCAAA
>DM027119.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
MWCHKYCAAG
>DM027118.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
MWCHKYCACA
>DM027117.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
MWCHKYCAAA
>DM027116.1 METHOD FOR PRODUCING A COMPOUND OF INTEREST IN A FILAMENTOUS FUNGAL CELL
MWCHKYCAMV
>DM015501.1 Therapeutic agent for periodontal disease and alveolar bone defect caused by surgical operation
GGGACTTTCC
>DM015500.1 Therapeutic agent for periodontal disease and alveolar bone defect caused by surgical operation
GGGATTTCCC
>DM015499.1 Therapeutic agent for periodontal disease and alveolar bone defect caused by surgical operation
GGGRHTYYHC
>DM037138.1 Reagents, Methods, and Libraries for Bead-Based Sequencing
TCTGTSTCGT
>DM026294.1 Ligation Based RNA Amplification
TTTTTTTTVN
>DM026291.1 Ligation Based RNA Amplification
TTTTTTTTVN
>DM026290.1 Ligation Based RNA Amplification
TTTTTTTTVN
>DM026289.1 Ligation Based RNA Amplification
TTTTTTTTVN
>DM014866.1 Recombinase Polymerase Amplification
ATGCGGTGTT
>GN043314.1 Sequence 14 from Patent WO2009014830
AAGCCAGCTT
>GN043304.1 Sequence 4 from Patent WO2009014830
AAGCAAGCTT
>GN042082.1 Sequence 68 from Patent WO2009015846
CACCCGCAAT
>GN042081.1 Sequence 67 from Patent WO2009015846
AGCTGTTCTA
>GN042080.1 Sequence 66 from Patent WO2009015846
CACTGCTCAA
>GN042079.1 Sequence 65 from Patent WO2009015846
TGGCATGGCT
>GN042078.1 Sequence 64 from Patent WO2009015846
CCTAGCCTGG
>GN042077.1 Sequence 63 from Patent WO2009015846
AGGGAATGGA
>GN042076.1 Sequence 62 from Patent WO2009015846
AGCCTGGACC
>GN042075.1 Sequence 61 from Patent WO2009015846
TGTCAAAAAA
>GN042074.1 Sequence 60 from Patent WO2009015846
TATGGGGGTC
>GN042073.1 Sequence 59 from Patent WO2009015846
ATGTGCCTGG
>GN042072.1 Sequence 58 from Patent WO2009015846
AGCTTAAGCA
>GN042071.1 Sequence 57 from Patent WO2009015846
AGATGGCCAG
>GN042070.1 Sequence 56 from Patent WO2009015846
CTAGACGACT
>GN042069.1 Sequence 55 from Patent WO2009015846
CAGAGCTGCC
>GN042068.1 Sequence 54 from Patent WO2009015846
AGCATCCAGA
>GN042067.1 Sequence 53 from Patent WO2009015846
AGTGGCTTTG
>GN042066.1 Sequence 52 from Patent WO2009015846
TCTAAAGCGG
>GN042065.1 Sequence 51 from Patent WO2009015846
CCCAACAATG
>GN042064.1 Sequence 50 from Patent WO2009015846
TCACCTGGGG
>GN042063.1 Sequence 49 from Patent WO2009015846
TCAGAAGAGA
>GN042062.1 Sequence 48 from Patent WO2009015846
CTAAAAAAAA
>GN042061.1 Sequence 47 from Patent WO2009015846
ACCCTGGCTG
>GN042060.1 Sequence 46 from Patent WO2009015846
AGGGGAAATG
>GN042059.1 Sequence 45 from Patent WO2009015846
AGCGTTCAGC
>GN042058.1 Sequence 44 from Patent WO2009015846
AGAAAGCTGT
>GN042057.1 Sequence 43 from Patent WO2009015846
TCTGACTACC
>GN042056.1 Sequence 42 from Patent WO2009015846
TCTGGAAAGA
>GN042055.1 Sequence 41 from Patent WO2009015846
GACTTTGACA
>GN042054.1 Sequence 40 from Patent WO2009015846
AGACTTTTAA
>GN042053.1 Sequence 39 from Patent WO2009015846
GTCGTTCTGG
>GN042052.1 Sequence 38 from Patent WO2009015846
TGCTGCAGGG
>GN042051.1 Sequence 37 from Patent WO2009015846
ATGAAGATAT
>GN042050.1 Sequence 36 from Patent WO2009015846
CCGCGTTGCT
>GN042049.1 Sequence 35 from Patent WO2009015846
AGAATATAAG
>GN042048.1 Sequence 34 from Patent WO2009015846
CTGCATTGCT
>GN042047.1 Sequence 33 from Patent WO2009015846
ATAGACGAGC
>GN042046.1 Sequence 32 from Patent WO2009015846
AGATAATTTG
>GN042045.1 Sequence 31 from Patent WO2009015846
CGTCCCTGTG
>GN042044.1 Sequence 30 from Patent WO2009015846
CCTTCCGACT
>GN042043.1 Sequence 29 from Patent WO2009015846
CACCCGCAAT
>GN042042.1 Sequence 28 from Patent WO2009015846
AATGACCGAC
>GN042041.1 Sequence 27 from Patent WO2009015846
GTCTAATCAC
>GN042040.1 Sequence 26 from Patent WO2009015846
ATTCATGTCA
>GN042039.1 Sequence 25 from Patent WO2009015846
TCGTCCCTTC
>GN042038.1 Sequence 24 from Patent WO2009015846
TCGCCTGGAC
>GN042037.1 Sequence 23 from Patent WO2009015846
GGTCATTCAT
>GN042036.1 Sequence 22 from Patent WO2009015846
CCTGTGCTGA
>GN042035.1 Sequence 21 from Patent WO2009015846
TCGTCCCTGT
>GN042034.1 Sequence 20 from Patent WO2009015846
TCACCCGCAA
>GN042033.1 Sequence 19 from Patent WO2009015846
ATTTCTAGGC
>GN042032.1 Sequence 18 from Patent WO2009015846
GAGGTGGAGA
>GN042031.1 Sequence 17 from Patent WO2009015846
AATACAAGTT
>GN042030.1 Sequence 16 from Patent WO2009015846
TGCTCAGGCT
>GN042029.1 Sequence 15 from Patent WO2009015846
AGTATCAACA
>GN042028.1 Sequence 14 from Patent WO2009015846
TATGAATAAG
>GN042027.1 Sequence 13 from Patent WO2009015846
TGATAGAAGA
>GN042026.1 Sequence 12 from Patent WO2009015846
ACAACTGGGG
>GN042025.1 Sequence 11 from Patent WO2009015846
CAGAGGGACA
>GN042024.1 Sequence 10 from Patent WO2009015846
AAGCTACACA
>GN042023.1 Sequence 9 from Patent WO2009015846
AGTTATGAAG
>GN042022.1 Sequence 8 from Patent WO2009015846
AAAGATTAAG
>GN042021.1 Sequence 7 from Patent WO2009015846
AACTCAATAA
>GN042020.1 Sequence 6 from Patent WO2009015846
AACCTAATTA
>GN042019.1 Sequence 5 from Patent WO2009015846
AAGTTCCCGC
>GN042018.1 Sequence 4 from Patent WO2009015846
TGACTATAAC
>GN042017.1 Sequence 3 from Patent WO2009015846
AAACCAAAGA
>GN042016.1 Sequence 2 from Patent WO2009015846
ACATCCATCA
>GN042015.1 Sequence 1 from Patent WO2009015846
ATTGTAGATG
>GN039510.1 Sequence 28 from Patent WO2009012246
ATGCATGCAT
>GN039430.1 Sequence 718 from Patent EP2022797
GATCCTCGGC
>GP066171.1 Sequence 400 from patent US 7488813
ACCACGCTGG
>GP066057.1 Sequence 255 from patent US 7488813
CTCCGCGGCA
>GP064433.1 Sequence 37 from patent US 7488710
CTTGATTGCC
>GP063694.1 Sequence 27 from patent US 7488479
GATCCTCGGC
>GP060158.1 Sequence 20 from patent US 7485441
ATGCAAATGA
>GP060075.1 Sequence 66 from patent US 7485421
ATGCGGAATA
>GP060074.1 Sequence 65 from patent US 7485421
ATGCGGAATA
>GP060073.1 Sequence 64 from patent US 7485421
TATCCGTCAT
>GP060072.1 Sequence 63 from patent US 7485421
TATCCGTCAT
>GP059031.1 Sequence 24 from patent US 7485299
GGCCCGTCCA
>GP057327.1 Sequence 16 from patent US 7482122
CGACACCGCC
>GP057326.1 Sequence 15 from patent US 7482122
GAGATCTCCT
>GP057289.1 Sequence 17 from patent US 7482121
TTGCCCAATT
>GP057288.1 Sequence 16 from patent US 7482121
AACGGGTTAA
>GP057274.1 Sequence 550 from patent US 7482118
GCGCCGAGGT
>GP057249.1 Sequence 525 from patent US 7482118
CATGGCCATG
>GP056436.1 Sequence 15 from patent US 7481997
GTGAATGAAG
>GP053841.1 Sequence 8 from patent US 7473775
GTTTAAACGA
>GP053722.1 Sequence 23 from patent US 7473768
AGCCTGACGC
>GP053721.1 Sequence 22 from patent US 7473768
GGACTCCACG
>GP053720.1 Sequence 21 from patent US 7473768
CATCCCGAAC
>GP053719.1 Sequence 20 from patent US 7473768
TTGTCTCAGG
>GP053718.1 Sequence 19 from patent US 7473768
GGATCTGAAC
>GP053717.1 Sequence 18 from patent US 7473768
AAGATAGCGG
>GP053716.1 Sequence 17 from patent US 7473768
AGGATACGTG
>GP053715.1 Sequence 16 from patent US 7473768
GTGCAATGAG
>GP053714.1 Sequence 15 from patent US 7473768
CCAAGCTTGC
>GP053713.1 Sequence 14 from patent US 7473768
CCCTGCAGGC
>GP053712.1 Sequence 13 from patent US 7473768
GCGAATTCCG
>GP053711.1 Sequence 12 from patent US 7473768
CGGGATCCGC
>GP053710.1 Sequence 11 from patent US 7473768
CTATCGCCGC
>GP053709.1 Sequence 10 from patent US 7473768
CACCCTGCGC
>GP053708.1 Sequence 9 from patent US 7473768
GCACGCCGGA
>GP053707.1 Sequence 8 from patent US 7473768
AACGTACGCG
>GP053706.1 Sequence 7 from patent US 7473768
TGCGCGATCG
>GP053705.1 Sequence 6 from patent US 7473768
GTCCTTAGCG
>GP053704.1 Sequence 5 from patent US 7473768
GTCCTACTCG
>GP053703.1 Sequence 4 from patent US 7473768
AAATCGGAGC
>GP053699.1 Sequence 3 from patent US 7473767
GAGAGAGAGA
>GP052606.1 Sequence 41 from patent US 7473422
CAATTAAAGA
>GP052594.1 Sequence 28 from patent US 7473422
CCTAGCGTTG
>GP052593.1 Sequence 27 from patent US 7473422
GGCTGCAAAC
>GP052592.1 Sequence 26 from patent US 7473422
TGCCAGTGGA
>GP052591.1 Sequence 25 from patent US 7473422
TGTTCGCCAG
>GP052590.1 Sequence 24 from patent US 7473422
AAGCGACCGA
>GP052199.1 Sequence 1 from patent US 7470783
TNCNGTNCAN
>GP050803.1 Sequence 5 from patent US 7470530
TCTAGAAGCT
>GP050714.1 Sequence 12 from patent US 7470523
TTAAGTCGAC
>GP050713.1 Sequence 11 from patent US 7470523
TTAAGTCGAC
>GP050675.1 Sequence 120 from patent US 7470517
TGGGGGGGGG
>GP050674.1 Sequence 119 from patent US 7470517
AGGGGGGGGG
>GP050673.1 Sequence 118 from patent US 7470517
CGGGGGGGGG
>GP050672.1 Sequence 117 from patent US 7470517
ATGGGGGGGG
>GP050671.1 Sequence 116 from patent US 7470517
AAGGGGGGGG
>GP050670.1 Sequence 115 from patent US 7470517
ACGGGGGGGG
>GP050669.1 Sequence 114 from patent US 7470517
AATGGGGGGG
>GP050668.1 Sequence 113 from patent US 7470517
AAAGGGGGGG
>GP050667.1 Sequence 112 from patent US 7470517
AACGGGGGGG
>GP050666.1 Sequence 111 from patent US 7470517
AAATGGGGGG
>GP050665.1 Sequence 110 from patent US 7470517
AAAAGGGGGG
>GP050664.1 Sequence 109 from patent US 7470517
AAACGGGGGG
>GP050663.1 Sequence 108 from patent US 7470517
AAAATGGGGG
>GP050662.1 Sequence 107 from patent US 7470517
AAAAAGGGGG
>GP050661.1 Sequence 106 from patent US 7470517
AAAACGGGGG
>GP050660.1 Sequence 105 from patent US 7470517
AAAAATGGGG
>GP050659.1 Sequence 104 from patent US 7470517
AAAAAAGGGG
>GP050658.1 Sequence 103 from patent US 7470517
AAAAACGGGG
>GP050657.1 Sequence 102 from patent US 7470517
AAAAAATGGG
>GP050656.1 Sequence 101 from patent US 7470517
AAAAAAAGGG
>GP050655.1 Sequence 100 from patent US 7470517
AAAAAAACGG
>GP050654.1 Sequence 99 from patent US 7470517
AAAAAAATGG
>GP050653.1 Sequence 98 from patent US 7470517
AAAAAAAAGG
>GP050652.1 Sequence 97 from patent US 7470517
AAAAAAACGG
>GP050651.1 Sequence 96 from patent US 7470517
AAAAAAAATG
>GP050650.1 Sequence 95 from patent US 7470517
AAAAAAAAAG
>GP050649.1 Sequence 94 from patent US 7470517
AAAAAAAACG
>GP050648.1 Sequence 93 from patent US 7470517
AAAAAAAAAT
>GP050647.1 Sequence 92 from patent US 7470517
AAAAAAAAAC
>GP050646.1 Sequence 91 from patent US 7470517
TTTTTTTTTT
>GP050645.1 Sequence 90 from patent US 7470517
GGGGGGGGGG
>GP050644.1 Sequence 89 from patent US 7470517
CCCCCCCCCC
>GP050643.1 Sequence 88 from patent US 7470517
AAAAAAAAAA
>GP050642.1 Sequence 87 from patent US 7470517
BAAAAACGGH
>GP050641.1 Sequence 86 from patent US 7470517
BAAAAAAAAC
>GP050640.1 Sequence 85 from patent US 7470517
BAAAAAAAAB
>GP050271.1 Sequence 10 from patent US 7470511
GTTTAAACGA
>GP044364.1 Sequence 31 from patent US 7468275
AATGGCTCAT
>GP044363.1 Sequence 30 from patent US 7468275
ACGAGCCATT
>GP044282.1 Sequence 1 from patent US 7468270
ACGCAGGCAC
>GP044104.1 Sequence 8 from patent US 7468261
GTTTAAACGA
>GP044048.1 Sequence 17 from patent US 7468251
TTGCCCAATT
>GP044047.1 Sequence 16 from patent US 7468251
AACGGGTTAA
>GP043905.1 Sequence 48 from patent US 7468244
GGATAGGTCC
>GP043576.1 Sequence 43 from patent US 7465851
CGGGATCCCG
>GP043452.1 Sequence 15 from patent US 7465787
GATCGAATTC
>GP043451.1 Sequence 14 from patent US 7465787
AATTGGTACC
>GP042406.1 Sequence 41 from patent US 7465564
MAMMATGNHS
>GP042312.1 Sequence 12 from patent US 7465553
CCTGTAATCC
>GP042311.1 Sequence 11 from patent US 7465553
GTGGCCCACG
>GP042310.1 Sequence 10 from patent US 7465553
GGCACCTCAG
>GP042309.1 Sequence 9 from patent US 7465553
CTATAGCATA
>GP042308.1 Sequence 8 from patent US 7465553
CGAATGTCCT
>GP042307.1 Sequence 7 from patent US 7465553
TGGAAGCACT
>GP042306.1 Sequence 6 from patent US 7465553
TGTTCTGGAG
>GP042305.1 Sequence 5 from patent US 7465553
GTGGCCACGG
>GP042304.1 Sequence 4 from patent US 7465553
GAGCAGCGCC
>GN014312.1 Sequence 54 from Patent WO2009007244
CCRGCCATGG
>DM002383.1 Structural Nucleic Acid Guided Chemical Synthesis
GTGAGCTCTG
>DM002382.1 Structural Nucleic Acid Guided Chemical Synthesis
GTCAGCTGTG
>DM002379.1 Structural Nucleic Acid Guided Chemical Synthesis
GTGGATCCTG
>DM002378.1 Structural Nucleic Acid Guided Chemical Synthesis
GTGGGCCCTG
>DM008063.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DL484786.1 Regulation of Angiogenesis With Zinc Finger Proteins
GCTGGGGGCG
>DM001571.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
RTTGCGYAAY
>DM001537.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
AGAATGTTCT
>DM001536.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
GGGAMTTYCC
>DM001498.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
RCTCATTAAY
>DL484761.1 Regulation of Angiogenesis With Zinc Finger Proteins
GCTGGAGCAC
>DL484760.1 Regulation of Angiogenesis With Zinc Finger Proteins
GCAGGGGCCG
>DL484759.1 Regulation of Angiogenesis With Zinc Finger Proteins
AAGGGGGAGG
>DL484758.1 Regulation of Angiogenesis With Zinc Finger Proteins
GGGGGTGACC
>DL484757.1 Regulation of Angiogenesis With Zinc Finger Proteins
GGGGGTGACC
>DL484756.1 Regulation of Angiogenesis With Zinc Finger Proteins
GCTGGGGGCK
>DL484755.1 Regulation of Angiogenesis With Zinc Finger Proteins
GGGGAGGATC
>DL484754.1 Regulation of Angiogenesis With Zinc Finger Proteins
GGGGCGGGGG
>DL484753.1 Regulation of Angiogenesis With Zinc Finger Proteins
GTGTGGGGTT
>DL484752.1 Regulation of Angiogenesis With Zinc Finger Proteins
GGGGGCGCTC
>DL484751.1 Regulation of Angiogenesis With Zinc Finger Proteins
GAAGAGGACC
>DL484211.1 Primers for identification of acid-fast bacillus
GGACCGGAAC
>DM001171.1 SINGLE STEP DETECTION ASSAY
CGCGCCGAGG
>DL484198.1 Primers for identification of acid-fast bacillus
GAGATCGGTG
>DL484195.1 Primers for identification of acid-fast bacillus
CGATCCGGGG
>DM000883.1 PROBIOTIC LACTOBACILLUS STRAINS FOR IMPROVED VAGINAL HEALTH
CCGCAGCCAA
>DM006724.1 MULTICISTRONIC SIRNA CONSTRUCTS TO INHIBIT TUMORS
AAAAAAAAAA
>DM003385.1 DOCOSAHEXAENOIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
MAMMATGNHS
>DM003271.1 HIGH EICOSAPENTAENOIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
MAMMATGNHS
>DL488838.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488837.1 Method for discriminating an Organism
TATAGCCTGC
>DL488835.1 Method for discriminating an Organism
TAGAGCCTGC
>DL488833.1 Method for discriminating an Organism
CATAGCCTAG
>DL488832.1 Method for discriminating an Organism
CTAGGCTATG
>DL488830.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488829.1 Method for discriminating an Organism
TAGAGCCTGC
>DL488828.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488827.1 Method for discriminating an Organism
TAGAGCCTGC
>DL488826.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488825.1 Method for discriminating an Organism
TAGAGCCTGC
>DL488823.1 Method for discriminating an Organism
CATAGCCTAG
>DL488822.1 Method for discriminating an Organism
CTAGGCTATG
>DL488820.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488819.1 Method for discriminating an Organism
TAGAGCCTGC
>DL488818.1 Method for discriminating an Organism
GCAGGCTCTA
>DL488817.1 Method for discriminating an Organism
TAGAGCCTTC
>DL488816.1 Method for discriminating an Organism
GAAGGCTCTA
>DL488815.1 Method for discriminating an Organism
TAGAGCCTTC
>DL488814.1 Method for discriminating an Organism
GAAGGCTCTA
>DL488813.1 Method for discriminating an Organism
TAGAGCCTTC
>DL488812.1 Method for discriminating an Organism
GAAGGCTCTA
>DL488811.1 Method for discriminating an Organism
TAGAGCCTTC
>DL488810.1 Method for discriminating an Organism
GAAGGCTCTA
>DL488809.1 Method for discriminating an Organism
TAGAGCCTTC
>DL488808.1 Method for discriminating an Organism
GAAGGCTCTA
>DL488657.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
CGTGGTTGTA
>DL488656.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
CAAACATCTA
>DL488655.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
TATGAGAGTA
>DL488654.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
GCCACAACTA
>DL488653.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
CGGTCTGTTA
>DL488652.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
AATCCTTCTA
>DL488651.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
CAATTGAGTA
>DL488650.1 ROLLING CIRCLE AMPLIFICATION OF CIRCULAR GENOMES
CCCCATTCCA
>DL488618.1 METHODS OF SCREENING FOR INTRODUCTION OF DNA INTO A TARGET CELL
AGGCGCGCCT
>DL487762.1 FUNCTIONAL DNA CLONE FOR HEPATITIS C VIRUS (HCV) AND USES THEREOF
TGTCGCATTC
>DM009346.1 RECOMBINANT INFLUENZA VECTORS WITH TANDEM TRANSCRIPTION UNITS
TTTTGCTCCC
>DM008862.1 HIGH ARACHIDONIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
MAMMATGNHS
>GM984180.1 Sequence 64 from Patent WO2008154098
CGAAGATGCC
>GM997891.1 Sequence 16 from Patent WO2008156778
GGGAGCAAAA
>GM980186.1 Sequence 23 from Patent WO2008147824
GACGTAAACG
>GM979912.1 Sequence 34 from Patent WO2008148862
TGCAAAATCT
>GM995195.1 Sequence 63 from Patent EP2014674
GGGCCACGAA
>GM979497.1 Sequence 76 from Patent WO2008147930
GCACACAGTA
>GM979487.1 Sequence 66 from Patent WO2008147930
GCACACAGTG
>GM979475.1 Sequence 54 from Patent WO2008147930
AGCGTTGAAG
>GM979463.1 Sequence 42 from Patent WO2008147930
AGCGTTGAAT
>GM979453.1 Sequence 32 from Patent WO2008147930
GGCTGAGCGA
>GM979443.1 Sequence 22 from Patent WO2008147930
GGCTGAGCGG
>GM979433.1 Sequence 12 from Patent WO2008147930
TAAGCCTAAC
>GM979423.1 Sequence 2 from Patent WO2008147930
TAAGCCTAAG
>GM994953.1 Sequence 7 from Patent WO2008155599
CCCACTCCCG
>GM994950.1 Sequence 4 from Patent WO2008155599
TTGCTGGGCG
>GM994855.1 Sequence 2 from Patent EP2014659
TTTGGGGTTT
>GM979273.1 Sequence 115 from Patent WO2008147887
CAGCCAGTCA
>GM979266.1 Sequence 108 from Patent WO2008147887
CAGCCAGTCG
>GM979259.1 Sequence 101 from Patent WO2008147887
TCCGGCCAAC
>GM979252.1 Sequence 94 from Patent WO2008147887
TCCGGCCAAA
>GM979245.1 Sequence 87 from Patent WO2008147887
CACATACATC
>GM979238.1 Sequence 80 from Patent WO2008147887
CACATACATT
>GM979231.1 Sequence 73 from Patent WO2008147887
CCATCCCAAC
>GM979224.1 Sequence 66 from Patent WO2008147887
CCATCCCAAT
>GM979217.1 Sequence 59 from Patent WO2008147887
CACAAGGGCA
>GM979210.1 Sequence 52 from Patent WO2008147887
CACAAGGGCG
>GM979201.1 Sequence 43 from Patent WO2008147887
GCACACAGTA
>GM979191.1 Sequence 33 from Patent WO2008147887
GCACACAGTG
>GM979179.1 Sequence 21 from Patent WO2008147887
AGCGTTGAAG
>GM979167.1 Sequence 9 from Patent WO2008147887
AGCGTTGAAT
>GM992725.1 Sequence 30 from Patent WO2008143972
CGGAGGCTAA
>GM992724.1 Sequence 29 from Patent WO2008143972
CGGAGGCTAA
>GM975225.1 Sequence 2 from Patent WO2008148560
TTTGGGGTTT
>GM974901.1 Sequence 93 from Patent WO2008147899
CGGGGCGGGG
>GM974891.1 Sequence 83 from Patent WO2008147899
CCCCGCCCCC
>GM974870.1 Sequence 62 from Patent WO2008147899
GGTCACGTGG
>GM974829.1 Sequence 21 from Patent WO2008147899
TATTGATCGG
>GM974824.1 Sequence 16 from Patent WO2008147899
GACGTCCGGG
>GM986883.1 Sequence 8 from Patent WO2008151631
AACTGAGCCA
>GM986882.1 Sequence 7 from Patent WO2008151631
GTTCCTGCTG
>GM986881.1 Sequence 6 from Patent WO2008151631
TGATAAGCTA
>GM969135.1 Sequence 8 from Patent WO2008145603
CTAGACTCTG
>GM969134.1 Sequence 7 from Patent WO2008145603
GATCCAGAGT
>GM986878.1 Sequence 3 from Patent WO2008151631
ATCGAATAGT
>GM999462.1 Sequence 43 from Patent EP2014770
ACCTGCCCGG
>FB986161.1 Sequence 8 from Patent EP1916311
CGTGGTTGTA
>FB986160.1 Sequence 7 from Patent EP1916311
CAAACATCTA
>FB986159.1 Sequence 6 from Patent EP1916311
TATGAGAGTA
>FB986158.1 Sequence 5 from Patent EP1916311
GCCACAACTA
>FB986157.1 Sequence 4 from Patent EP1916311
CGGTCTGTTA
>FB986156.1 Sequence 3 from Patent EP1916311
AATCCTTCTA
>FB986155.1 Sequence 2 from Patent EP1916311
CAATTGAGTA
>FB986154.1 Sequence 1 from Patent EP1916311
CCCCATTCCA
>FB740785.1 Sequence 2 from Patent WO2008010928
GCCGTGCTCC
>AM773786.1 Artificial RAPD primer sequence, RBa18
TGTCAGTGGA
>AM773785.1 Artificial RAPD primer sequence, RBa17
TGGGCGTCAA
>AM773784.1 Artificial RAPD primer sequence, RBa16
TGCGGGTCAA
>AM773783.1 Artificial RAPD primer sequence, RBa15
TCGTTCACCC
>AM773782.1 Artificial RAPD primer sequence, RBa14
GTGCCCGATG
>AM773781.1 Artificial RAPD primer sequence, RBa13
GTCAGAGTCG
>AM773780.1 Artificial RAPD primer sequence, RBa12
GAGGGCGACT
>AM773778.1 Artificial RAPD primer sequence, RBa10
ATCCTGCCTG
>AM773777.1 Artificial RAPD primer sequence, RBa9
AGGTGACCGT
>AM773776.1 Artificial RAPD primer sequence, RBa8
AGGCGGCAAG
>AM773775.1 Artificial RAPD primer sequence, RBa7
AGCCTGAGCC
>AM773774.1 Artificial RAPD primer sequence, RBa6
ACTTCGCCAC
>AM773773.1 Artificial RAPD primer sequence, RBa5
ACCACCCACC
>AM773772.1 Artificial RAPD primer sequence, RBa4
ACAGGGGTGT
>AM773771.1 Artificial RAPD primer sequence, RBa3
ACACACGCTG
>AM773770.1 Artificial RAPD primer sequence, RBa2
AATCGGGCTG
>AM773769.1 Artificial RAPD primer sequence, RBa1
AATCGCGCTG
>AM773329.1 Artificial oligonucleotide RFu18 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
TGTGTGCAAC
>AM773328.1 Artificial oligonucleotide RFu17 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
TGGCGTCCTC
>AM773327.1 Artificial oligonucleotide RFu16 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
TGCGCTCCAT
>AM773326.1 Artificial oligonucleotide RFu15 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
TCCCACGCAG
>AM773325.1 Artificial oligonucleotide RFu14 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
GTGCCCGTTA
>AM773324.1 Artificial oligonucleotide RFu13 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
GGCACCATTC
>AM773323.1 Artificial oligonucleotide RFu12 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
GAGCTCGCAT
>AM773322.1 Artificial oligonucleotide RFu11 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
GAGCACGGAG
>AM773319.1 Artificial oligonucleotide RFu8 RAPD primer sequence for Boletus edulis genome analysis
CCGGGGTTTG
>AM773318.1 Artificial oligonucleotide RFu7 RAPD primer sequence for Boletus edulis genome analysis
ATCGGGTCCT
>AM773317.1 Artificial oligonucleotide RFu6 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
AGTCCGCCTC
>AM773316.1 Artificial oligonucleotide RFu5 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
ACGGCAACCT
>AM773315.1 Artificial oligonucleotide RFu4 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
ACCGCCTATG
>AM773312.1 Artificial oligonucleotide RFu3 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
ACATCGCCCA
>AM773311.1 Artificial oligonucleotide RFu2 RAPD primer seuqence for Saccharomyces cerevisiae genome analysis
ACAGGGCTCT
>AM773310.1 Artificial oligonucleotide RFu1 RAPD primer sequence for Saccharomyces cerevisiae genome analysis
AAGCGACCTG
>AM765836.1 Homo sapiens RAPD primer RHu18
TGTCGTGGTC
>AM765835.1 Homo sapiens RAPD primer RHu17
TGAGCGGACA
>AM765834.1 Homo sapiens RAPD primer RHu16
GGCACGTAAC
>AM765833.1 Homo sapiens RAPD primer RHu15
GTCGCCGTCT
>AM765831.1 Homo sapiens RAPD primer RHu13
CCGGGGAAAC
>AM765830.1 Homo sapiens RAPD primer RHu12
AGGCTGTGTC
>AM765829.1 Homo sapiens RAPD primer RHu11
GGTGCGCCTT
>AM765828.1 Homo sapiens RAPD primer RHu10
GGGCACGATG
>AM765827.1 Homo sapiens RAPD primer RHu9
GGCGGAATCG
>AM765826.1 Homo sapiens RAPD primer RHu8
GCCCGGTTCA
>AM765825.1 Homo sapiens RAPD primer RHu7
GATGACCGCC
>AM765824.1 Homo sapiens RAPD primer RHu6
GAGGGCGATC
>AM765823.1 Homo sapiens RAPD primer RHu5
GAGCACCTGT
>AM765821.1 Homo sapiens RAPD primer RHu3
CCAGCCGAAC
>AM765820.1 Homo sapiens RAPD primer RHu2
CACGAACCTC
>AM765819.1 Homo sapiens RAPD primer RHu1
AAAGCTGCGG
>AM750061.1 Oryza sativa Indica Group RPl18 RAPD primer
TGCCGGCTTG
>AM750060.1 Oryza sativa Indica Group RPl17 RAPD primer
TTAACCGCGC
>AM750059.1 Oryza sativa Indica Group RPl16 RAPD primer
GGCATGACCT
>AM750058.1 Oryza sativa Indica Group RPl15 RAPD primer
CCGGGGTTAT
>AM750057.1 Oryza sativa Indica Group RPl14 RAPD primer
GTGCCAAATG
>AM750056.1 Oryza sativa Indica Group RPl13 RAPD primer
GAGGGCATGT
>AM750055.1 Oryza sativa Indica Group RPl12 RAPD primer
GGGCACGCAA
>AM750054.1 Oryza sativa Indica Group RPl11 RAPD primer
GAGCGCCTTC
>AM750053.1 Oryza sativa Indica Group RPl10 RAPD primer
GAGCACGTCA
>AM750052.1 Oryza sativa Indica Group RPl9 RAPD primer
GGGTAACGCC
>AM750051.1 Oryza sativa Indica Group RPl8 RAPD primer
CCGGCCATAC
>AM750050.1 Oryza sativa Indica Group RPl7 RAPD primer
GAGGGCGGCA
>AM750049.1 Oryza sativa Indica Group RPl6 RAPD primer
GAGCACGGCA
>AM750048.1 Oryza sativa Indica Group RPl5 RAPD primer
CCTGGGGGAT
>AM750047.1 Oryza sativa Indica Group RPl4 RAPD primer
CCGGCCATAC
>AM750046.1 Arabidopsis thaliana RPl3 RAPD primer
ACGGCAAGGA
>AM750045.1 Arabidopsis thaliana RPl2 RAPD primer
ACGATGAGCG
>AM750044.1 Arabidopsis thaliana Rpl1 RAPD primer
AACGCGTCGG
>DL479941.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCNTCNTTTT
>DL479940.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
GGGGGCCCCC
>DL479939.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
CCCCCGGGGG
>DL479907.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGCGTCGTT
>DL479906.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGCGACGTT
>DL479905.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGACGA
>DL479904.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGACGTCGA
>DL479903.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGTTNN
>DL479902.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGTTTT
>DL479833.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
TCGGTCCGCG
>DL479832.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
TCGAGCTCTG
>DL479831.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
CCGGTCCGTG
>DL479830.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
CCGGTCCCCG
>DL479829.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
TACGTTCGCG
>DL479828.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
TAGGTCCGCA
>DL479827.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
TCGGTCCGCA
>DL479826.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
CCGAGCTCTG
>DL479825.1 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES
CCGATCTCTG
>DL479501.1 PRIMERS, PROBES AND METHODS FOR NUCLEIC ACID AMPLIFICATION
AATGRCTTTA
>DL479190.1 Plant promoters and uses thereof
TTGTAGCWAW
>DL479189.1 Plant promoters and uses thereof
AGTAATWTYW
>DL465915.1 Glycine Riboswitches, Methods for Their Use, and Compositions for Use with Glycine Riboswitches
RRRGACAGAG
>DL465912.1 Glycine Riboswitches, Methods for Their Use, and Compositions for Use with Glycine Riboswitches
NTCTGGARAG
>DL465803.1 SINGLE-STRANDED ANTIMICROBIAL OLIGONUCLEOTIDES AND USES THEREOF
ATACAATTGC
>DL464801.1 STRAIN-INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
AGAGTGAGGG
>DL464799.1 STRAIN-INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
AGAGTGAAGG
>DL464798.1 STRAIN-INDEPENDENT AMPLIFICATION OF PATHOGENS AND VACCINES THERETO
AGAGTGATGG
>DL464321.1 A composition for promoting a recovery of cytopenia
AGCTGTTAAC
>DL464320.1 A composition for promoting a recovery of cytopenia
TCGAGTTAAC
>DL477533.1 KALLIKREIN INHIBITORS AND USES THEREOF
GACGTACGTC
>DL477108.1 DELIVERY OF POLYNUCLEOTIDES
GGACTTTCCC
>DL477103.1 DELIVERY OF POLYNUCLEOTIDES
AGTTGAAGGC
>DL477089.1 DELIVERY OF POLYNUCLEOTIDES
CCTTGAATCC
>DL477088.1 DELIVERY OF POLYNUCLEOTIDES
GGGACTTTCC
>DL477085.1 DELIVERY OF POLYNUCLEOTIDES
GGGACTTTCC
>DL477084.1 DELIVERY OF POLYNUCLEOTIDES
GGGRNNYYCC
>DL483324.1 ANTIVIRAL OLIGONUCLEOTIDES
CCCCCATGGA
>DL483321.1 ANTIVIRAL OLIGONUCLEOTIDES
TCCGAAGACG
>DL482511.1 IDENTIFYING A TARGET POLYNUCLEOTIDE
CCCCCCGTTT
>DL482510.1 IDENTIFYING A TARGET POLYNUCLEOTIDE
CCCCCCATTT
>DL482509.1 IDENTIFYING A TARGET POLYNUCLEOTIDE
TTTTTTGCCC
>DL482508.1 IDENTIFYING A TARGET POLYNUCLEOTIDE
TTTTTTACCC
>DL482290.1 COMPOSITIONS, METHODS, AND KITS FOR IDENTIFYING AND QUANTITATING SMALL RNA MOLECULES
CACGCGGTGA
>DL475555.1 Molecular Antigen Arrays
GACGATCGTC
>DL461078.1 ENCODED COMBINATORIAL CHEMICAL LIBRARIES
CTATTCTTAG
>DL461077.1 ENCODED COMBINATORIAL CHEMICAL LIBRARIES
CAAGGGGGCC
>DL461076.1 ENCODED COMBINATORIAL CHEMICAL LIBRARIES
AGCTACTTCC
>GM712194.1 Sequence 2 from Patent WO2008093141
CAGGTAAGTA
>GM712193.1 Sequence 1 from Patent WO2008093141
MAGGTRAGTA
>GM692349.1 Sequence 3 from Patent WO2007069092
CACCGTAGCG
>GM692348.1 Sequence 2 from Patent WO2007069092
GTGGCGTCGC
>GM692347.1 Sequence 1 from Patent WO2007069092
GTGGCATCGC
>GM773927.1 Sequence 59 from Patent WO2008116931
ATTTTTTANN
>GM773925.1 Sequence 57 from Patent WO2008116931
ATTTTTANNN
>GM773923.1 Sequence 55 from Patent WO2008116931
ATTTTANNNN
>GM773921.1 Sequence 53 from Patent WO2008116931
TAAAAAATNN
>GM773919.1 Sequence 51 from Patent WO2008116931
TAAAAATNNN
>GM773917.1 Sequence 49 from Patent WO2008116931
TAAAATNNNN
>GM773915.1 Sequence 47 from Patent WO2008116931
TTTTTTNNNN
>GM773913.1 Sequence 45 from Patent WO2008116931
TTTTTNNNNN
>GM773911.1 Sequence 43 from Patent WO2008116931
TTTTNNNNNN
>GM773909.1 Sequence 41 from Patent WO2008116931
AAAAAANNNN
>GM773907.1 Sequence 39 from Patent WO2008116931
AAAAANNNNN
>GM773905.1 Sequence 37 from Patent WO2008116931
AAAANNNNNN
>GM755554.1 Sequence 58 from Patent EP1978098
AAAGCTGGGT
>GM755553.1 Sequence 57 from Patent EP1978098
AAAGCAGGCT
>GM044601.1 Sequence 18 from Patent EP1930340
TGGTGGTGGT
>GM836200.1 Sequence 3 from Patent EP1983057
TATAAGTGAG
>GM836090.1 Sequence 20 from Patent EP1982998
GCGGGNCGCG
>GM835314.1 Sequence 100 from Patent EP1983052
AAAAAAAAAA
>GM835293.1 Sequence 79 from Patent EP1983052
NNNNNGCGTC
>GM835271.1 Sequence 57 from Patent EP1983052
AAAAAAACCG
>GM835268.1 Sequence 54 from Patent EP1983052
AAAAAAAAAC
>GM835263.1 Sequence 49 from Patent EP1983052
AAGAGATGAA
>DL467525.1 Synthetic nucleic acid molecule and methods of preparation
CACCATGGCT
>DL467497.1 Synthetic nucleic acid molecule and methods of preparation
GCCACCATGA
>GM746312.1 Sequence 51 from Patent EP1975256
AATAACAACC
>GM746311.1 Sequence 50 from Patent EP1975256
AATAAGAACC
>GM746310.1 Sequence 49 from Patent EP1975256
AATAAAAACC
>GM746309.1 Sequence 48 from Patent EP1975256
AATCATAACC
>GM746308.1 Sequence 47 from Patent EP1975256
AATGATAACC
>GM746307.1 Sequence 46 from Patent EP1975256
AATTATAACC
>GM746306.1 Sequence 45 from Patent EP1975256
AATAATAACC
>GM746305.1 Sequence 44 from Patent EP1975256
AGCACTGACT
>GM746304.1 Sequence 43 from Patent EP1975256
AGCATTGACT
>GM746303.1 Sequence 42 from Patent EP1975256
AGCAATGACT
>GM746302.1 Sequence 41 from Patent EP1975256
AGCAGCGACT
>GM746301.1 Sequence 40 from Patent EP1975256
AGCAGGGACT
>GM746300.1 Sequence 39 from Patent EP1975256
AGCAGAGACT
>GM746299.1 Sequence 38 from Patent EP1975256
AGCCGTGACT
>GM746298.1 Sequence 37 from Patent EP1975256
AGCGGTGACT
>GM746297.1 Sequence 36 from Patent EP1975256
AGCTGTGACT
>GM746296.1 Sequence 35 from Patent EP1975256
AGCTGTGACT
>GM746277.1 Sequence 16 from Patent EP1975256
GTAATAATAA
>GM746276.1 Sequence 15 from Patent EP1975256
CCAATAATAA
>GM746275.1 Sequence 14 from Patent EP1975256
ACAATGATAA
>GM746274.1 Sequence 13 from Patent EP1975256
TCAATGACAG
>GM746273.1 Sequence 12 from Patent EP1975256
TCAGTGACAA
>GM746272.1 Sequence 11 from Patent EP1975256
TCAGTGACGA
>GM746271.1 Sequence 10 from Patent EP1975256
ACAGCGACGT
>GM746270.1 Sequence 9 from Patent EP1975256
ACAGCGGCGT
>GM746269.1 Sequence 8 from Patent EP1975256
TCGGCGGCGT
>GM678684.1 Sequence 30 from Patent WO2008054713
GWGGGGGGGT
>GM678683.1 Sequence 29 from Patent WO2008054713
CTAWWWWTAG
>GM678662.1 Sequence 8 from Patent WO2008054713
GTGGGGGGGT
>GM678661.1 Sequence 7 from Patent WO2008054713
GAGGGGGGGT
>GM678658.1 Sequence 4 from Patent WO2008054713
CTATTTTTAG
>GM678657.1 Sequence 3 from Patent WO2008054713
CTAAAAATAG
>GM827472.1 Sequence 18 from Patent WO2008116937
GANNNNNNTG
>FB508021.1 Sequence 2 from Patent WO2008098248
TTGGCAGCCC
>FB505662.1 Sequence 8 from Patent EP1961818
ACCTGCCCGG
>GM739578.1 Sequence 59 from Patent EP1975228
ATTTTTTANN
>GM739576.1 Sequence 57 from Patent EP1975228
ATTTTTANNN
>GM739574.1 Sequence 55 from Patent EP1975228
ATTTTANNNN
>GM739572.1 Sequence 53 from Patent EP1975228
TAAAAAATNN
>GM739570.1 Sequence 51 from Patent EP1975228
TAAAAATNNN
>GM739568.1 Sequence 49 from Patent EP1975228
TAAAATNNNN
>GM739566.1 Sequence 47 from Patent EP1975228
TTTTTTNNNN
>GM739564.1 Sequence 45 from Patent EP1975228
TTTTTNNNNN
>GM739562.1 Sequence 43 from Patent EP1975228
TTTTNNNNNN
>GM739560.1 Sequence 41 from Patent EP1975228
AAAAAANNNN
>GM739558.1 Sequence 39 from Patent EP1975228
AAAAANNNNN
>GM739556.1 Sequence 37 from Patent EP1975228
AAAANNNNNN
>GM699191.1 Sequence 1343 from Patent WO2008088422
AATAACATAT
>GM620776.1 Sequence 26 from Patent EP1941867
GACGTACGTC
>GM698533.1 Sequence 685 from Patent WO2008088422
TAAGGATCCG
>GM698532.1 Sequence 684 from Patent WO2008088422
TCCACCACCA
>GM963640.1 Sequence 35 from Patent EP2000536
GAAGATCTTC
>GM697306.1 Sequence 11 from Patent WO2008085652
TAGGCTGCTG
>GM697305.1 Sequence 10 from Patent WO2008085652
TAGGCCGCTG
>GM719187.1 Sequence 12 from Patent WO2008101216
CGCCATATTC
>GM719186.1 Sequence 11 from Patent WO2008101216
TGCACACTGA
>GM697130.1 Sequence 1 from Patent WO2008086364
AAAAAAAAAA
>GM886182.1 Sequence 51 from Patent EP1995330
AATAACAACC
>GM886181.1 Sequence 50 from Patent EP1995330
AATAAGAACC
>GM886180.1 Sequence 49 from Patent EP1995330
AATAAAAACC
>GM886179.1 Sequence 48 from Patent EP1995330
AATCATAACC
>GM886178.1 Sequence 47 from Patent EP1995330
AATGATAACC
>GM886177.1 Sequence 46 from Patent EP1995330
AATTATAACC
>GM886176.1 Sequence 45 from Patent EP1995330
AATAATAACC
>GM886175.1 Sequence 44 from Patent EP1995330
AGCACTGACT
>GM886174.1 Sequence 43 from Patent EP1995330
AGCATTGACT
>GM886173.1 Sequence 42 from Patent EP1995330
AGCAATGACT
>GM886172.1 Sequence 41 from Patent EP1995330
AGCAGCGACT
>GM886171.1 Sequence 40 from Patent EP1995330
AGCAGGGACT
>GM886170.1 Sequence 39 from Patent EP1995330
AGCAGAGACT
>GM886169.1 Sequence 38 from Patent EP1995330
AGCCGTGACT
>GM886168.1 Sequence 37 from Patent EP1995330
AGCGGTGACT
>GM886167.1 Sequence 36 from Patent EP1995330
AGCTGTGACT
>GM886166.1 Sequence 35 from Patent EP1995330
AGCTGTGACT
>GM886147.1 Sequence 16 from Patent EP1995330
GTAATAATAA
>GM886146.1 Sequence 15 from Patent EP1995330
CCAATAATAA
>GM886145.1 Sequence 14 from Patent EP1995330
ACAATGATAA
>GM886144.1 Sequence 13 from Patent EP1995330
TCAATGACAG
>GM886143.1 Sequence 12 from Patent EP1995330
TCAGTGACAA
>GM886142.1 Sequence 11 from Patent EP1995330
TCAGTGACGA
>GM886141.1 Sequence 10 from Patent EP1995330
ACAGCGACGT
>GM886140.1 Sequence 9 from Patent EP1995330
ACAGCGGCGT
>GM886139.1 Sequence 8 from Patent EP1995330
TCGGCGGCGT
>GM716311.1 Sequence 103 from Patent EP1964850
CTTCAACCTC
>GM716310.1 Sequence 102 from Patent EP1964850
AAGAGGGTAC
>GM716309.1 Sequence 101 from Patent EP1964850
TCTGTCCACA
>GM716308.1 Sequence 100 from Patent EP1964850
CTATCCATGG
>GM716307.1 Sequence 99 from Patent EP1964850
AGTCTATGCG
>GM716306.1 Sequence 98 from Patent EP1964850
GGTACTAAGG
>GM716305.1 Sequence 97 from Patent EP1964850
TCGATACAGG
>GM716304.1 Sequence 96 from Patent EP1964850
GGAACCAATC
>GM716303.1 Sequence 95 from Patent EP1964850
TTTTGGCTCC
>GM716302.1 Sequence 94 from Patent EP1964850
CTTTCTACCC
>GM716301.1 Sequence 93 from Patent EP1964850
TGGATTGGTC
>GM716300.1 Sequence 92 from Patent EP1964850
TACAACGAGG
>GM716299.1 Sequence 91 from Patent EP1964850
TCGGTCATAG
>GM716298.1 Sequence 90 from Patent EP1964850
TGGTAAAGGG
>GM716296.1 Sequence 88 from Patent EP1964850
AGTAGTTGCC
>GM716295.1 Sequence 87 from Patent EP1964850
CTCCTAGGCT
>GM869926.1 Sequence 1 from Patent WO2008130735
TTTTTTTTTT
>GM714413.1 Sequence 845 from Patent EP1959012
TTACATTCCA
>GM714407.1 Sequence 839 from Patent EP1959012
CGTGCCTTAA
>GM836201.1 Sequence 4 from Patent EP1983057
CATCAGTGAA
>FB775682.1 Sequence 10 from Patent WO2008036273
TATAAATTCG
>FB775681.1 Sequence 9 from Patent WO2008036273
CGAATTTATA
>FB775674.1 Sequence 2 from Patent WO2008036273
GTTACCTACA
>FB775673.1 Sequence 1 from Patent WO2008036273
TGTAGGTAAC
>FB765854.1 Sequence 10 from Patent WO2008024518
ACAAAACAAA
>FB765802.1 Sequence 10 from Patent WO2008025711
TCATCTTCTT
>FB748000.1 Sequence 6 from Patent WO2008008785
AAAAAAAAAA
>FB744622.1 Sequence 68 from Patent WO2008014979
GGGTTTTGGG
>FB744611.1 Sequence 57 from Patent WO2008014979
GGTTTTTTGG
>FB735983.1 Sequence 8 from Patent WO2007146057
GGGAGCAAAA
>FB735911.1 Sequence 21 from Patent WO2008005310
GCGTGGGCGT
>FB735908.1 Sequence 18 from Patent WO2008005310
TCCACGTAGA
>FB735906.1 Sequence 16 from Patent WO2008005310
AGTGACTCAT
>FB735899.1 Sequence 9 from Patent WO2008005310
GGGACTTTCC
>FB735897.1 Sequence 7 from Patent WO2008005310
GGGAATTCCC
>GM036662.1 Sequence 6 from Patent WO2008051316
TTTTTTTTTT
>GM036661.1 Sequence 5 from Patent WO2008051316
ATCAAAGATG
>GM036660.1 Sequence 4 from Patent WO2008051316
CAAACCTGAT
>GM036659.1 Sequence 3 from Patent WO2008051316
CAAACATGAT
>GM036658.1 Sequence 2 from Patent WO2008051316
CAAAGATGAT
>GM036657.1 Sequence 1 from Patent WO2008051316
ATCATCTTTG
>GM876836.1 Sequence 295 from Patent WO2008131807
TCACCTGGGT
>GM876835.1 Sequence 294 from Patent WO2008131807
TTCACCTGGG
>GM876834.1 Sequence 293 from Patent WO2008131807
TTTCACCTGG
>GM876833.1 Sequence 292 from Patent WO2008131807
TTTTCACCTG
>GM876832.1 Sequence 291 from Patent WO2008131807
CTTTTCACCT
>GM876827.1 Sequence 286 from Patent WO2008131807
ACTTTTCACC
>GM876824.1 Sequence 283 from Patent WO2008131807
CACCTGGGTC
>GM876820.1 Sequence 279 from Patent WO2008131807
CTAGAAAGAA
>GM876819.1 Sequence 278 from Patent WO2008131807
CCTAGAAAGA
>GM876818.1 Sequence 277 from Patent WO2008131807
TCCTAGAAAG
>GM876817.1 Sequence 276 from Patent WO2008131807
GTCCTAGAAA
>GM876816.1 Sequence 275 from Patent WO2008131807
AGTCCTAGAA
>GM876811.1 Sequence 270 from Patent WO2008131807
CAGTCCTAGA
>GM876808.1 Sequence 267 from Patent WO2008131807
TAGAAAGAAA
>GM876804.1 Sequence 263 from Patent WO2008131807
ATCAGTCCTA
>GM876803.1 Sequence 262 from Patent WO2008131807
AATCAGTCCT
>GM876802.1 Sequence 261 from Patent WO2008131807
CAATCAGTCC
>GM876801.1 Sequence 260 from Patent WO2008131807
ACAATCAGTC
>GM876800.1 Sequence 259 from Patent WO2008131807
CACAATCAGT
>GM876797.1 Sequence 256 from Patent WO2008131807
CCACAATCAG
>GM876794.1 Sequence 253 from Patent WO2008131807
TCAGTCCTAG
>GM719975.1 Sequence 10 from Patent EP1967592
ATCNNNNNAC
>GM719974.1 Sequence 9 from Patent EP1967592
ATCGGATGAC
>GM953056.1 Sequence 10 from Patent WO2008142034
TTGCTCTTCG
>GM953055.1 Sequence 9 from Patent WO2008142034
TTGCTCTTCC
>GM952192.1 Sequence 1 from Patent WO2008140615
AGAAAGGAGG
>GM952254.1 Sequence 41 from Patent WO2008139262
TTTTTGGGGG
>GM952245.1 Sequence 32 from Patent WO2008139262
TTTTTTTTTT
>GM951780.1 Sequence 62 from Patent WO2008138619
CCAAAACAAG
>GM951773.1 Sequence 55 from Patent WO2008138619
CTTCCAGCCA
>GM951769.1 Sequence 51 from Patent WO2008138619
CTGCAGTAAT
>GM951768.1 Sequence 50 from Patent WO2008138619
ACTTACAGAC
>GM951765.1 Sequence 47 from Patent WO2008138619
CTGCAGTAAT
>GM963823.1 Sequence 155 from Patent WO2008142411
ATAGAATAAA
>GM890031.1 Sequence 3 from Patent WO2008138835
NYNNATGYNN
>GM963483.1 Sequence 52 from Patent WO2008142509
TCGACGTCGT
>GM963451.1 Sequence 20 from Patent WO2008142509
ACGACGTCGT
>GM963449.1 Sequence 18 from Patent WO2008142509
TCGACGTCGT
>GM747626.1 Sequence 2 from Patent WO2008113983
AGGAAAGTAC
>GM747625.1 Sequence 1 from Patent WO2008113983
GGGAATTTCC
>GM746941.1 Sequence 49 from Patent WO2008113830
GCATTGGTAT
>GM746940.1 Sequence 48 from Patent WO2008113830
GCATTGGTAT
>GM746939.1 Sequence 47 from Patent WO2008113830
GCATTGGTAT
>GM007587.1 Sequence 393 from Patent WO2008045148
TGCACCATAG
>GM007586.1 Sequence 392 from Patent WO2008045148
AATTCTATGG
>GM006273.1 Sequence 34 from Patent WO2008040355
CGNCCNNNNN
>GM006257.1 Sequence 18 from Patent WO2008040355
ANNANNNNNN
>GM688687.1 Sequence 59 from Patent WO2008077956
CCAAGAAGCC
>FB984967.1 Sequence 1 from Patent WO2008036255
GCCRCCATGG
>FB754843.1 Sequence 1 from Patent WO2008017073
GAAGNNNNNN
>GM879257.1 Sequence 15 from Patent EP1992695
CGGCTCCTAG
>GM618736.1 Sequence 92 from Patent WO2008042338
AGCGGCCGCG
>GM842444.1 Sequence 11 from Patent WO2008124109
GGATATCCAG
>GM968170.1 Sequence 9 from Patent WO2008142521
TTCGGAGCTC
>GM968169.1 Sequence 8 from Patent WO2008142521
AAGCTTCGAG
>GM617861.1 Sequence 5 from Patent WO2008071721
GCCTCAGCCC
>GM879877.1 Sequence 8 from Patent EP1994942
CTAGACTCTG
>GM879876.1 Sequence 7 from Patent EP1994942
GATCCAGAGT
>GM731733.1 Sequence 10 from Patent WO2008057529
GGGGGCCCCC
>GM731732.1 Sequence 9 from Patent WO2008057529
CCCCCGGGGG
>GM615187.1 Sequence 1 from Patent WO2008071959
GTTGAACCTG
>GM878441.1 Sequence 105 from Patent EP1992635
TCGACGTCGA
>GM878237.1 Sequence 1 from Patent WO2008132310
TGCGTTCCAC
>GM721427.1 Sequence 11 from Patent EP1967586
CGGCTCCTAG
>AM891788.1 Nyctotherus ovalis GSS, clone HK1994, genomic survey sequence
TGNTAGAGCN
>CS727205.1 Sequence 107 from Patent WO2007103382
HMHDWTMGKK
>GM876726.1 Sequence 185 from Patent WO2008131807
AGAACCTTAC
>GM876725.1 Sequence 184 from Patent WO2008131807
CAGAACCTTA
>GM876724.1 Sequence 183 from Patent WO2008131807
GCAGAACCTT
>GM876723.1 Sequence 182 from Patent WO2008131807
AGCAGAACCT
>GM876722.1 Sequence 181 from Patent WO2008131807
GAGCAGAACC
>GM876721.1 Sequence 180 from Patent WO2008131807
AGAGCAGAAC
>GM876720.1 Sequence 179 from Patent WO2008131807
GAACCTTACT
>GM876718.1 Sequence 177 from Patent WO2008131807
TCACCTGGGT
>GM876717.1 Sequence 176 from Patent WO2008131807
TTCACCTGGG
>GM876716.1 Sequence 175 from Patent WO2008131807
TTTCACCTGG
>GM876715.1 Sequence 174 from Patent WO2008131807
TTTTCACCTG
>GM876714.1 Sequence 173 from Patent WO2008131807
CTTTTCACCT
>GM876709.1 Sequence 168 from Patent WO2008131807
ACTTTTCACC
>GM876706.1 Sequence 165 from Patent WO2008131807
CACCTGGGTC
>GM876702.1 Sequence 161 from Patent WO2008131807
CTAGAAAGAA
>GM876701.1 Sequence 160 from Patent WO2008131807
CCTAGAAAGA
>GM876700.1 Sequence 159 from Patent WO2008131807
TCCTAGAAAG
>GM876699.1 Sequence 158 from Patent WO2008131807
GTCCTAGAAA
>GM876698.1 Sequence 157 from Patent WO2008131807
AGTCCTAGAA
>GM876693.1 Sequence 152 from Patent WO2008131807
CAGTCCTAGA
>GM876690.1 Sequence 149 from Patent WO2008131807
TAGAAAGAAA
>GM876686.1 Sequence 145 from Patent WO2008131807
ATCAGTCCTA
>GM876685.1 Sequence 144 from Patent WO2008131807
AATCAGTCCT
>GM876684.1 Sequence 143 from Patent WO2008131807
CAATCAGTCC
>GM876683.1 Sequence 142 from Patent WO2008131807
ACAATCAGTC
>GM876682.1 Sequence 141 from Patent WO2008131807
CACAATCAGT
>GM876677.1 Sequence 136 from Patent WO2008131807
CCACAATCAG
>GM876674.1 Sequence 133 from Patent WO2008131807
TCAGTCCTAG
>GM010177.1 Sequence 69 from Patent WO2008051306
AGAACCTTAC
>GM010176.1 Sequence 68 from Patent WO2008051306
CAGAACCTTA
>GM010175.1 Sequence 67 from Patent WO2008051306
GCAGAACCTT
>GM010174.1 Sequence 66 from Patent WO2008051306
AGCAGAACCT
>GM010173.1 Sequence 65 from Patent WO2008051306
GAGCAGAACC
>GM010172.1 Sequence 64 from Patent WO2008051306
AGAGCAGAAC
>GM010171.1 Sequence 63 from Patent WO2008051306
GAACCTTACT
>GM010169.1 Sequence 61 from Patent WO2008051306
TCACCTGGGT
>GM010168.1 Sequence 60 from Patent WO2008051306
TTCACCTGGG
>GM010167.1 Sequence 59 from Patent WO2008051306
TTTCACCTGG
>GM010166.1 Sequence 58 from Patent WO2008051306
TTTTCACCTG
>GM010165.1 Sequence 57 from Patent WO2008051306
CTTTTCACCT
>GM010160.1 Sequence 52 from Patent WO2008051306
ACTTTTCACC
>GM010157.1 Sequence 49 from Patent WO2008051306
CACCTGGGTC
>GM010153.1 Sequence 45 from Patent WO2008051306
CTAGAAAGAA
>GM010152.1 Sequence 44 from Patent WO2008051306
CCTAGAAAGA
>GM010151.1 Sequence 43 from Patent WO2008051306
TCCTAGAAAG
>GM010150.1 Sequence 42 from Patent WO2008051306
GTCCTAGAAA
>GM010149.1 Sequence 41 from Patent WO2008051306
AGTCCTAGAA
>GM010144.1 Sequence 36 from Patent WO2008051306
CAGTCCTAGA
>GM010141.1 Sequence 33 from Patent WO2008051306
TAGAAAGAAA
>GM010137.1 Sequence 29 from Patent WO2008051306
ATCAGTCCTA
>GM010136.1 Sequence 28 from Patent WO2008051306
AATCAGTCCT
>GM010135.1 Sequence 27 from Patent WO2008051306
CAATCAGTCC
>GM010134.1 Sequence 26 from Patent WO2008051306
ACAATCAGTC
>GM010133.1 Sequence 25 from Patent WO2008051306
CACAATCAGT
>GM010128.1 Sequence 20 from Patent WO2008051306
CCACAATCAG
>GM010125.1 Sequence 17 from Patent WO2008051306
TCAGTCCTAG
>GM006634.1 Sequence 57 from Patent WO2008049078
CTTCGGAGTT
>GM006627.1 Sequence 50 from Patent WO2008049078
CTTCGGAGTT
>GM006619.1 Sequence 42 from Patent WO2008049078
GGATCTTATT
>GM006610.1 Sequence 33 from Patent WO2008049078
CTACACAAAT
>GM006605.1 Sequence 28 from Patent WO2008049078
AGCGATTTTT
>GM006598.1 Sequence 21 from Patent WO2008049078
GGATCTTATT
>GM006587.1 Sequence 10 from Patent WO2008049078
CTTCGGAGTT
>FB754774.1 Sequence 8 from Patent WO2008027452
AAATTCCCGG
>FB712212.1 Sequence 54 from Patent WO2007134907
AGTTTAAAAG
>GM878561.1 Sequence 225 from Patent EP1992635
NNNNCGNNNN
>GM878560.1 Sequence 224 from Patent EP1992635
NNNCGNNNCG
>GM878559.1 Sequence 223 from Patent EP1992635
CGNNNNCGCG
>GM878557.1 Sequence 221 from Patent EP1992635
NNNCGCGNNN
>GM878556.1 Sequence 220 from Patent EP1992635
NNCGCGNNCG
>GM878552.1 Sequence 216 from Patent EP1992635
NNCGNNCGNN
>GM839491.1 Sequence 2 from Patent WO2008120027
GCGAATTCCG
>GM839490.1 Sequence 1 from Patent WO2008120027
CGGGATCCGC
>FB753435.1 Sequence 18 from Patent WO2007038720
TTTTTTTTTT
>FB746793.1 Sequence 260 from Patent EP1903111
TCCGGAAGCC
>FB746785.1 Sequence 252 from Patent EP1903111
AGCATCTGCC
>FB746779.1 Sequence 246 from Patent EP1903111
TGGGAATTCC
>FB746775.1 Sequence 242 from Patent EP1903111
ACCATCTGTT
>FB746767.1 Sequence 234 from Patent EP1903111
CCCAACTGAC
>GM668474.1 Sequence 5 from Patent WO2008076414
TACAGCTGTA
>GM604002.1 Sequence 248 from Patent WO2008066752
TAGCGGATGC
>GM668577.1 Sequence 4 from Patent WO2008058282
NNNCATGNNN
>GM603529.1 Sequence 13 from Patent WO2008068024
GCTAGCAGAC
>GM603528.1 Sequence 12 from Patent WO2008068024
CACCCTCAAT
>GM603527.1 Sequence 11 from Patent WO2008068024
CATGGCTAGC
>FB723100.1 Sequence 22 from Patent EP1895007
ATTCCTCCAC
>FB723099.1 Sequence 21 from Patent EP1895007
TAAGGAGGTG
>FB721895.1 Sequence 4 from Patent WO2008001054
GAANNNNTTC
>FB718231.1 Sequence 40 from Patent WO2007139982
ATCTAGATAA
>FB718230.1 Sequence 39 from Patent WO2007139982
ATCCTGATAA
>FB706501.1 Sequence 55 from Patent WO2007127461
CTCTTCAGAA
>FB702527.1 Sequence 71 from Patent WO2007107162
GCAGGTTCTT
>FB702526.1 Sequence 70 from Patent WO2007107162
TTTCTGAGCT
>FB702524.1 Sequence 68 from Patent WO2007107162
GCAGGTTCTT
>FB702523.1 Sequence 67 from Patent WO2007107162
TTTCTGAGCT
>FB702520.1 Sequence 64 from Patent WO2007107162
GCATTCGTCC
>FB702514.1 Sequence 58 from Patent WO2007107162
AGGTGTATGG
>FB702512.1 Sequence 56 from Patent WO2007107162
TGAATACAAT
>FB702509.1 Sequence 53 from Patent WO2007107162
TGAATACAAT
>FB702483.1 Sequence 27 from Patent WO2007107162
GACGTAAACG
>FB702478.1 Sequence 22 from Patent WO2007107162
GACGTAAACG
>FB702476.1 Sequence 20 from Patent WO2007107162
GACGTAAACG
>FB702470.1 Sequence 14 from Patent WO2007107162
GACGTAAACG
>FB702463.1 Sequence 7 from Patent WO2007107162
GACGTAAACG
>FB677497.1 Sequence 20 from Patent WO2007121489
TCTGTSTCGT
>GM720959.1 Sequence 74 from Patent EP1967594
CGCCGTCCCG
>GM682008.1 Sequence 58 from Patent EP1950296
GAGCGTTCTC
>GM597252.1 Sequence 59 from Patent EP1935428
CCAAGAAGCC
>GM668900.1 Sequence 24 from Patent WO2008073661
CGNNNNCGCG
>GM668897.1 Sequence 21 from Patent WO2008073661
NNNCGCGNNN
>GM668895.1 Sequence 19 from Patent WO2008073661
NNCGCGNNCG
>GM668888.1 Sequence 12 from Patent WO2008073661
NNCGNNCGNN
>GM668883.1 Sequence 7 from Patent WO2008073661
NNNNCGNNNN
>GM668881.1 Sequence 5 from Patent WO2008073661
NNNCGNNNCG
>GC675722.1 Sequence 60 from patent US 7453023
GTAGGTAGAC
>GC675466.1 Sequence 64 from patent US 7452986
ATAGAATNAA
>GC675086.1 Sequence 4 from patent US 7452730
TATGTANATG
>GC675085.1 Sequence 3 from patent US 7452730
CATNTACATA
>GC674017.1 Sequence 16 from patent US 7449565
TTCCAGTGGC
>GC674014.1 Sequence 13 from patent US 7449565
TCTGTCTGTT
>GC673085.1 Sequence 2999 from patent US 7449548
GATCCTCGGC
>GC673061.1 Sequence 7 from patent US 7449335
TTTTTANTTT
>GC669408.1 Sequence 20 from patent US 7446243
AGCCTGACGC
>GC669407.1 Sequence 19 from patent US 7446243
CATCCCGAAC
>GC669406.1 Sequence 18 from patent US 7446243
TTGTCTCAGG
>GC669405.1 Sequence 17 from patent US 7446243
AGGATACGTG
>GC669404.1 Sequence 16 from patent US 7446243
GTGCAATGAG
>GC669403.1 Sequence 15 from patent US 7446243
CTATCGCCGC
>GC669402.1 Sequence 14 from patent US 7446243
CACCCTGCGC
>GC669401.1 Sequence 13 from patent US 7446243
GCACGCCGGA
>GC669400.1 Sequence 12 from patent US 7446243
GTCCTTAGCG
>GC669399.1 Sequence 11 from patent US 7446243
GTCCTACTCG
>GC669398.1 Sequence 10 from patent US 7446243
GGACTCCACG
>GC669397.1 Sequence 9 from patent US 7446243
GGATCTGAAC
>GC669396.1 Sequence 8 from patent US 7446243
AAGATAGCGG
>GC669395.1 Sequence 7 from patent US 7446243
CCAAGCTTGC
>GC669394.1 Sequence 6 from patent US 7446243
CCCTGCAGGC
>GC669393.1 Sequence 5 from patent US 7446243
GCGAATTCCG
>GC669392.1 Sequence 4 from patent US 7446243
CGGGATCCGC
>GC669391.1 Sequence 3 from patent US 7446243
AACGTACGCG
>GC669390.1 Sequence 2 from patent US 7446243
TGCGCGATCG
>GC669389.1 Sequence 1 from patent US 7446243
AAATCGGAGC
>GC668511.1 Sequence 22 from patent US 7445896
TCGGTCCGCG
>GC668510.1 Sequence 21 from patent US 7445896
TCGAGCTCTG
>GC668509.1 Sequence 20 from patent US 7445896
CCGGTCCGTG
>GC668508.1 Sequence 19 from patent US 7445896
CCGGTCCCCG
>GC668507.1 Sequence 18 from patent US 7445896
TACGTTCGCG
>GC668506.1 Sequence 17 from patent US 7445896
TAGGTCCGCA
>GC668505.1 Sequence 16 from patent US 7445896
TCGGTCCGCA
>GC668504.1 Sequence 15 from patent US 7445896
CCGAGCTCTG
>GC668503.1 Sequence 14 from patent US 7445896
CCGATCTCTG
>GC667979.1 Sequence 86 from patent US 7442786
CCCACCTACC
>GC667792.1 Sequence 40 from patent US 7442782
TGTCTGCCTG
>GC667757.1 Sequence 5 from patent US 7442782
TGTCTGCCTG
>GC663871.1 Sequence 713 from patent US 7442506
TACCGCATAA
>GC663870.1 Sequence 712 from patent US 7442506
TACCGCATAT
>GC662804.1 Sequence 46 from patent US 7442160
GCGNNNNCCG
>GC662803.1 Sequence 45 from patent US 7442160
CCGNNNNGCC
>GC662802.1 Sequence 44 from patent US 7442160
GCCNNNNCGC
>GC662790.1 Sequence 32 from patent US 7442160
CCCGAGTCGA
>GC662786.1 Sequence 28 from patent US 7442160
AATTCGTACC
>GC662782.1 Sequence 24 from patent US 7442160
TCGTATTCCA
>GC662781.1 Sequence 23 from patent US 7442160
AATTCGTACC
>GC662777.1 Sequence 19 from patent US 7442160
TCACCTAGCA
>GC662776.1 Sequence 18 from patent US 7442160
AATTCGTACC
>GC662775.1 Sequence 17 from patent US 7442160
TCCCGAGTCG
>GC662770.1 Sequence 12 from patent US 7442160
ATTCGTACCA
>GC662767.1 Sequence 9 from patent US 7442160
AATTCTTACC
>GC662766.1 Sequence 8 from patent US 7442160
AAATCTTCCC
>GC661928.1 Sequence 3 from patent US 7439060
GTACTAGTTA
>GC660678.1 Sequence 74 from patent US 7439016
CGCCGTCCCG
>GC660036.1 Sequence 20 from patent US 7435877
AGCCTGACGC
>GC660035.1 Sequence 19 from patent US 7435877
GGACTCCACG
>GC660034.1 Sequence 18 from patent US 7435877
CATCCCGAAC
>GC660033.1 Sequence 17 from patent US 7435877
TTGTCTCAGG
>GC660032.1 Sequence 16 from patent US 7435877
GGATCTGAAC
>GC660031.1 Sequence 15 from patent US 7435877
AAGATAGCGG
>GC660030.1 Sequence 14 from patent US 7435877
AGGATACGTG
>GC660029.1 Sequence 13 from patent US 7435877
GTGCAATGAG
>GC660028.1 Sequence 12 from patent US 7435877
CCAAGCTTGC
>GC660027.1 Sequence 11 from patent US 7435877
CCCTGCAGGC
>GC660026.1 Sequence 10 from patent US 7435877
GCGAATTCCG
>GC660025.1 Sequence 9 from patent US 7435877
CGGGATCCGC
>GC660024.1 Sequence 8 from patent US 7435877
CTATCGCCGC
>GC660023.1 Sequence 7 from patent US 7435877
CACCCTGCGC
>GC660022.1 Sequence 6 from patent US 7435877
GCACGCCGGA
>GC660021.1 Sequence 5 from patent US 7435877
AACGTACGCG
>GC660020.1 Sequence 4 from patent US 7435877
TGCGCGATCG
>GC660019.1 Sequence 3 from patent US 7435877
GTCCTTAGCG
>GC660018.1 Sequence 2 from patent US 7435877
GTCCTACTCG
>GC660017.1 Sequence 1 from patent US 7435877
AAATCGGAGC
>GC659505.1 Sequence 64 from patent US 7435794
GCCCTATAGT
>GC659502.1 Sequence 61 from patent US 7435794
AGCGAGCACT
>GC659498.1 Sequence 54 from patent US 7435794
GCTCGCTGAG
>GC659497.1 Sequence 53 from patent US 7435794
GCCCTGTAGT
>GC659492.1 Sequence 48 from patent US 7435794
CGTGTGCGGC
>GC659491.1 Sequence 47 from patent US 7435794
CGTGCGCGGC
>GC659488.1 Sequence 44 from patent US 7435794
AGGCAAGGAA
>GC659487.1 Sequence 43 from patent US 7435794
AGGCAAGGAA
>GC659486.1 Sequence 42 from patent US 7435794
AGGCGAGGAA
>GC659483.1 Sequence 39 from patent US 7435794
TCGACTCCCG
>GC659482.1 Sequence 38 from patent US 7435794
TCGGCTCCCG
>GC659481.1 Sequence 37 from patent US 7435794
GCTTGCTGAG
>GC659480.1 Sequence 36 from patent US 7435794
GCTCGCTGAG
>GC659479.1 Sequence 35 from patent US 7435794
TGGACAGTGC
>GC659478.1 Sequence 34 from patent US 7435794
TGGGCAGTGC
>GC659471.1 Sequence 27 from patent US 7435794
GTGAGCTACA
>GC659470.1 Sequence 26 from patent US 7435794
GCCCTATAGT
>GC659469.1 Sequence 25 from patent US 7435794
GCCCTGTAGT
>GC659237.1 Sequence 24 from patent US 7435572
AACCGGCGAN
>GC657843.1 Sequence 16 from patent US 7432346
GATCCTCGGC
>GC596538.1 Sequence 426 from patent US 7432048
GCGCCGAGGC
>GC596536.1 Sequence 424 from patent US 7432048
GCGCCGAGGT
>GC596019.1 Sequence 2 from patent US 7430475
TGGGCGGCTA
>GC594057.1 Sequence 51 from patent US 7429455
TCAGACAGCG
>GC594056.1 Sequence 50 from patent US 7429455
ACCAGAGAGC
>GC592610.1 Sequence 4 from patent US 7427679
CCCCCCCCCT
>GC592609.1 Sequence 3 from patent US 7427679
CTCTCTCTCT
>GC592608.1 Sequence 2 from patent US 7427679
AAAAAAAAAT
>GC592607.1 Sequence 1 from patent US 7427679
ATATATATAT
>GC592491.1 Sequence 34 from patent US 7427672
TTTTTTTTNT
>GC592479.1 Sequence 22 from patent US 7427672
TTTTTTTTNT
>GC592469.1 Sequence 12 from patent US 7427672
TTTTTTTTNT
>GC591016.1 Sequence 12 from patent US 7427405
TCNAACNTTC
>GC590903.1 Sequence 5 from patent US 7427397
ACGCAGGCAC
>GC590900.1 Sequence 2 from patent US 7427397
TGGGCGTCAA
>GC590899.1 Sequence 1 from patent US 7427397
GGCATGACCT
>GC588156.1 Sequence 70 from patent US 7425612
CCCGGGATGA
>GC584157.1 Sequence 45 from patent US 7425436
GCCACCATGG
>GC561911.1 Sequence 33 from patent US 7419828
AAAAAAAAAA
>GC560530.1 Sequence 4 from patent US 7417139
CCCCCCCCCT
>GC560529.1 Sequence 3 from patent US 7417139
CTCTCTCTCT
>GC560528.1 Sequence 2 from patent US 7417139
AAAAAAAAAT
>GC560527.1 Sequence 1 from patent US 7417139
ATATATATAT
>GC559151.1 Sequence 22 from patent US 7416866
AGGAAGGGCT
>GC555811.1 Sequence 844 from patent US 7416849
GGCACCTGCC
>GC555807.1 Sequence 840 from patent US 7416849
GTGTGATGTT
>GC555806.1 Sequence 839 from patent US 7416849
CGCCATTGCC
>GC555805.1 Sequence 838 from patent US 7416849
GCCCAGTCAC
>GC555784.1 Sequence 817 from patent US 7416849
CGGCCACTGC
>GC555781.1 Sequence 814 from patent US 7416849
CGGACTGTGA
>GC555780.1 Sequence 813 from patent US 7416849
GACTCGCATC
>GC555777.1 Sequence 810 from patent US 7416849
GGACACTGTT
>GC555771.1 Sequence 804 from patent US 7416849
GTGAGACGCC
>GC555770.1 Sequence 803 from patent US 7416849
AGACCTACCT
>GC551912.1 Sequence 1 from patent US 7414055
CTGCGGCCGC
>GC551069.1 Sequence 19377 from patent US 7413875
TCCGGAAGCC
>GC551062.1 Sequence 19366 from patent US 7413875
AGCATCTGCC
>GC551056.1 Sequence 19350 from patent US 7413875
TGGGAATTCC
>GC551052.1 Sequence 19346 from patent US 7413875
ACCATCTGTT
>GC551044.1 Sequence 19337 from patent US 7413875
CCCAACTGAC
>GC535362.1 Sequence 537 from patent US 7413864
TAGGGATTAG
>GC535352.1 Sequence 527 from patent US 7413864
TTAGGGTTAG
>GC535172.1 Sequence 105 from patent US 7413864
GGGRHTYYHC
>GC690464.1 Sequence 65 from patent US 7459546
MAMMATGNHS
>GC690345.1 Sequence 2590 from patent US 7459539
GATCCTCGGC
>GC689324.1 Sequence 20 from patent US 7459172
GAGTCNNNNN
>GC689319.1 Sequence 15 from patent US 7459172
AAGGGAGGAG
>GC689318.1 Sequence 14 from patent US 7459172
CGCGCTGGAC
>GC689102.1 Sequence 162 from patent US 7462758
ATAGAATAAA
>GC687090.1 Sequence 57 from patent US 7456336
GTCGACGAGG
>GC687024.1 Sequence 11 from patent US 7456334
AATAAAYAAA
>GC686998.1 Sequence 1 from patent US 7456309
TTTTTTTTTT
>GC686996.1 Sequence 22 from patent US 7456294
GAACTGAAGT
>GC686995.1 Sequence 21 from patent US 7456294
CTTGACTTCA
>GC686992.1 Sequence 18 from patent US 7456294
GTTCAGTCTC
>GC686991.1 Sequence 17 from patent US 7456294
CAAGTCAGAG
>GC686976.1 Sequence 2 from patent US 7456294
CTCTGACTTG
>GC686975.1 Sequence 1 from patent US 7456294
CAAGTCAGAG
>GC686949.1 Sequence 5 from patent US 7456274
CCAAACTTGG
>GC686925.1 Sequence 91 from patent US 7456273
AATGGCTCAT
>GC686924.1 Sequence 90 from patent US 7456273
ACGAGCCATT
>GC686384.1 Sequence 25 from patent US 7456015
GCCRCCATGG
>GC685958.1 Sequence 24 from patent US 7455991
GGCCCGTCCA
>GC685356.1 Sequence 9267 from patent US 7455965
CACACACACA
>DL260367.1 HCV NON-STRUCTURAL PROTEIN MUTANTS AND USES THEREOF
ACAAAACAAA
>DL257839.1 Nucleic Acids and Corresponding Proteins Entitled 58P1D12 Useful in Treatment and Detection of Cancer
GATCCTCGGC
>DL257722.1 Antibodies and Molecules Derived therefrom that Bind to STEAP-1 Proteins
GATCCTCGGC
>DL257047.1 AN ULTRA HIGH-THROUGHPUT OPTI-NANOPORE DNA READOUT PLATFORM
GCCGCCCGTT
>DL257046.1 AN ULTRA HIGH-THROUGHPUT OPTI-NANOPORE DNA READOUT PLATFORM
CGGCGGGCAA
>DL257045.1 AN ULTRA HIGH-THROUGHPUT OPTI-NANOPORE DNA READOUT PLATFORM
TAAATAATCC
>DL257044.1 AN ULTRA HIGH-THROUGHPUT OPTI-NANOPORE DNA READOUT PLATFORM
ATTTATTAGG
>DL256382.1 Methods of Diagnosis
CACACACATG
>DL241641.1 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE B2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS
ACCACGGACA
>DL241640.1 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE B2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS
ACCACTTACA
>DL241993.1 Nucleic acid nanoelectronics using nucleic acid nanoblocks
TAAAAACTCG
>DL241853.1 Method of regenerating blood cells from gene transferred hematopoietic cells
AGGGTGAAAG
>DL241852.1 Method of regenerating blood cells from gene transferred hematopoietic cells
AGGGTGAATG
>DL241851.1 Method of regenerating blood cells from gene transferred hematopoietic cells
AGGGTCAAAG
>DL241850.1 Method of regenerating blood cells from gene transferred hematopoietic cells
TCCCACTTTC
>DL241849.1 Method of regenerating blood cells from gene transferred hematopoietic cells
TCCCACTTAC
>DL241848.1 Method of regenerating blood cells from gene transferred hematopoietic cells
TCCCAGTTTC
>DL241847.1 Method of regenerating blood cells from gene transferred hematopoietic cells
TCCCWVTTWC
>DL240758.1 PCA2501 GENE
CTGATCCATG
>FB749198.1 Sequence 38 from Patent WO2008015447
AAGGAGGTGA
>FB748856.1 Sequence 19 from Patent WO2007016507
AAGCCGAATT
>FB748126.1 Sequence 5 from Patent EP1903117
GTCTTTGCTT
>FB748125.1 Sequence 4 from Patent EP1903117
TCGTCTCTGT
>FB748124.1 Sequence 3 from Patent EP1903117
TCGTTTCTGT
>FB748123.1 Sequence 2 from Patent EP1903117
TCTCTGCTTT
>DL236118.1 Methods for Placing, Accepting, and Filling Orders for Products and Services
CAGCTCCTGC
>DL236117.1 Methods for Placing, Accepting, and Filling Orders for Products and Services
AGATAGGCAG
>DL233754.1 BIOLOCICAL DISCOVERY USING GENE REGULATORY NETWORKS GENERATED FROM MULTIPLE-DISRUPTION EXPRESSION LIBRARIES
TGGGCGGCTA
>DL233627.1 Random integration of a polynucleotide by in vivo linearization
GGGTAATATA
>DL233469.1 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER
GATCCTCGGC
>DL231815.1 Synthesis of Glycoproteins Using Bacterial Glycosyltransferases
GAGCCAGTTA
>DL231800.1 Synthesis of Glycoproteins Using Bacterial Glycosyltransferases
TCGTCTTTGG
>DL207347.1 Probe for analysis of nucleic acids
GTCGACCGCT
>DL207342.1 Probe for analysis of nucleic acids
TTTTCTTCTT
>DL207335.1 Probe for analysis of nucleic acids
TTCTTCTTTT
>DL205691.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
CCTGTAATCC
>DL205690.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
GTGGCCCACG
>DL205689.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
GGCACCTCAG
>DL205688.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
CTATAGCATA
>DL205687.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
CGAATGTCCT
>DL205686.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
TGGAAGCACT
>DL205685.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
TGTTCTGGAG
>DL205684.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
GTGGCCACGG
>DL205683.1 PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
GAGCAGCGCC
>DL205663.1 FUSED QUINOXALINE DERIVATIVES AS INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DL213322.1 PREVENTION AND REDUCTION OF BLOOD LOSS
GACGTACGTC
>DL213270.1 EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS USING NICKING AGENTS
NNNNNGATCC
>DL213269.1 EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS USING NICKING AGENTS
GGATCNNNNN
>DL213268.1 EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS USING NICKING AGENTS
NNNNNGACTC
>DL213267.1 EXPONENTIAL AMPLIFICATION OF NUCLEIC ACIDS USING NICKING AGENTS
GAGTCNNNNN
>DL210129.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGAAACCCCG
>DL210127.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGGGATTCCA
>DL210125.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGGACTCTCC
>DL210120.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGAAATATTG
>DL210119.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGAAACCCCG
>DL210118.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
ATCGATTCCA
>DL210117.1 IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
GGGGATTCCA
>DL227045.1 Method and Apparatus for Biological Sequence Data Processing
ACAAACCCTT
>DL204153.1 Mitochondrial Biology Expression Arrays
TCGACTATCC
>DL227059.1 Method and Apparatus for Biological Sequence Data Processing
ACAAACCCTT
>DL230234.1 NON-STOCHASTIC GENERATION OF GENETIC VACCINES AND ENZYMES
GAGTCNNNNN
>DL230171.1 Novel full length cDNA
TTAAGTGGTT
>DL230162.1 Novel full length cDNA
TGCGTGGGCG
>DL230160.1 Novel full length cDNA
GGGGGGGGGG
>DL230158.1 Novel full length cDNA
CCAGATAAGG
>DL230156.1 Novel full length cDNA
TGAACTTTGA
>DL230146.1 Novel full length cDNA
GTCACGTGGT
>DL230143.1 Novel full length cDNA
AACAGATGGT
>DL213614.1 Probiotic propionibacterium
ACGCAGGCAC
>DL213611.1 Probiotic propionibacterium
TGGGCGTCAA
>DL213610.1 Probiotic propionibacterium
GGCATGACCT
>DL206109.1 HUMAN GROWTH GENE AND SHORT STATURE GENE REGION
TGTTACGTGG
>DL206108.1 HUMAN GROWTH GENE AND SHORT STATURE GENE REGION
AAAAAATAGC
>DL206098.1 HUMAN GROWTH GENE AND SHORT STATURE GENE REGION
GTGATCCACC
>DL220674.1 NON-SEQUENCE COMPLEMENTARY ANTIVIRAL OLIGONUCLEOTIDES
CCCCCATGGA
>DL220671.1 NON-SEQUENCE COMPLEMENTARY ANTIVIRAL OLIGONUCLEOTIDES
TCCGAAGACG
>DL220653.1 Abasic Site Endonuclease Assay
NGTCCTTGCN
>DL220649.1 Abasic Site Endonuclease Assay
CCGCCACATT
>DL220599.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATAACAACC
>DL220598.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATAAGAACC
>DL220597.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATAAAAACC
>DL220596.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATCATAACC
>DL220595.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATGATAACC
>DL220594.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATTATAACC
>DL220593.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AATAATAACC
>DL220592.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCACTGACT
>DL220591.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCATTGACT
>DL220590.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCAATGACT
>DL220589.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCAGCGACT
>DL220588.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCAGGGACT
>DL220587.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCAGAGACT
>DL220586.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCCGTGACT
>DL220585.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCGGTGACT
>DL220584.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCTGTGACT
>DL220583.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
AGCTGTGACT
>DL220564.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
GTAATAATAA
>DL220563.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
CCAATAATAA
>DL220562.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
ACAATGATAA
>DL220561.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
TCAATGACAG
>DL220560.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
TCAGTGACAA
>DL220559.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
TCAGTGACGA
>DL220558.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
ACAGCGACGT
>DL220557.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
ACAGCGGCGT
>DL220556.1 Systems and Methods for Predicting Oligonucleotide Melting Temperatures (T-ms)
TCGGCGGCGT
>DL203970.1 Mitochondrial Biology Expression Arrays
TCGACTATCC
>FB719505.1 Sequence 980 from Patent WO2007137973
TTGCTCTTCG
>FB719504.1 Sequence 979 from Patent WO2007137973
TTGCTCTTCC
>FB714114.1 Sequence 3 from Patent WO2007134869
CACCCCTTCT
>FB713676.1 Sequence 2 from Patent WO2007137586
TGCGGCCGCA
>FB708089.1 Sequence 4 from Patent WO2007131776
AGCGGCCGCT
>FB708088.1 Sequence 3 from Patent WO2007131776
AGCGGCCGCG
>FB708087.1 Sequence 2 from Patent WO2007131776
AGCGGCCGCC
>FB708086.1 Sequence 1 from Patent WO2007131776
AGCGGCCGCA
>FB673933.1 Sequence 1557 from Patent WO2007146511
AGCCACCAAC
>FB667275.1 Sequence 1 from Patent WO2007144150
GACGATCGTC
>FB675515.1 Sequence 50 from Patent WO2006138666
GACTACTAGG
>FB675514.1 Sequence 49 from Patent WO2006138666
AGAGCCTAGT
>FB675509.1 Sequence 44 from Patent WO2006138666
GACTGCTAGG
>FB675508.1 Sequence 43 from Patent WO2006138666
TCAGCCTAGT
>FB675503.1 Sequence 38 from Patent WO2006138666
GAGAAAGGCA
>FB675502.1 Sequence 37 from Patent WO2006138666
TGACTGCCTT
>FB675497.1 Sequence 32 from Patent WO2006138666
GAGAAAGGCA
>FB675496.1 Sequence 31 from Patent WO2006138666
ACACTGCCTT
>FB675491.1 Sequence 26 from Patent WO2006138666
CACAATCGCA
>FB675490.1 Sequence 25 from Patent WO2006138666
ACTGTGCGAT
>FB701738.1 Sequence 3 from Patent EP1882747
TTACTACTCG
>FB701737.1 Sequence 2 from Patent EP1882747
CGATCAACAT
>FB707071.1 Sequence 22 from Patent WO2007023390
TCNNGGTACA
>FB707070.1 Sequence 21 from Patent WO2007023390
CTAAGGTCAA
>FB707069.1 Sequence 20 from Patent WO2007023390
TCAANNTACA
>FB707068.1 Sequence 19 from Patent WO2007023390
CTAANNTCAA
>FB707064.1 Sequence 15 from Patent WO2007023390
TGTANNTTGA
>FB707063.1 Sequence 14 from Patent WO2007023390
TTGANNTTAG
>FB707060.1 Sequence 11 from Patent WO2007023390
TGTACCTTGA
>FB707059.1 Sequence 10 from Patent WO2007023390
TCAAGGTACA
>FB707056.1 Sequence 7 from Patent WO2007023390
TCNNNNTACA
>FB707050.1 Sequence 1 from Patent WO2007023390
TCNNNNTACA
>FB707065.1 Sequence 16 from Patent WO2007023390
NGNNNNTTGN
>FB707051.1 Sequence 2 from Patent WO2007023390
NGNNNNTTGN
>FB702672.1 Sequence 11 from Patent WO2007015168
TCAAGGTACA
>FB702670.1 Sequence 9 from Patent WO2007015168
TCNNNNTACA
>FB702665.1 Sequence 4 from Patent WO2007015168
NGNNNNTTGN
>FB702664.1 Sequence 3 from Patent WO2007015168
TCNNNNTACA
>FB702662.1 Sequence 1 from Patent WO2007015168
TGTACCTTGA
>FB581933.1 Sequence 58 from Patent WO2006102342
AGCGGCCGCG
>FB580716.1 Sequence 23 from Patent EP1852186
TCACCCCACT
>FB580714.1 Sequence 21 from Patent EP1852186
GGGGCGGGGC
>FB580708.1 Sequence 15 from Patent EP1852186
TGATNNATKR
>FB580706.1 Sequence 13 from Patent EP1852186
GGGRNNYYCC
>FB655052.1 Sequence 103 from Patent EP1876241
CTTCAACCTC
>FB655051.1 Sequence 102 from Patent EP1876241
AAGAGGGTAC
>FB655050.1 Sequence 101 from Patent EP1876241
TCTGTCCACA
>FB655049.1 Sequence 100 from Patent EP1876241
CTATCCATGG
>FB655048.1 Sequence 99 from Patent EP1876241
AGTCTATGCG
>FB655047.1 Sequence 98 from Patent EP1876241
GGTACTAAGG
>FB655046.1 Sequence 97 from Patent EP1876241
TCGATACAGG
>FB655045.1 Sequence 96 from Patent EP1876241
GGAACCAATC
>FB655044.1 Sequence 95 from Patent EP1876241
TTTTGGCTCC
>FB655043.1 Sequence 94 from Patent EP1876241
CTTTCTACCC
>FB655042.1 Sequence 93 from Patent EP1876241
TGGATTGGTC
>FB655041.1 Sequence 92 from Patent EP1876241
TACAACGAGG
>FB655040.1 Sequence 91 from Patent EP1876241
TCGGTCATAG
>FB655039.1 Sequence 90 from Patent EP1876241
TGGTAAAGGG
>FB655037.1 Sequence 88 from Patent EP1876241
AGTAGTTGCC
>FB655036.1 Sequence 87 from Patent EP1876241
CTCCTAGGCT
>FB654935.1 Sequence 4 from Patent EP1875922
GGGCGGCCGC
>FB665784.1 Sequence 22 from Patent WO2007026252
TCNNGGTACA
>FB665783.1 Sequence 21 from Patent WO2007026252
CTAAGGTCAA
>FB665782.1 Sequence 20 from Patent WO2007026252
TCAANNTACA
>FB665781.1 Sequence 19 from Patent WO2007026252
CTAANNTCAA
>FB665777.1 Sequence 15 from Patent WO2007026252
TGTANNTTGA
>FB665776.1 Sequence 14 from Patent WO2007026252
TTGANNTTAG
>FB665773.1 Sequence 11 from Patent WO2007026252
TGTACCTTGA
>FB665772.1 Sequence 10 from Patent WO2007026252
TCAAGGTACA
>FB665769.1 Sequence 7 from Patent WO2007026252
TCNNNNTACA
>FB665763.1 Sequence 1 from Patent WO2007026252
TCNNNNTACA
>FB665778.1 Sequence 16 from Patent WO2007026252
NGNNNNTTGN
>FB665764.1 Sequence 2 from Patent WO2007026252
NGNNNNTTGN
>FB584267.1 Sequence 16 from Patent EP1870417
AAAAAAAAAA
>FB579896.1 Sequence 44 from Patent WO2006103211
TNACATTNNT
>FB579895.1 Sequence 43 from Patent WO2006103211
TNACATGNNT
>FB579887.1 Sequence 35 from Patent WO2006103211
ATTAANANNA
>DL193222.1 METHODS AND COMPOSITIONS FOR INDUCING INNATE IMMUNE RESPONSES
GGGGGCCCCC
>DL193221.1 METHODS AND COMPOSITIONS FOR INDUCING INNATE IMMUNE RESPONSES
CCCCCGGGGG
>DL193216.1 METHODS AND COMPOSITIONS FOR INDUCING INNATE IMMUNE RESPONSES
TCNTNNCGNN
>DL192783.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GTGCTGGAGC
>DL192633.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
CTCCGCGGCA
>DL192577.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GTGAACTTAC
>DL192506.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
CCAAACCCAA
>DL191992.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GTGCTGGAGC
>DL201521.1 Covalent Tethering of Functional Groups to Proteins and Substrates Therefor
GCCACCATGG
>DL196303.1 NOTCH Mutations Leading to Increased Receptor Signaling
TCCTCACCCC
>DL196302.1 NOTCH Mutations Leading to Increased Receptor Signaling
GTCCCCTGAC
>DL193945.1 METHODS AND COMPOSITIONS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
GGGGGCCCCC
>DL193944.1 METHODS AND COMPOSITIONS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
CCCCCGGGGG
>DL193695.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TACGGAACGA
>DL193694.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TCGCCCCCGA
>DL193692.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
CGGAAGCCGA
>DL193691.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCGATGAT
>DL193690.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCGGGGGCT
>DL193688.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCCAAAGG
>DL193686.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCGGGGGCT
>DL193682.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
TCGCCCCCGA
>DL183334.1 Discrimination methods and materials for Angelica acutiloba
GATCAATCGC
>DL193663.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCACTCTTC
>FB513957.1 Sequence 6 from Patent EP1829891
ACAAAACAAA
>FB511849.1 Sequence 329 from Patent WO2006116458
TTGTGGGTCA
>FB511848.1 Sequence 328 from Patent WO2006116458
GGGGGTTTTT
>FB511847.1 Sequence 327 from Patent WO2006116458
TTTTTGGGGG
>FB511846.1 Sequence 326 from Patent WO2006116458
TTTTTTTTTT
>FB511845.1 Sequence 325 from Patent WO2006116458
AATCTTAGCT
>FB511844.1 Sequence 324 from Patent WO2006116458
CCTGCTTTTG
>FB511843.1 Sequence 323 from Patent WO2006116458
CGCTTCTGCT
>FB511842.1 Sequence 322 from Patent WO2006116458
CTTGTCTGGT
>FB511841.1 Sequence 321 from Patent WO2006116458
CTTGTTCGGT
>FB511840.1 Sequence 320 from Patent WO2006116458
CTTGTTTGGT
>FB511839.1 Sequence 319 from Patent WO2006116458
CTTTTGCTAA
>FB511838.1 Sequence 318 from Patent WO2006116458
GCTTTTGCTA
>FB511837.1 Sequence 317 from Patent WO2006116458
TCCCCTTGGT
>FB511836.1 Sequence 316 from Patent WO2006116458
TCTGTTTGGT
>FB511835.1 Sequence 315 from Patent WO2006116458
TGCTTCTGCT
>FB511834.1 Sequence 314 from Patent WO2006116458
TGCTTTCGCT
>FB511833.1 Sequence 313 from Patent WO2006116458
TGCTTTTCGT
>FB511832.1 Sequence 312 from Patent WO2006116458
TGCTTTTGCT
>FB511831.1 Sequence 311 from Patent WO2006116458
TGTGTGTCCG
>FB511830.1 Sequence 310 from Patent WO2006116458
TGTTAAGCGT
>FB511829.1 Sequence 309 from Patent WO2006116458
TTCCCCTTGG
>FB511828.1 Sequence 308 from Patent WO2006116458
TTGTCTTCGT
>FB511827.1 Sequence 307 from Patent WO2006116458
TTGTGTGCCC
>FB511826.1 Sequence 306 from Patent WO2006116458
TTGTGTGTCT
>FB511825.1 Sequence 305 from Patent WO2006116458
TTTATGATAC
>FB511824.1 Sequence 304 from Patent WO2006116458
TTTCTTATAC
>FB511823.1 Sequence 303 from Patent WO2006116458
TTTGTCTGGT
>FB511822.1 Sequence 302 from Patent WO2006116458
TTTGTGTGTC
>FB511821.1 Sequence 301 from Patent WO2006116458
TTTGTTTGGT
>FB511820.1 Sequence 300 from Patent WO2006116458
TTTTCTCCGT
>FB511819.1 Sequence 299 from Patent WO2006116458
TTTTCTTCGT
>FB511818.1 Sequence 298 from Patent WO2006116458
TTTTTCCCGT
>FB511817.1 Sequence 297 from Patent WO2006116458
TTTTTCGCGT
>FB511816.1 Sequence 296 from Patent WO2006116458
TTTTTCTCGT
>FB511815.1 Sequence 295 from Patent WO2006116458
TTTTTCTGGT
>FB511814.1 Sequence 294 from Patent WO2006116458
TTTTTGATAC
>FB511813.1 Sequence 293 from Patent WO2006116458
TTTTTTATAC
>CS793371.1 Sequence 12 from Patent EP1832567
ATTCGTACCA
>CS793368.1 Sequence 9 from Patent EP1832567
AATTCTTACC
>CQ787957.1 Sequence 263 from Patent WO2004020664
TTTAGTTCAG
>CQ787956.1 Sequence 262 from Patent WO2004020664
ACTGAACAGT
>CQ787924.1 Sequence 230 from Patent WO2004020664
CAGTTCAGCT
>CQ787884.1 Sequence 190 from Patent WO2004020664
TTCTTTTTGT
>CQ787877.1 Sequence 183 from Patent WO2004020664
CAGTTCAGCT
>DL146344.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
CTTCTCATCT
>DL176511.1 GENETICALLY ENGINEERED VACCINE STRAIN
TCGAGGATCC
>DL162724.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
GCCGTTAGGC
>DL176341.1 GENETICALLY ENGINEERED VACCINE STRAIN
AGCTTCTAGA
>DL176340.1 GENETICALLY ENGINEERED VACCINE STRAIN
TCGATCTAGA
>DL176136.1 Positional Sequencing by Hybridization
GCATCNNNNN
>DL176133.1 Positional Sequencing by Hybridization
GACGCNNNNN
>DL175883.1 PLASTIC AND ELASTIC PROTEIN COPOLYMERS
CTCTTCNNNN
>DL181909.1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
GGGGAAACCC
>DL181908.1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
AGGGATTTCC
>DL181907.1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
GGGGATTTCC
>DL175489.1 Bulge base recognizing molecule and bulge base detecting method
GTTGWNTGGA
>DL157584.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TTCATTCATT
>DL157583.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TCATTCATTC
>DL157582.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
CATTCATTCA
>DL157581.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
ATTCATTCAT
>DL174903.1 Method and Apparatus for Biological Sequence Data Processing
ACAAACCCTT
>DL174888.1 Method and Apparatus for Biological Sequence Data Processing
ACAAACCCTT
>DL181322.1 TRANSGENIC NON-HUMAN ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
CTAANTGGGG
>DL180811.1 Simple method for detecting human cytochrome P4502A6 genetic polymorphism and reagent for detection
CAGGAGGAGT
>DL180810.1 Simple method for detecting human cytochrome P4502A6 genetic polymorphism and reagent for detection
GCCACCCTGA
>DL174538.1 INTRON ASSOCIATED WITH MYOTONIC DYSTROPHY TYPE 2 AND METHODS OF USE
TGTCTGCCTG
>DL180123.1 Novel full length cDNA
TTAAGTGGTT
>DL180114.1 Novel full length cDNA
TGCGTGGGCG
>DL180112.1 Novel full length cDNA
GGGGGGGGGG
>DL180110.1 Novel full length cDNA
CCAGATAAGG
>DL180108.1 Novel full length cDNA
TGAACTTTGA
>DL180098.1 Novel full length cDNA
GTCACGTGGT
>DL180095.1 Novel full length cDNA
AACAGATGGT
>DL182951.1 Recombinant VSV for the treatment of tumor cells
TTGTCNNTAG
>FB361114.1 Sequence 3 from Patent WO2006065751
NNNTCGWNNN
>CU951823.1 Brassica napus GSS, clone JBnB142B10, end read, primer SACR2(reverse), genomic survey sequence
CCTTTTAAAG
>CU958922.1 Brassica napus GSS, clone JBnB057L20, end read, primer SACL2(forward), genomic survey sequence
GATCAGAGTC
>CU955426.1 Brassica napus GSS, clone JBnB170G15, end read, primer SACL2(forward), genomic survey sequence
GATCTCAGAT
>CU969291.1 Brassica napus GSS, clone JBnB175M16, end read, primer SACR2(reverse), genomic survey sequence
CCGCGGCCGC
>CU957166.1 Brassica napus GSS, clone JBnB186I10, end read, primer SACL2(forward), genomic survey sequence
GATCATAATA
>CU969616.1 Brassica napus GSS, clone JBnB188H07, end read, primer SACR2(reverse), genomic survey sequence
CCTGATACTC
>CU962499.1 Brassica napus GSS, clone JBnB069C10, end read, primer SACR2(reverse), genomic survey sequence
GTGGCCTATC
>CU933606.1 Brassica napus GSS, clone JBnB051J22, end read, primer SACR2(reverse), genomic survey sequence
CCTTATAAAG
>FB326364.1 Sequence 665 from Patent EP1854809
GATCCTCGGC
>FB316498.1 Sequence 106 from Patent WO2007000663
TAGTCATGCG
>FB316497.1 Sequence 105 from Patent WO2007000663
TGGTCGTGCG
>FB316496.1 Sequence 104 from Patent WO2007000663
TAGCCATGCT
>FB316495.1 Sequence 103 from Patent WO2007000663
AAGTTATGAG
>FB355477.1 Sequence 3 from Patent EP1860197
CACCCCTTCT
>DL129110.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NDANCGKTCG
>DL129073.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAANGTTCG
>DL129072.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAANGTTCG
>DL129071.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAANGTTCG
>DL129070.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NGAANGTTCG
>DL129069.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NGAANGTTCG
>DL129068.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
CGAANGTTCG
>DL129067.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NGACNGTTCG
>DL129066.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GAAANGTTCG
>DL129065.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GAACNGTTCG
>DL129064.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GTACNGTTCG
>DL129063.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GTATNGGTCG
>DL129062.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGATNGGTCG
>DL129061.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGACNGTTCG
>DL129060.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGAANGTTCG
>DL129059.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAACGTTCG
>DL129058.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAACGTTCG
>DL129057.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TTAACGTTCG
>DL129056.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NGAACGTTCG
>DL129055.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
CGACCGTTCG
>DL129054.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
CGAACGTTCG
>DL129053.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NGACCGTTCG
>DL129052.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GAACCGTTCG
>DL129051.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GTACCGTTCG
>DL129050.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GTATCGGTCG
>DL129049.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GTAACGTTCG
>DL129048.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGAACGGTCG
>DL129047.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGATCGTTCG
>DL129046.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGATCGGTCG
>DL129045.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGACCGTTCG
>DL129044.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGAACGTTCG
>DL129043.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGAANGTTCG
>DL129042.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NDANNGKTCG
>DL129041.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
GGAACGTTCG
>DL129040.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
TGAACGTTCG
>DL129039.1 IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
NDANCGKTCG
>DL128579.1 Method for MALDI-TOF-MS analysis and/or sequencing of oligonucleotides
GATCTCAGCT
>DL128576.1 Method for MALDI-TOF-MS analysis and/or sequencing of oligonucleotides
CCCCCCCCCC
>DL128573.1 Method for MALDI-TOF-MS analysis and/or sequencing of oligonucleotides
GATCTCAGCT
>DL128570.1 Method for MALDI-TOF-MS analysis and/or sequencing of oligonucleotides
GATCTCAGCT
>DL135750.1 MN Gene and Protein
TGTGAGACTT
>DL135749.1 MN Gene and Protein
YYYCAYYYYY
>DL135747.1 MN Gene and Protein
CCACCCCCAT
>DL135746.1 MN Gene and Protein
CTCCATCTCT
>DL135700.1 Transgenic animal
GCCGCCATGG
>DL139270.1 Therapeutic agents for the treatment of HMGB1-related pathologies
GCACCGAACA
>DL139268.1 Therapeutic agents for the treatment of HMGB1-related pathologies
GCACCGAACA
>DL139266.1 Therapeutic agents for the treatment of HMGB1-related pathologies
GCACCGAACA
>DL139264.1 Therapeutic agents for the treatment of HMGB1-related pathologies
GCACCGAACA
>DL139262.1 Therapeutic agents for the treatment of HMGB1-related pathologies
GCACCGAACA
>DL128114.1 METHOD OF MAKING A PROTEIN POLYMER AND USES OF THE POLYMER
GAGTCNNNNN
>DL128108.1 METHOD OF MAKING A PROTEIN POLYMER AND USES OF THE POLYMER
CGCGCTGGAC
>DL131445.1 Complex Element Micro-array and Methods of Use
GCTTCTCGAG
>DL131444.1 Complex Element Micro-array and Methods of Use
ATGCTGCCAA
>DL131443.1 Complex Element Micro-array and Methods of Use
AATGCTGCCA
>DL131442.1 Complex Element Micro-array and Methods of Use
GAATGCTGCC
>DL131441.1 Complex Element Micro-array and Methods of Use
GGAATGCTGC
>DL131440.1 Complex Element Micro-array and Methods of Use
CGGAATGCTG
>DL127274.1 Method and apparatus for reading reporter labeled beads
CCCGGTATTA
>DL127273.1 Method and apparatus for reading reporter labeled beads
ATCCCGGTAT
>DL127272.1 Method and apparatus for reading reporter labeled beads
TATCCCGGTA
>DL127271.1 Method and apparatus for reading reporter labeled beads
CTTATCCCGG
>DL127270.1 Method and apparatus for reading reporter labeled beads
TAGCTTATCC
>DL127268.1 Method and apparatus for reading reporter labeled beads
ATTAAATCGA
>DL127267.1 Method and apparatus for reading reporter labeled beads
TATTAAATCG
>DL127266.1 Method and apparatus for reading reporter labeled beads
GTATTAAATC
>DL127265.1 Method and apparatus for reading reporter labeled beads
GGTATTAAAT
>DL127264.1 Method and apparatus for reading reporter labeled beads
CGGTATTAAA
>DL127263.1 Method and apparatus for reading reporter labeled beads
ACGGTATTAA
>DL127262.1 Method and apparatus for reading reporter labeled beads
CACGGTATTA
>DL127261.1 Method and apparatus for reading reporter labeled beads
TCACGGTATT
>DL127260.1 Method and apparatus for reading reporter labeled beads
ATCACGGTAT
>DL127259.1 Method and apparatus for reading reporter labeled beads
TATCACGGTA
>DL127258.1 Method and apparatus for reading reporter labeled beads
TTATCACGGT
>DL127257.1 Method and apparatus for reading reporter labeled beads
CTTATCACGG
>DL127256.1 Method and apparatus for reading reporter labeled beads
GCTTATCACG
>DL127255.1 Method and apparatus for reading reporter labeled beads
AGCTTATCAC
>DL127254.1 Method and apparatus for reading reporter labeled beads
TAGCTTATCA
>DL127253.1 Method and apparatus for reading reporter labeled beads
TTAGCTTATC
>DL127252.1 Method and apparatus for reading reporter labeled beads
TTTAGCTTAT
>DL127251.1 Method and apparatus for reading reporter labeled beads
CTTTAGCTTA
>DL127250.1 Method and apparatus for reading reporter labeled beads
GCTTTAGCTT
>DL127249.1 Method and apparatus for reading reporter labeled beads
AGCTTTAGCT
>DL127248.1 Method and apparatus for reading reporter labeled beads
TAGCTTTAGC
>DL141672.1 EGFR Mutations
GGAATTAAGA
>DL141652.1 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
AAAAAAAAAA
>DL145222.1 COPY CHOICE RECOMBINATION AND USES THEREOF
CAACCGCGTT
>DL145214.1 COPY CHOICE RECOMBINATION AND USES THEREOF
CAACCGCGTT
>DL126749.1 Method of nucleic acid typing and sequencing
AGGCRAGGAA
>DL145199.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCGCATGTCC
>DL144872.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ACCAAGGCAG
>DL144870.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAAGGCGG
>DL144869.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144868.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144866.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144865.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144863.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144862.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144861.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144856.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144855.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144854.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144853.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144852.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144851.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144850.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144849.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144848.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144847.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144846.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144844.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL137583.1 Amplification method of small amount mRNA and their use
GATCCCCGGG
>DL144520.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ATTAAAGTGG
>DL144519.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ATCAAAGCAG
>DL144518.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ATCAAAGCAG
>DL144516.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ATCAAAGCAG
>DL144515.1 COPY CHOICE RECOMBINATION AND USES THEREOF
ATCAAAGCAG
>DL144512.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GTCAAAGCAG
>DL144511.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GTCAAAGCAG
>DL144508.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GTCAAAGCGG
>DL144507.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCCAAAGCGG
>DL144503.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144502.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144501.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144500.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144499.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144498.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144497.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144496.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTAGGATGT
>DL144495.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144494.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144493.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144492.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144491.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144490.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL144489.1 COPY CHOICE RECOMBINATION AND USES THEREOF
GCTGGGATGT
>DL137454.1 Biomaterial
GGGACTTTCC
>DL137453.1 Biomaterial
GGGATTTCCC
>DL137452.1 Biomaterial
NGGRHTYYHC
>DL136898.1 Site-Specific Incorporation of Foreign Molecules into Protein, and Use thereof
ACCCTTCCTC
>pdb|1FV7|B Chain B, A Two B-Z Junction Containing Dna Resolves Into An All Right Handed Double Helix
CGCGNNCGCG
>pdb|1FV7|A Chain A, A Two B-Z Junction Containing Dna Resolves Into An All Right Handed Double Helix
CGCGNNCGCG
>DL075998.1 A METHOD FOR THE TREATMENT OF MALIGNANT DISEASES BY INHIBITING NUCLEOLIN
GGGTTTTGGG
>DL075994.1 A METHOD FOR THE TREATMENT OF MALIGNANT DISEASES BY INHIBITING NUCLEOLIN
GGGTTTTGGG
>DL075697.1 Recombinase Polymerase Amplification
ATGCGGTGTT
>DL079391.1 Rapid Production of Oligonucleotides
GAGTCNNNNN
>DL079153.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTC
>DL073374.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TGGTGATGGA
>DL073373.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCCATCACCA
>DL073372.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TTAACTGGTT
>DL073371.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AACCAGTTAA
>DL073370.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CCAGTAACGA
>DL073369.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCGTTACTGG
>DL073368.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TAGGGGTCCT
>DL073367.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AGGACCCCTA
>DL073366.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GGCCTACAGA
>DL073365.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCTGTAGGCC
>DL073364.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CGAGGGTGTC
>DL073363.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GACACCCTCG
>DL073362.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
ATCCTACAGA
>DL073361.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCTGTAGGAT
>DL073360.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CGTGTTGGGG
>DL073359.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CCCCAACACG
>DL073358.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
ACCTACGGGA
>DL073357.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCCCGTAGGT
>DL073356.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CAAATGTTAG
>DL073355.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CTAACATTTG
>DL073354.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CCTTTAGCGA
>DL073353.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCGCTAAAGG
>DL073352.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AAATGTCCAC
>DL073351.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GTGGACATTT
>DL073350.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AGCAATGTTT
>DL073349.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AAACATTGCT
>DL073348.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GTAAGTTTAG
>DL073347.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CTAAACTTAC
>DL073346.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CCTAAATCGA
>DL073345.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCGATTTAGG
>DL073344.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TTCAGTAGTC
>DL073343.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GACTACTGAA
>DL073342.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
ACCTACACGA
>DL073341.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCGTGTAGGT
>DL073340.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CAATGTTGGA
>DL073339.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCCAACATTG
>DL073338.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TGCTGATAGA
>DL073337.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCTATCAGCA
>DL073336.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
ATGTTTGTCC
>DL073335.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GGACAAACAT
>DL073334.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GATGACTGAA
>DL073333.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TTCAGTCATC
>DL073332.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TGCTGCTGCT
>DL073331.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AGCAGCAGCA
>DL073330.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GACGTTTGCA
>DL073329.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TGCAAACGTC
>DL073328.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TCGGTTTGAC
>DL073327.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
GTCAAACCGA
>DL073326.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
AAATGAATCG
>DL073325.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
CGATTCATTT
>DL073324.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TAAGTGTCAA
>DL073323.1 A system for detection and identification of a tick and fungus that cause the development of allergy to house dust
TTGACACTTA
>DL072178.1 Nucleic Acids and Proteins from Streptococcus Pneumoniae
TTGCGGCCGC
>DL071922.1 INTESTINAL TREFOIL PROTEINS
GGGCGGCCGC
>DL081134.1 METHODS AND DEVICES FOR SEQUENCING NUCLEIC ACIDS
TCAGTCATCA
>GC534655.1 Sequence 9 from patent US 7411065
ACCCTACTGT
>GC534654.1 Sequence 8 from patent US 7411065
CTCATTTCCA
>GC534653.1 Sequence 7 from patent US 7411065
CCCTACTGTG
>GC534652.1 Sequence 6 from patent US 7411065
GTGCATGATG
>GC534651.1 Sequence 5 from patent US 7411065
GTGCTCCTCC
>GC534650.1 Sequence 4 from patent US 7411065
TCTTCTAGTG
>GC534649.1 Sequence 3 from patent US 7411065
ACCAGCGGCA
>GC534648.1 Sequence 2 from patent US 7411065
TCGTGTCGTA
>GC534647.1 Sequence 1 from patent US 7411065
CTCGTTTCCA
>GC515849.1 Sequence 61 from patent US 7407944
CTATCTGACG
>GC515847.1 Sequence 59 from patent US 7407944
CGTTCTCTGT
>GC515844.1 Sequence 56 from patent US 7407944
CGTTCTCTGT
>GC515829.1 Sequence 41 from patent US 7407944
CTGACGTTCT
>GC515041.1 Sequence 8 from patent US 7407757
CCCTTAGCTG
>GC514795.1 Sequence 25 from patent US 7407748
GGGACTTCCC
>GC514794.1 Sequence 23 from patent US 7407748
ATATTGATTT
>GC514789.1 Sequence 17 from patent US 7407748
GGGGCGGGGC
>GC514788.1 Sequence 15 from patent US 7407748
GGGACTTTCC
>GC514786.1 Sequence 13 from patent US 7407748
TAGGCGCGAA
>GC511648.1 Sequence 756 from patent US 7405290
CGGCTCCTAG
>GC511581.1 Sequence 65 from patent US 7405287
CTCTATTCCA
>GC511492.1 Sequence 12 from patent US 7405285
TCNAACNTTC
>GC511250.1 Sequence 38 from patent US 7405273
AGGACAAAAG
>GC506129.1 Sequence 308 from patent US 7402660
GATCTCCGTG
>GC506016.1 Sequence 127 from patent US 7402660
TTTGGTTTCC
>GC506015.1 Sequence 126 from patent US 7402660
TGAAATAAAC
>GC505893.1 Sequence 4 from patent US 7402660
CCCTTGTCCG
>GC505581.1 Sequence 6 from patent US 7402434
TAGGGAGGGC
>GC505580.1 Sequence 5 from patent US 7402434
TAGGGCAGGC
>GC505374.1 Sequence 8 from patent US 7402427
CTTTCACCCT
>GC505147.1 Sequence 38 from patent US 7402410
CTGGCCAACG
>GC503911.1 Sequence 16 from patent US 7400980
ACCGAGATCT
>GC503906.1 Sequence 11 from patent US 7400980
ACCGAGATCT
>GC503898.1 Sequence 3 from patent US 7400980
TGATGTTTGA
>GC502759.1 Sequence 1 from patent US 7399764
CTGCGGCCGC
>GC502542.1 Sequence 183 from patent US 7399752
RCACGAYACA
>GC502485.1 Sequence 123 from patent US 7399752
CGAAGAATYC
>GC500749.1 Sequence 69 from patent US 7399584
GCGCCCCGAT
>GC500748.1 Sequence 68 from patent US 7399584
GCCCCCCGAT
>GC500747.1 Sequence 67 from patent US 7399584
GCACCCCGAT
>GC500746.1 Sequence 66 from patent US 7399584
GCTCCCCGAT
>GC500739.1 Sequence 59 from patent US 7399584
CACGGGAGCA
>GC500284.1 Sequence 107 from patent US 7399461
GGGRHTYYHC
>GC497976.1 Sequence 1 from patent US 7396832
CTGCGGCCGC
>GC497209.1 Sequence 120 from patent US 7396643
AGGAAGTTCC
>GC497208.1 Sequence 119 from patent US 7396643
AAGTGTTTGC
>GC497205.1 Sequence 110 from patent US 7396643
ATCACCCCAC
>GC497200.1 Sequence 98 from patent US 7396643
AAGTGAAAGT
>GC497194.1 Sequence 84 from patent US 7396643
GGGAMTNYCC
>GC497189.1 Sequence 71 from patent US 7396643
YTAWAAATAR
>GC497184.1 Sequence 63 from patent US 7396643
GCCTGCAGGC
>GC497182.1 Sequence 61 from patent US 7396643
GCTTCAGTTT
>GC497181.1 Sequence 60 from patent US 7396643
CTTTCTCTTT
>GC497180.1 Sequence 59 from patent US 7396643
CTTTCAGTTT
>GC497178.1 Sequence 55 from patent US 7396643
GCCATCTGCT
>GC497162.1 Sequence 28 from patent US 7396643
CCGCCCCCGC
>GC497153.1 Sequence 8 from patent US 7396643
YCAGCTGYGG
>GC497088.1 Sequence 23 from patent US 7396533
ACCTGCCCGG
>GC494005.1 Sequence 308 from patent US 7393932
GATCTCCGTG
>GC493892.1 Sequence 127 from patent US 7393932
TTTGGTTTCC
>GC493891.1 Sequence 126 from patent US 7393932
TGAAATAAAC
>GC493769.1 Sequence 4 from patent US 7393932
CCCTTGTCCG
>GC492446.1 Sequence 3 from patent US 7393665
NACCACACAN
>GC490153.1 Sequence 58 from patent US 7393632
AAAGCTGGGT
>GC490152.1 Sequence 57 from patent US 7393632
AAAGCAGGCT
>GC487522.1 Sequence 23 from patent US 7390636
AGAACAGAGA
>GC487521.1 Sequence 22 from patent US 7390636
TTATCATTGT
>GC483995.1 Sequence 19 from patent US 7388091
GCCGGCTCCA
>GC483994.1 Sequence 18 from patent US 7388091
GGCCCGTCCA
>GC481182.1 Sequence 68 from patent US 7388084
CTCTCYMMCA
>GC479313.1 Sequence 3 from patent US 7387865
CCTCGTCAGA
>GC479312.1 Sequence 2 from patent US 7387865
GGAGTAGTCT
>GC479311.1 Sequence 1 from patent US 7387865
GGAGCAGTCT
>GC475887.1 Sequence 20 from patent US 7385032
CAGTCTGCAG
>GC475886.1 Sequence 19 from patent US 7385032
CAGTGTGCTG
>GC473954.1 Sequence 14 from patent US 7384634
CCWWWWWWGG
>GC473952.1 Sequence 12 from patent US 7384634
GNNTTGGTGA
>GC473950.1 Sequence 10 from patent US 7384634
GAGTTGATGA
>EA000398.3 Sequence 31 from patent US 7122303
AGTATGACAA
>DL069398.1 Modulation of Chromosome Function by Chromatin Remodeling Agents
AACACAACAC
>DL069395.1 Modulation of Chromosome Function by Chromatin Remodeling Agents
AAGAGAAGAG
>DL069394.1 Modulation of Chromosome Function by Chromatin Remodeling Agents
GAGAAGAGAA
>DL071600.1 Synthetic nucleic acid molecule compositions and methods of preparation
AACCATGGCT
>DL071070.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
GATCTCCGTG
>DL070957.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TTTGGTTTCC
>DL070956.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
TGAAATAAAC
>DL070834.1 ENDOTHELIAL CELL EXPRESSION PATTERNS
CCCTTGTCCG
>DL070194.1 HCV ANTIGEN/ANTIBODY COMBINATION ASSAY
ACAAAACAAA
>DL069808.1 IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES
ACAAAACAAA
>DL069717.1 DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHOD
CGCCGTCCCG
>DL069596.1 NOVEL TUMOR ANTIGEN USEFUL IN DIAGNOSIS AND THERAPY OF BLADDER, OVARY, LUNG, AND KIDNEY CANCERS
ACCTGCCCGG
>DL000680.1 CHIMERIC ADENOVIRUS CAPSID PROTEINS
GTGATATTGG
>DL005586.1 BIO-BARCODE BASED DETECTION OF TARGET ANALYTES
AAAAAAAAAA
>DJ493989.1 Cosmid vector for transforming plant and use thereof
GTTAATTAAC
>DJ493377.1 Methods of classifying antibodies, methods of identifying antigens, methods of obtaining antibodies or sets of antibodies, methods of making antibody panels, antibodies or sets of antibodies and uses the same
ATCGACAGCT
>DJ493091.1 Nonreplicating SeV vectors
CTTTCACCCT
>DL002660.1 Aptamer-Nanoparticle Conjugates and Method of Use For Target Analyte Detection
AAAAAAAAAA
>DJ447642.1 Sequence specific DNA recombination in eukaryotic cells
MAGTCACTAT
>DJ446945.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAAACATC
>DJ446944.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCGGACATC
>DJ446943.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTTAGGTGCT
>DJ446942.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGATATC
>DJ446941.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GCCAGGTACT
>DJ446940.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGCATC
>DJ446939.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGGCGTC
>DJ446938.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAAATACT
>DJ446937.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTTAGGCGTC
>DJ446936.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGTGCT
>DJ446935.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGCACT
>DJ446934.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GCCAGGCGCT
>DJ446933.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAAATGCT
>DJ446932.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTTAGGCGTC
>DJ446931.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGGCGCT
>DJ446930.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGACGTC
>DJ446929.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGACGCT
>DJ446928.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCGGACGTC
>DJ446927.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAGATACT
>DJ446926.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAAACGCT
>DJ446925.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTTAGGTACT
>DJ446924.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGCGTC
>DJ446923.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTTAGGCGCT
>DJ446922.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGTACT
>DJ446921.1 A method of estimation of haplotype frequencies by use of pooled DNA data
GTCAAATACT
>DJ446920.1 A method of estimation of haplotype frequencies by use of pooled DNA data
CTCAGGCGCT
>DJ446491.1 GENE EXPRESSION FOR ANALYZING PHOTODAMAGE
ACGTTAAAGA
>DJ446315.1 Fluorescent RNA Probe
GTTCGGCATG
>DJ442595.1 Method for Construction and Use of Kluyveromyces lactis Promoter Variants in K. lactis that Substantially Lack E. coli Transcriptional Capability
AGAACAGAGA
>DJ442594.1 Method for Construction and Use of Kluyveromyces lactis Promoter Variants in K. lactis that Substantially Lack E. coli Transcriptional Capability
TTATCATTGT
>DJ442560.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DJ442547.1 INHIBITORS OF AKT ACTIVITY
CTGCGGCCGC
>DJ442450.1 NOVEL METHODS FOR QUANTIFICATION OF microRNAS AND SMALL INTER-FERING RNAS
TTGTGGATAT
>DJ442421.1 NOVEL METHODS FOR QUANTIFICATION OF microRNAS AND SMALL INTER-FERING RNAS
AGNNNNTNAT
>DJ442420.1 NOVEL METHODS FOR QUANTIFICATION OF microRNAS AND SMALL INTER-FERING RNAS
AGNNNNTAAT
>DJ442419.1 NOVEL METHODS FOR QUANTIFICATION OF microRNAS AND SMALL INTER-FERING RNAS
AGNANNTAAT
>DJ442418.1 NOVEL METHODS FOR QUANTIFICATION OF microRNAS AND SMALL INTER-FERING RNAS
AGNANATAAT
>DJ437603.1 NUCLEIC ACID APTAMERS CONJUGATED TO HIGH MOLECULAR WEIGHT STERIC GROUPS
GAAGAATTGG
>DJ432898.1 Secretory and/or cargo system related proteins involving protein secretion and/or cargo systems, and method for identification and functional analysis thereof
CCCCCCCCCC
>DJ432897.1 Secretory and/or cargo system related proteins involving protein secretion and/or cargo systems, and method for identification and functional analysis thereof
GGGGGGGGGG
>DJ436634.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DJ436633.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DJ436631.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DJ436629.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DJ436624.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTATCTGACG
>DJ436622.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CGTTCTCTGT
>DJ436619.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CGTTCTCTGT
>DJ436604.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTGACGTTCT
>DJ445779.1 Functional Mutations in Respiratory Syncytial Virus
GGGGCAAATA
>DJ445726.1 PROCESSES AND REAGENTS FOR OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION
ACGTCGATAT
>DJ445717.1 PROCESSES AND REAGENTS FOR OLIGONUCLEOTIDE SYNTHESIS AND PURIFICATION
CATCGCTGAT
>DJ440564.1 Modified Polynucleotides For Reducing Off-Target Effects In RNA Interference
CTTCCTGTCA
>DJ445027.1 Nucleic Acid Ligands Specific to Immunoglobulin E and their Use as Atopic Disease Therapeutics
AACGTTCGAG
>DJ430821.1 13-TRANSMEMBRANE PROTEIN EXPRESSED IN PROSTATE CANCER
CGGCTCCTAG
>DJ435271.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNAACNTTC
>DJ435256.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CTCACCTCTG
>DJ435255.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CTCACCTCTG
>DJ435254.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435252.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435251.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435195.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435187.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435185.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CTGACGTTCT
>DJ435162.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ435161.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
CAGAGCTCTG
>DJ434704.1 Cosmid vector for transforming plant and use thereof
GTTAATTAAC
>DJ439139.1 Methods and Means for Nucleic Acid Sequencing
AAAAAAAAAA
>DJ434156.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACGACGTCGT
>DJ434155.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACAACGTTGT
>DJ434154.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACGTCGACGT
>DJ434153.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
TCCGATCGGA
>DJ434152.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GCCGATCGGC
>DJ434151.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GACGGCCGTC
>DJ434150.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CCCGATCGGG
>DJ434149.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CTAGCGCTAG
>DJ434148.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GACGTACGTC
>DJ434147.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CAGCGCGCTG
>DJ434146.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GCATCGATGC
>DJ434145.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GCAACGTTGC
>DJ434144.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GATCGCGATC
>DJ434143.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CGATCGATCG
>DJ434142.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GGCGATCGCC
>DJ434141.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GACGATCGTC
>DJ434055.1 Therapeutic agents for Alzheimer's disease
AGGGTGAAAG
>DJ434054.1 Therapeutic agents for Alzheimer's disease
AGGGTGAATG
>DJ434053.1 Therapeutic agents for Alzheimer's disease
AGGGTCAAAG
>DJ434052.1 Therapeutic agents for Alzheimer's disease
CTTTCACCCT
>DJ434051.1 Therapeutic agents for Alzheimer's disease
CATTCACCCT
>DJ434050.1 Therapeutic agents for Alzheimer's disease
CTTTGACCCT
>DJ434049.1 Therapeutic agents for Alzheimer's disease
CWTTVWCCCT
>DJ443012.1 METHOD FOR DETECTING ncRNA
AACGCGTATA
>DJ443011.1 METHOD FOR DETECTING ncRNA
TACGCGTATA
>DJ443010.1 METHOD FOR DETECTING ncRNA
TACTACCTCA
>DJ443007.1 METHOD FOR DETECTING ncRNA
TACTACCTCA
>DJ443004.1 METHOD FOR DETECTING ncRNA
TACTACCTCA
>DJ443001.1 METHOD FOR DETECTING ncRNA
TACTACCTCA
>DJ442992.1 METHOD FOR DETECTING ncRNA
CTGCGGCACT
>DJ442986.1 METHOD FOR DETECTING ncRNA
TGCCTGCTGT
>DJ442977.1 METHOD FOR DETECTING ncRNA
TTCACTGTGA
>DJ442971.1 METHOD FOR DETECTING ncRNA
ATTACTTGAA
>DJ442959.1 METHOD FOR DETECTING ncRNA
TAGGCCAGTT
>DJ442956.1 METHOD FOR DETECTING ncRNA
CTTCATCTCA
>DJ442953.1 METHOD FOR DETECTING ncRNA
AAACACTACA
>DJ442950.1 METHOD FOR DETECTING ncRNA
AGACAGTGTT
>DJ442947.1 METHOD FOR DETECTING ncRNA
CACGGTACGA
>DJ442944.1 METHOD FOR DETECTING ncRNA
CGTGCTGCTA
>DJ442935.1 METHOD FOR DETECTING ncRNA
TGTGCTGCTA
>DJ442929.1 METHOD FOR DETECTING ncRNA
CATTGCACTG
>DJ438244.1 POLYNUCLEOTIDE SYNTHESIS
GGAGACCCTA
>DJ438243.1 POLYNUCLEOTIDE SYNTHESIS
ACCTGCGTTC
>DJ427879.1 Sequencing method for nucleic acid
AACGTTCGAC
>DJ430198.1 A new pathogenesis-inducible PR4 promoter
GGACCCAACC
>DJ429667.1 Discrimination between forms of beans
GTGGGTTGTG
>DJ429666.1 Discrimination between forms of beans
GGAGAGGAGA
>DJ429665.1 Discrimination between forms of beans
CGAATTGCTG
>DJ429664.1 Discrimination between forms of beans
AGCGCCGACG
>DJ429663.1 Discrimination between forms of beans
ACGGAAGCGC
>DJ429662.1 Discrimination between forms of beans
ATACGGCGTC
>DJ429661.1 Discrimination between forms of beans
GAGCACGGGA
>DJ429660.1 Discrimination between forms of beans
CCGGCTGGAA
>DJ429656.1 Discrimination between forms of beans
CCGGACACGA
>DJ429655.1 Discrimination between forms of beans
GTATGGGGCT
>DJ429654.1 Discrimination between forms of beans
ATCAAGCTGC
>DJ429653.1 Discrimination between forms of beans
AGGATCAAGC
>DJ429652.1 Discrimination between forms of beans
CGCGTGCCAG
>DJ429651.1 Discrimination between forms of beans
CTCAGCCCAG
>DJ429650.1 Discrimination between forms of beans
CGTGGGCAGG
>DJ429649.1 Discrimination between forms of beans
CTCGGGTGGG
>EA766392.1 Sequence 25 from patent US 7378509
GGACTTTCCC
>EA766388.1 Sequence 5 from patent US 7378509
GGGACTTTCC
>EA766387.1 Sequence 2 from patent US 7378509
GGGACTTTCC
>EA766386.1 Sequence 1 from patent US 7378509
GGGRNNYYCC
>EA764542.1 Sequence 39 from patent US 7378485
CACACCAAAA
>EA764541.1 Sequence 38 from patent US 7378485
AAAACCACAC
>EA764540.1 Sequence 37 from patent US 7378485
GTGATGATAA
>EA764539.1 Sequence 36 from patent US 7378485
ATTAGTAGTG
>EA764538.1 Sequence 35 from patent US 7378485
AATAGTAGTG
>EA764531.1 Sequence 28 from patent US 7378485
AAAAACAAAA
>EA764530.1 Sequence 27 from patent US 7378485
AAAATAAAAA
>EA764529.1 Sequence 26 from patent US 7378485
AAAACAAAAA
>EA764528.1 Sequence 25 from patent US 7378485
AAAAATAAAA
>EA764527.1 Sequence 24 from patent US 7378485
GAGTGGAAAA
>EA764526.1 Sequence 23 from patent US 7378485
GAGATGAAAA
>EA764525.1 Sequence 22 from patent US 7378485
AAAAGGTGAG
>EA764524.1 Sequence 21 from patent US 7378485
AAAAGTAGAG
>EA764523.1 Sequence 20 from patent US 7378485
GAGAGGAAAA
>EA764522.1 Sequence 19 from patent US 7378485
AAAAGGAGAG
>EA764519.1 Sequence 16 from patent US 7378485
TTCTTCTTTT
>EA764518.1 Sequence 15 from patent US 7378485
TTTTTCTTCT
>EA764517.1 Sequence 14 from patent US 7378485
TTTTTCTTTT
>EA764516.1 Sequence 13 from patent US 7378485
TTTTCTTCTT
>EA764515.1 Sequence 12 from patent US 7378485
TTTTCTTTTT
>EA764514.1 Sequence 11 from patent US 7378485
AAAAGAAGAA
>EA764513.1 Sequence 10 from patent US 7378485
AAAAGAAAAA
>EA764512.1 Sequence 9 from patent US 7378485
AAAAAGAAAA
>EA764511.1 Sequence 8 from patent US 7378485
AAAAAGAAAA
>EA764510.1 Sequence 7 from patent US 7378485
TTTTTTTTTT
>EA764507.1 Sequence 3 from patent US 7378485
AAAAAAAAAA
>EA761041.1 Sequence 23 from patent US 7378086
CTAGTAGGTC
>EA761040.1 Sequence 22 from patent US 7378086
AGCTGACCTA
>EA760755.1 Sequence 20 from patent US 7375260
AGCCTGACGC
>EA760754.1 Sequence 19 from patent US 7375260
GGACTCCACG
>EA760753.1 Sequence 18 from patent US 7375260
CATCCCGAAC
>EA760752.1 Sequence 17 from patent US 7375260
TTGTCTCAGG
>EA760751.1 Sequence 16 from patent US 7375260
GGATCTGAAC
>EA760750.1 Sequence 15 from patent US 7375260
AAGATAGCGG
>EA760749.1 Sequence 14 from patent US 7375260
AGGATACGTG
>EA760748.1 Sequence 13 from patent US 7375260
GTGCAATGAG
>EA760747.1 Sequence 12 from patent US 7375260
CCAAGCTTGC
>EA760746.1 Sequence 11 from patent US 7375260
CCCTGCAGGC
>EA760745.1 Sequence 10 from patent US 7375260
GCGAATTCCG
>EA760744.1 Sequence 9 from patent US 7375260
CGGGATCCGC
>EA760743.1 Sequence 8 from patent US 7375260
CTATCGCCGC
>EA760742.1 Sequence 7 from patent US 7375260
CACCCTGCGC
>EA760741.1 Sequence 6 from patent US 7375260
GCACGCCGGA
>EA760740.1 Sequence 5 from patent US 7375260
AACGTACGCG
>EA760739.1 Sequence 4 from patent US 7375260
TGCGCGATCG
>EA760738.1 Sequence 3 from patent US 7375260
GTCCTTAGCG
>EA760737.1 Sequence 2 from patent US 7375260
GTCCTACTCG
>EA760736.1 Sequence 1 from patent US 7375260
AAATCGGAGC
>EA760020.1 Sequence 27 from patent US 7375198
NCGCGGCGCG
>EA760019.1 Sequence 26 from patent US 7375198
NATATTATAN
>EA760018.1 Sequence 24 from patent US 7375198
NTNTNNTNTN
>EA760017.1 Sequence 22 from patent US 7375198
NTNTNNTNTN
>EA760016.1 Sequence 21 from patent US 7375198
CGCGCCGCGN
>EA760012.1 Sequence 17 from patent US 7375198
AAGNTGCTAN
>EA760011.1 Sequence 16 from patent US 7375198
AAGANGCTAN
>EA760010.1 Sequence 15 from patent US 7375198
AAGATNCTAN
>EA760009.1 Sequence 14 from patent US 7375198
AAGATGNTAN
>EA760004.1 Sequence 4 from patent US 7375198
CGCGCCGCGC
>EA760003.1 Sequence 3 from patent US 7375198
ATATAATATA
>EA760001.1 Sequence 1 from patent US 7375198
AAGATGCTAC
>EA756864.1 Sequence 9 from patent US 7371860
ACCCTACTGT
>EA756863.1 Sequence 8 from patent US 7371860
CTCATTTCCA
>EA756862.1 Sequence 7 from patent US 7371860
CCCTACTGTG
>EA756861.1 Sequence 6 from patent US 7371860
GTGCATGATG
>EA756860.1 Sequence 5 from patent US 7371860
GTGCTCCTCC
>EA756859.1 Sequence 4 from patent US 7371860
TCTTCTAGTG
>EA756858.1 Sequence 3 from patent US 7371860
ACCAGCGGCA
>EA756857.1 Sequence 2 from patent US 7371860
TCGTGTCGTA
>EA756856.1 Sequence 1 from patent US 7371860
CTCGTTTCCA
>EA756855.1 Sequence 9 from patent US 7371859
ACCCTACTGT
>EA756854.1 Sequence 8 from patent US 7371859
CTCATTTCCA
>EA756853.1 Sequence 7 from patent US 7371859
CCCTACTGTG
>EA756852.1 Sequence 6 from patent US 7371859
GTGCATGATG
>EA756851.1 Sequence 5 from patent US 7371859
GTGCTCCTCC
>EA756850.1 Sequence 4 from patent US 7371859
TCTTCTAGTG
>EA756849.1 Sequence 3 from patent US 7371859
ACCAGCGGCA
>EA756848.1 Sequence 2 from patent US 7371859
TCGTGTCGTA
>EA756847.1 Sequence 1 from patent US 7371859
CTCGTTTCCA
>EA756841.1 Sequence 100 from patent US 7371851
AAAAAAAAAA
>EA756820.1 Sequence 79 from patent US 7371851
NNNNNGCGTC
>EA756798.1 Sequence 57 from patent US 7371851
AAAAAAACCG
>EA756795.1 Sequence 54 from patent US 7371851
AAAAAAAAAC
>EA756790.1 Sequence 49 from patent US 7371851
AAGAGATGAA
>EA756525.1 Sequence 4 from patent US 7371840
TACAACGAGG
>EA753689.1 Sequence 6 from patent US 7371540
ACTTACCTGT
>EA752615.1 Sequence 62 from patent US 7368556
GTACTTGGGC
>EA752610.1 Sequence 57 from patent US 7368556
AGTGGCTGGC
>EA752260.1 Sequence 51 from patent US 7368549
AATAACAACC
>EA752259.1 Sequence 50 from patent US 7368549
AATAAGAACC
>EA752258.1 Sequence 49 from patent US 7368549
AATAAAAACC
>EA752257.1 Sequence 48 from patent US 7368549
AATCATAACC
>EA752256.1 Sequence 47 from patent US 7368549
AATGATAACC
>EA752255.1 Sequence 46 from patent US 7368549
AATTATAACC
>EA752254.1 Sequence 45 from patent US 7368549
AATAATAACC
>EA752253.1 Sequence 44 from patent US 7368549
AGCACTGACT
>EA752252.1 Sequence 43 from patent US 7368549
AGCATTGACT
>EA752251.1 Sequence 42 from patent US 7368549
AGCAATGACT
>EA752250.1 Sequence 41 from patent US 7368549
AGCAGCGACT
>EA752249.1 Sequence 40 from patent US 7368549
AGCAGGGACT
>EA752248.1 Sequence 39 from patent US 7368549
AGCAGAGACT
>EA752247.1 Sequence 38 from patent US 7368549
AGCCGTGACT
>EA752246.1 Sequence 37 from patent US 7368549
AGCGGTGACT
>EA752245.1 Sequence 36 from patent US 7368549
AGCTGTGACT
>EA752244.1 Sequence 35 from patent US 7368549
AGCTGTGACT
>EA752225.1 Sequence 16 from patent US 7368549
GTAATAATAA
>EA752224.1 Sequence 15 from patent US 7368549
CCAATAATAA
>EA752223.1 Sequence 14 from patent US 7368549
ACAATGATAA
>EA752222.1 Sequence 13 from patent US 7368549
TCAATGACAG
>EA752221.1 Sequence 12 from patent US 7368549
TCAGTGACAA
>EA752220.1 Sequence 11 from patent US 7368549
TCAGTGACGA
>EA752219.1 Sequence 10 from patent US 7368549
ACAGCGACGT
>EA752218.1 Sequence 9 from patent US 7368549
ACAGCGGCGT
>EA752217.1 Sequence 8 from patent US 7368549
TCGGCGGCGT
>EA752105.1 Sequence 323 from patent US 7368548
CTATGAGAAG
>EA751902.1 Sequence 109 from patent US 7368548
CTCCGCGGCA
>EA751762.1 Sequence 16 from patent US 7368546
TTCCAAGGAA
>EA751712.1 Sequence 11 from patent US 7368538
TGGGCGGGGC
>EA730864.1 Sequence 3 from patent US 7368113
GCCRCCATGG
>EA620827.1 Sequence 19 from patent US 7365179
NNNGATCNNN
>EA620823.1 Sequence 15 from patent US 7365179
GCATCAAAAA
>EA620820.1 Sequence 12 from patent US 7365179
CGATCAAAAA
>EA620422.1 Sequence 40 from patent US 7365163
ATATATCAGC
>EA620421.1 Sequence 39 from patent US 7365163
CCTCGTATCA
>EA620420.1 Sequence 38 from patent US 7365163
TCCATTTTAG
>EA620419.1 Sequence 37 from patent US 7365163
GTATGAGCTG
>EA620418.1 Sequence 36 from patent US 7365163
ACTCCGCCAT
>EA620417.1 Sequence 35 from patent US 7365163
GGATCACCTC
>EA620416.1 Sequence 34 from patent US 7365163
GCTCTTGCAG
>EA620415.1 Sequence 33 from patent US 7365163
GTAAGAGGAG
>EA620414.1 Sequence 32 from patent US 7365163
ACCTCTCTAG
>EA620413.1 Sequence 31 from patent US 7365163
GTGACTTCAT
>EA620412.1 Sequence 30 from patent US 7365163
GTCTTTTCAG
>EA620411.1 Sequence 29 from patent US 7365163
GTAAGCGTGC
>EA620410.1 Sequence 28 from patent US 7365163
ACCCCAGTTG
>EA620409.1 Sequence 27 from patent US 7365163
TTTCCTATCC
>EA620408.1 Sequence 26 from patent US 7365163
TCCTTTCCAG
>EA620407.1 Sequence 25 from patent US 7365163
GTGAGTACCT
>EA620406.1 Sequence 24 from patent US 7365163
TTCTCTAGCT
>EA620405.1 Sequence 23 from patent US 7365163
GATGACCATT
>EA620404.1 Sequence 22 from patent US 7365163
TCCCTTCCAG
>EA620403.1 Sequence 21 from patent US 7365163
GTATGTCAAG
>EA620402.1 Sequence 20 from patent US 7365163
ACACAATTAG
>EA620401.1 Sequence 19 from patent US 7365163
GAATACACCA
>EA620400.1 Sequence 18 from patent US 7365163
TTCCCACCAG
>EA620399.1 Sequence 17 from patent US 7365163
GTGAGTACTA
>EA620398.1 Sequence 16 from patent US 7365163
CCTAGACATG
>EA620397.1 Sequence 15 from patent US 7365163
AGAAGCCCAC
>EA620396.1 Sequence 14 from patent US 7365163
TCCCTTATAG
>EA620395.1 Sequence 13 from patent US 7365163
GTGAGGAGCA
>EA620394.1 Sequence 12 from patent US 7365163
GGCATTGGAG
>EA620393.1 Sequence 11 from patent US 7365163
GGTCGAGGGA
>EA620392.1 Sequence 10 from patent US 7365163
AATGTTATAG
>EA620391.1 Sequence 9 from patent US 7365163
GTGAGTCTCC
>EA620390.1 Sequence 8 from patent US 7365163
TCCAGTCGAG
>EA620389.1 Sequence 7 from patent US 7365163
CGCGACCTCC
>EA619495.1 Sequence 1106 from patent US 7364878
CGGNNNNCTC
>EA619481.1 Sequence 1088 from patent US 7364878
CCGNNNNCCC
>EA619477.1 Sequence 1084 from patent US 7364878
CCGNNNNGTC
>EA619461.1 Sequence 1066 from patent US 7364878
CACNNNNGGG
>EA619450.1 Sequence 1054 from patent US 7364878
CGCNNNNGCC
>EA619421.1 Sequence 1019 from patent US 7364878
ACCNNNNGCG
>EA619416.1 Sequence 1012 from patent US 7364878
CGCNNNNGGA
>EA619389.1 Sequence 977 from patent US 7364878
CACNNNNCGC
>EA619387.1 Sequence 975 from patent US 7364878
CCTNNNNGGC
>EA619365.1 Sequence 947 from patent US 7364878
CGCNNNNCAG
>EA619350.1 Sequence 929 from patent US 7364878
AGGNNNNCCG
>EA619330.1 Sequence 907 from patent US 7364878
CCCNNNNCAC
>EA619311.1 Sequence 883 from patent US 7364878
GCCNNNNCCC
>EA619308.1 Sequence 880 from patent US 7364878
CTGNNNNGCC
>EA619305.1 Sequence 877 from patent US 7364878
CGGNNNNGCC
>EA619283.1 Sequence 843 from patent US 7364878
CCCNNNNCCG
>EA619282.1 Sequence 842 from patent US 7364878
GCCNNNNCCA
>EA619257.1 Sequence 810 from patent US 7364878
GAGNNNNGGC
>EA619255.1 Sequence 807 from patent US 7364878
CCCNNNNGGC
>EA619252.1 Sequence 803 from patent US 7364878
CCCNNNNCAG
>EA619250.1 Sequence 800 from patent US 7364878
GAGNNNNCCC
>EA619246.1 Sequence 794 from patent US 7364878
GCCNNNNTCC
>EA619234.1 Sequence 781 from patent US 7364878
CGGNNNNGGC
>EA619210.1 Sequence 748 from patent US 7364878
CAGNNNNCGG
>EA619200.1 Sequence 733 from patent US 7364878
AGGNNNNGCG
>EA619125.1 Sequence 633 from patent US 7364878
CGGNNNNGAC
>EA619123.1 Sequence 630 from patent US 7364878
AGANNNNCCG
>EA619113.1 Sequence 619 from patent US 7364878
AGCNNNNCCC
>EA619107.1 Sequence 613 from patent US 7364878
GCGNNNNCGA
>EA619102.1 Sequence 605 from patent US 7364878
AGGNNNNCCC
>EA619091.1 Sequence 592 from patent US 7364878
GGCNNNNCCC
>EA619054.1 Sequence 539 from patent US 7364878
CAGNNNNGGG
>EA619035.1 Sequence 518 from patent US 7364878
CGGNNNNAGA
>EA619015.1 Sequence 488 from patent US 7364878
CGCNNNNGAG
>EA619012.1 Sequence 483 from patent US 7364878
GCGNNNNCCC
>EA618967.1 Sequence 426 from patent US 7364878
CCANNNNCCC
>EA618957.1 Sequence 411 from patent US 7364878
GCCNNNNGGA
>EA618955.1 Sequence 408 from patent US 7364878
CCCNNNNGCC
>EA618954.1 Sequence 403 from patent US 7364878
CGCNNNNGAC
>EA618950.1 Sequence 398 from patent US 7364878
CTGNNNNCGC
>EA618945.1 Sequence 393 from patent US 7364878
CCCNNNNCGC
>EA618633.1 Sequence 326 from patent US 7364864
GGGRNNYYCC
>EA618208.1 Sequence 11 from patent US 7364855
AGCGCACTCT
>EA618206.1 Sequence 9 from patent US 7364855
AGCGCACTCC
>EA618205.1 Sequence 8 from patent US 7364855
AGCGCACTCA
>EA618199.1 Sequence 2 from patent US 7364855
AGCGCACGCG
>EA618049.1 Sequence 1 from patent US 7364847
GCTCTACAAG
>EA501282.1 Sequence 17 from patent US 7361806
CGAGGCCTCG
>EA499890.1 Sequence 17 from patent US 7361467
TTGCCCAATT
>EA499889.1 Sequence 16 from patent US 7361467
AACGGGTTAA
>EA498880.1 Sequence 32 from patent US 7358353
GATCCTCGGC
>EA498801.1 Sequence 308 from patent US 7358351
GATCTCCGTG
>EA498688.1 Sequence 127 from patent US 7358351
TTTGGTTTCC
>EA498687.1 Sequence 126 from patent US 7358351
TGAAATAAAC
>EA498565.1 Sequence 4 from patent US 7358351
CCCTTGTCCG
>EA497577.1 Sequence 7 from patent US 7358068
CCCCCATGGA
>EA497574.1 Sequence 4 from patent US 7358068
TCCGAAGACG
>EA497058.1 Sequence 27 from patent US 7357928
GGGTTTTGGG
>EA497054.1 Sequence 23 from patent US 7357928
GGGTTTTGGG
>DJ401976.1 CHRNA2 Genetic Markers Associated with Galantamine Response
AGCGGATAAC
>DJ401975.1 CHRNA2 Genetic Markers Associated with Galantamine Response
CTCCCCTTCC
>DJ401974.1 CHRNA2 Genetic Markers Associated with Galantamine Response
AGGGGAACCC
>DJ401973.1 CHRNA2 Genetic Markers Associated with Galantamine Response
AGCCAGAACG
>DJ401972.1 CHRNA2 Genetic Markers Associated with Galantamine Response
TGGGTCCTGG
>DJ401971.1 CHRNA2 Genetic Markers Associated with Galantamine Response
CAGCCTTGGA
>DJ401970.1 CHRNA2 Genetic Markers Associated with Galantamine Response
AGGGCTCTTC
>DJ401969.1 CHRNA2 Genetic Markers Associated with Galantamine Response
CTTGGTTCTT
>DJ401968.1 CHRNA2 Genetic Markers Associated with Galantamine Response
CTGCATGAAG
>DJ401967.1 CHRNA2 Genetic Markers Associated with Galantamine Response
AGACCCAGGA
>DJ401966.1 CHRNA2 Genetic Markers Associated with Galantamine Response
GCTGGGCTTG
>DJ391753.1 SFRP AND PEPTIDE MOTIFS THAT INTERACT WITH SFRP AND METHODS OF THEIR USE
CTTGATTGCC
>DJ419438.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TGTTAAACTT
>DJ419440.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTGTCAAGGG
>DJ419442.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCACCTGACA
>DJ419444.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGATGCCACT
>DJ419446.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GATAGCAAGT
>DJ419448.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CAATCCTTGA
>DJ419450.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ACCCGAGTGT
>DJ419452.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGAGCTTGAC
>DJ419454.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CAGCGGCGGC
>DJ419456.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GAACCAAAAT
>DJ419458.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CCTCACGGCA
>DJ419460.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ACCATATTCT
>DJ419476.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CAGGCAGACA
>DJ419474.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AGGGCCGGCG
>DJ419472.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAGTAGGAAG
>DJ419470.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCCGGTGGGC
>DJ419468.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTCGGCTGCA
>DJ419466.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GTTGAGCAGG
>DJ419464.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TACTACTACC
>DJ419462.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTCTTGATAA
>DJ419436.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GATATGGACG
>DJ419434.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAATTTTAAT
>DJ419432.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGTATGCTTC
>DJ419430.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCCGCCGAGC
>DJ419428.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TGTTAGTATT
>DJ419426.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GACGAGGACG
>DJ419424.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCACCCACGA
>DJ419422.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CTCGACTTCG
>DJ419420.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGATATTGGA
>DJ419418.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAGCAATGCC
>DJ419416.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GAACTTTGGG
>DJ419414.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CCAATACTGG
>DJ419412.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAACAAGCGA
>DJ419410.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCTATTGCAA
>DJ419408.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTTGATGCTT
>DJ419406.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GAGAAAATTA
>DJ419404.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TGTAACTAAA
>DJ419402.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AAGTGTTATA
>DJ419400.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCTTGAGCCC
>DJ419398.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AGTGACTGTT
>DJ419396.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CAGCAATACT
>DJ419394.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAACAAGCAG
>DJ419392.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TATATGTTTT
>DJ419390.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AACCAGGATT
>DJ419388.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CAGGCCGTCG
>DJ419386.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATATATATAT
>DJ419384.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCAAGTTACC
>DJ419382.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CCTAACTTGC
>DJ419334.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CATATGTTGA
>DJ419332.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATGTAGATCG
>DJ419330.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGTTTCAGCT
>DJ419328.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AAGCTACTTG
>DJ419326.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AGCATTGTTT
>DJ419324.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TCGTGGGGTA
>DJ419322.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAAACAAACC
>DJ419320.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCTGTGTTGT
>DJ419318.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCTCTTTCTG
>DJ419316.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TGTTACTAGC
>DJ419314.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TATGTATGTA
>DJ419312.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGGGGCGGCA
>DJ419310.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTCATATGAA
>DJ419308.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GAATCAATAC
>DJ419306.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTTGACAAGA
>DJ419304.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TACATAAATG
>DJ419302.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTGTGATTCA
>DJ419300.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ACGATTGGTG
>DJ419298.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAATGGTACA
>DJ419296.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TATATTTATC
>DJ419294.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CTCAAGATGA
>DJ419292.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTTGTAACTC
>DJ419290.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTCGGCTTCT
>DJ419288.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATGATGATAT
>DJ419286.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATGGCCTGAG
>DJ419284.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CGAAATCGAT
>DJ419282.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTGTAATACT
>DJ419280.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GATCCGTCTC
>DJ391322.1 5' Region differential display
AGGGAACGAG
>DJ391321.1 5' Region differential display
CTGCTGGGAC
>DJ391318.1 5' Region differential display
TTTGCCCGGA
>DJ391317.1 5' Region differential display
TCCGCTCTGG
>DJ391316.1 5' Region differential display
TTCCCCCGCA
>DJ419380.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCCGCCACCT
>DJ419378.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
AGATACTGTA
>DJ419376.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GCGGCGGCGA
>DJ419374.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CGAGAATGCT
>DJ419372.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GTCGCCTCTC
>DJ419370.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GTCCCAGCTT
>DJ419368.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATATATCACA
>DJ419366.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGCCGCCTCC
>DJ419364.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CGATTTTGAG
>DJ419362.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAGAGTTAGA
>DJ419360.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAATAATCTG
>DJ419358.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TATCAATGTA
>DJ419356.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GTCCGCGCCC
>DJ419354.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CGGGTGCTCC
>DJ419352.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GATCATTGCT
>DJ419350.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TTCATCAGCA
>DJ419348.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
ATAATTATTG
>DJ419346.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGACAATGTC
>DJ419344.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GGAAAAGCTA
>DJ419342.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
CTGGTATTCT
>DJ419340.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
GTAATTGTCC
>DJ419338.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TGTAACTCAC
>DJ419336.1 USE OF A TYPE III RESTRICTION ENZYME TO ISOLATE IDENTIFICATION TAGS COMPRISING MORE THAN 25 NUCLEOTIDES
TAACTTACTC
>DJ390573.1 Aptamer
CCTACCAGTG
>DJ390569.1 Aptamer
CACTGGCCCC
>DJ381593.1 Mitochondrial Dosimeter
CACACTACTA
>DJ379186.1 Methods For Producing A Polypeptide Using A Consensus Translational Initiator Sequence
NYCNNHCACC
>DJ388944.1 DIRECTED EVOLUTION OF OXIDASE ENZYMES
CTTAATTAAG
>DJ388943.1 DIRECTED EVOLUTION OF OXIDASE ENZYMES
GAATTAATTC
>DJ388942.1 DIRECTED EVOLUTION OF OXIDASE ENZYMES
TTCGATCGAA
>DJ388941.1 DIRECTED EVOLUTION OF OXIDASE ENZYMES
AAGCTAGCTT
>DJ388455.1 REPAIR OF NERVE DAMAGE
GCCCCCATGG
>DJ388454.1 REPAIR OF NERVE DAMAGE
GCCACCATGG
>CS725924.1 Sequence 12 from Patent WO2007105041
CCCGTCAGCA
>CS725923.1 Sequence 11 from Patent WO2007105041
AACGCGCAAC
>CS725922.1 Sequence 10 from Patent WO2007105041
AAGAGCCCGT
>CS725921.1 Sequence 9 from Patent WO2007105041
GTAGACCCGT
>CS725920.1 Sequence 8 from Patent WO2007105041
GTTTCGCTCC
>CS725919.1 Sequence 7 from Patent WO2007105041
GGTGCGGGAA
>DD135927.1 A novel transposon-like element
TACCGTCGCC
>DD135923.1 A novel transposon-like element
TCCAGAAGAT
>DJ358714.1 TRANSITION STATE ANALOG INHIBITORS OF RICIN A-CHAIN
CGCNNNAGCG
>DJ358713.1 TRANSITION STATE ANALOG INHIBITORS OF RICIN A-CHAIN
CGCGNNAGCG
>DJ358712.1 TRANSITION STATE ANALOG INHIBITORS OF RICIN A-CHAIN
CGCNNGAGCG
>DJ358709.1 TRANSITION STATE ANALOG INHIBITORS OF RICIN A-CHAIN
CGCGNGAGCG
>DJ348051.1 WT1 17AA(-) isoform-specific siRNA and Use thereof
CTTCCTGTCA
>DJ348047.1 WT1 17AA(-) isoform-specific siRNA and Use thereof
AAGGGCCACA
>DJ360049.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TCGTCGTTTT
>DJ360041.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
AATCTTAGCT
>DJ360037.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGCTTCTGCT
>DJ360021.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CGCTTCTGCT
>DJ360007.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CCTGCTTTTG
>DJ359981.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CTTTTGCTAA
>DJ359977.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
GCTTTTGCTA
>DJ359945.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGCTTTTGCT
>DJ359938.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGCTTTTCGT
>DJ359932.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGCTTTCGCT
>DJ359925.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTCCCGT
>DJ359919.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTCGCGT
>DJ359905.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CTTGTCTGGT
>DJ359893.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CTTGTTTGGT
>DJ359887.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTCCCCTTGG
>DJ358474.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
ACCCCACCCG
>DJ358473.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GGGGACGCGA
>DJ358472.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CGGGGCGCGA
>DJ358471.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCCCCCGCGA
>DJ358470.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GAGAGGCGCG
>DJ358469.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
AGGGGACGCG
>DJ358468.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GAGGTGCGCG
>DJ358467.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CTCCCACGCG
>DJ358466.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
AGCGGCCGCG
>DJ358465.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCCCGCGNNG
>DJ358464.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCCGCGNGNG
>DJ358463.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCGACGTGCG
>DJ358462.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCGCATGCGG
>DJ358461.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
ATCCCGCCCG
>DJ358460.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
TGCGACGCCG
>DJ358459.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
TGGCCGCCGA
>DJ358458.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CCGCGATCGC
>DJ358457.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CGGGACGCGA
>DJ358456.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCGCCGACGT
>DJ358455.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCGGGGCGGC
>DJ358454.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GCGCGCCGCG
>DJ358453.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CGCGGGGGCG
>DJ358452.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
CCCCGCGGGG
>DJ358451.1 METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE DEVELOPMENT OF PROSTATE CELL PROLIFERATIVE DISORDERS
GGGCCGCGGC
>DJ352739.1 Bio-Barcode Based Detection of Target Analytes
AAAAAAAAAA
>DJ359879.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TCCCCTTGGT
>DJ359867.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TCTGTTTGGT
>DJ359863.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTCTGGT
>DJ359855.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTGTCTGGT
>DJ359846.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTGTTTGGT
>DJ359843.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
CTTGTTCGGT
>DJ359839.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTCTCCGT
>DJ359835.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTCTCGT
>DJ359829.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTCTTCGT
>DJ359815.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTGTCTTCGT
>DJ359804.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGTTAAGCGT
>DJ359800.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTGATAC
>DJ359795.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTATGATAC
>DJ359791.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTTTTATAC
>DJ359787.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTCTTATAC
>DJ359781.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTGTGTGCCC
>DJ359777.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TGTGTGTCCG
>DJ359772.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTTGTGTGTC
>DJ359768.1 IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES
TTGTGTGTCT
>DJ359688.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
AGCGGATAAC
>DJ359672.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
ACTGCCAGGC
>DJ359671.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
AGGCGGCCGC
>DJ359670.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
CCAGGGTCTG
>DJ359669.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
GAGGCCAGGG
>DJ359668.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
TGGGGGCGGT
>DJ359667.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
CCTGCAGAAG
>DJ359666.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
GGAGGACGTG
>DJ359665.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
CCCCATTCAG
>DJ359664.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
ACCCTGGGAA
>DJ359663.1 APOE Genetic Markers Associated with Age of Onset of Alzheimer's Disease
AGGCGTGAGC
>DJ352269.1 Nucleic Acids and Corresponding Proteins Entitled 109P1D4 Useful in Treatment and Detection of Cancer
GATCCTCGGC
>DJ357385.1 GASTROINTESTINAL PROLIFERATIVE FACTOR AND USES THEREOF
AGCTGTTAAC
>DJ357384.1 GASTROINTESTINAL PROLIFERATIVE FACTOR AND USES THEREOF
TCGAGTTAAC
>DJ357145.1 RECOMBINANT INFLUENZA VIRUSES HOLDING A MUTATION IN A TRANSMEMBRANE PROTEIN GENE
GGGAGCAAAA
>DJ357129.1 Pancreatic Cancer Associated Antigen, Antibody Thereto, and Diagnostic and Treatment Methods
ATCCCCTAGG
>DJ350952.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGGG
>DJ350951.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGGG
>DJ350950.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGGG
>DJ350949.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGGG
>DJ350945.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGTG
>DJ350944.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGTG
>DJ350934.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGTG
>DJ350930.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTGTG
>DJ350927.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
ACAGGCTACG
>DJ350911.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
AACGTTCGAG
>DJ350889.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
AACGTTCGAG
>DJ350809.1 Modified Polynucleotides for Use in RNA Interference
CTTCCTGTCA
>DJ350805.1 Modified Polynucleotides for Use in RNA Interference
CTTCCTGTCA
>DJ349998.1 TARGETS FOR TUMOR GROWTH INHIBITION
TGGCCAATAA
>DJ349933.1 Methods for Selecting Medications
AAGGAGCTGG
>DJ349919.1 Methods for Selecting Medications
GCCGAGTGCA
>DJ349908.1 Methods for Selecting Medications
AAGGGAGCCG
>DJ349899.1 Methods for Selecting Medications
CGTCGGAGAC
>DJ349894.1 Methods for Selecting Medications
CATGCGTCGA
>DJ349893.1 Methods for Selecting Medications
CATGCGTCGG
>DJ349879.1 Methods for Selecting Medications
GTCCAGCTCT
>DJ349878.1 Methods for Selecting Medications
GTCCAGCTCC
>DJ349874.1 Methods for Selecting Medications
GCCACGAAGC
>DJ349873.1 Methods for Selecting Medications
GCCACGAAGA
>DJ349864.1 Methods for Selecting Medications
CTGCGGACAT
>DJ349863.1 Methods for Selecting Medications
CTGCGGACAC
>DJ349859.1 Methods for Selecting Medications
CGGGGGGAAT
>DJ349858.1 Methods for Selecting Medications
CGGGGGGAAC
>DJ349853.1 Methods for Selecting Medications
CCGACAGGGT
>DJ362388.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
TAGCCGCCSA
>DJ362387.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCGNNNNCGG
>DJ362385.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
GCSGSGNNSG
>DJ362381.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CGGNSTTATA
>DJ362373.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
AYCCRTACAY
>DJ362372.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCCCTTAAGG
>DJ362371.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CTAWWWWTAG
>DJ362364.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCGCCGRAWR
>DJ362363.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCNRAWNNGG
>DJ362360.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCNRATNNGG
>DJ362358.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CCGGTACCGG
>DJ362357.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
CATGTGAAAT
>DJ362356.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
ATTTCACATC
>DJ362343.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
MTTASTMAKC
>DJ362336.1 BIOLOGICALLY-ACTIVE DNA-BINDING SITES AND RELATED METHODS
TTTACCCGGM
>DJ349839.1 Methods for Selecting Medications
TCAGGTGGCC
>DJ349829.1 Methods for Selecting Medications
GGTGGGACGA
>DJ349824.1 Methods for Selecting Medications
CCATGGTGGC
>DJ349823.1 Methods for Selecting Medications
CCATGGTGGG
>DJ349814.1 Methods for Selecting Medications
CCAGGAGCGG
>DJ349813.1 Methods for Selecting Medications
CCAGGAGCGT
>DJ349809.1 Methods for Selecting Medications
CCCAGGAGCC
>DJ349787.1 Methods for Selecting Medications
AGCTGCCACT
>DJ349786.1 Methods for Selecting Medications
AGCTGCCACC
>DJ349782.1 Methods for Selecting Medications
GAGAACCTGT
>DJ349781.1 Methods for Selecting Medications
GAGAACCTGC
>DJ349779.1 Methods for Selecting Medications
ACTGAGCACG
>DJ349778.1 Methods for Selecting Medications
ACTGAGCACA
>DJ349774.1 Methods for Selecting Medications
CCACCCCCAA
>DJ349773.1 Methods for Selecting Medications
CCACCCCCAG
>DJ349771.1 Methods for Selecting Medications
CTTCTCCGTC
>DJ349770.1 Methods for Selecting Medications
CTTCTCCGTG
>DJ349766.1 Methods for Selecting Medications
TGCCCATCAT
>DJ349765.1 Methods for Selecting Medications
TGCCCATCAC
>DJ349761.1 Methods for Selecting Medications
GCACGCTACT
>DJ349760.1 Methods for Selecting Medications
GCACGCTACC
>DJ355092.1 Agent
TAATAAGCTT
>DJ344131.1 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER
GATCCTCGGC
>DJ361251.1 Aptamers to the Human IL-12 Cytokine Family and Their Use as Autoimmune Disease Therapeutics
AACGTTCGAG
>DJ348086.1 Screening Method
GGGRNNYYCC
>EA492907.1 Sequence 31 from patent US 7354898
GGAAATATTG
>EA492906.1 Sequence 30 from patent US 7354898
GGAAACCCCG
>EA492905.1 Sequence 29 from patent US 7354898
ATCGATTCCA
>EA492904.1 Sequence 28 from patent US 7354898
GGGGATTCCA
>EA492814.1 Sequence 72 from patent US 7354761
AAAACTGCAG
>EA492813.1 Sequence 71 from patent US 7354761
AAAACTGCAG
>EA492332.1 Sequence 14 from patent US 7354710
CCCACTACAG
>EA492331.1 Sequence 13 from patent US 7354710
CGCCCACTAC
>EA491891.1 Sequence 143 from patent US 7351877
CTAGGCGCGC
>EA491887.1 Sequence 139 from patent US 7351877
GTACGAATTC
>EA491851.1 Sequence 103 from patent US 7351877
GATCACGCGT
>EA491842.1 Sequence 94 from patent US 7351877
AGCTCTCGAG
>EA491839.1 Sequence 91 from patent US 7351877
AGCTACTAGT
>EA491836.1 Sequence 88 from patent US 7351877
CGCGACTAGT
>EA491831.1 Sequence 83 from patent US 7351877
ACTAGTGGCC
>EA491824.1 Sequence 76 from patent US 7351877
ACTAGTGGCC
>EA491811.1 Sequence 63 from patent US 7351877
AGCTACTAGT
>EA491810.1 Sequence 62 from patent US 7351877
AGCTAGATCT
>EA491795.1 Sequence 47 from patent US 7351877
GATCACTAGT
>EA491472.1 Sequence 15 from patent US 7351813
AAATCAATTT
>EA491471.1 Sequence 14 from patent US 7351813
AAGYCAAYHA
>EA491470.1 Sequence 13 from patent US 7351813
ATATTGATTT
>EA489522.1 Sequence 25 from patent US 7351583
GATCCTCGGC
>EA489385.1 Sequence 58 from patent US 7351578
AAAGCTGGGT
>EA489384.1 Sequence 57 from patent US 7351578
AAAGCAGGCT
>EA489311.1 Sequence 4 from patent US 7351572
ATGTAACGCC
>EA488770.1 Sequence 19 from patent US 7351536
TACCGTCGCC
>EA488766.1 Sequence 15 from patent US 7351536
TCCAGAAGAT
>EA488750.1 Sequence 59 from patent US 7351535
AANCTTCAAN
>EA488408.1 Sequence 16 from patent US 7349808
ATTCGTTATA
>EA488407.1 Sequence 15 from patent US 7349808
CGTACTATCC
>EA488406.1 Sequence 14 from patent US 7349808
ATTAATAGAT
>EA488405.1 Sequence 13 from patent US 7349808
ATTCGTTATA
>EA488404.1 Sequence 12 from patent US 7349808
CGTACTATCC
>EA488403.1 Sequence 11 from patent US 7349808
ATTCATAGAT
>EA488357.1 Sequence 14 from patent US 7348471
CCTACGTGGC
>EA488356.1 Sequence 13 from patent US 7348471
TGTACGTGCA
>EA488311.1 Sequence 7 from patent US 7348427
AATTAATCAT
>EA485374.1 Sequence 26 from patent US 7348181
ACACCGCCGG
>EA485366.1 Sequence 18 from patent US 7348181
CCGGCGGTGT
>EA485051.1 Sequence 16 from patent US 7348161
CACATTGAAT
>EA482743.1 Sequence 12 from patent US 7345156
CCCGCCATGC
>EA481755.1 Sequence 175 from patent US 7345142
CTGACCACAG
>EA481673.1 Sequence 93 from patent US 7345142
CCTTTTCCAT
>EA480676.1 Sequence 2 from patent US 7344834
ATGATGCAAG
>EA480389.1 Sequence 2 from patent US 7344701
TTTTTTTTTT
>EA446088.1 Sequence 21 from patent US 7338800
GAANNNNTTC
>EA446085.1 Sequence 18 from patent US 7338800
GACNNNNGTC
>EA446082.1 Sequence 15 from patent US 7338800
CAYNNNNRTG
>EA446081.1 Sequence 14 from patent US 7338800
GAGTCNNNNN
>EA446073.1 Sequence 5 from patent US 7338800
GATNNNNATC
>EA442408.1 Sequence 50 from patent US 7338656
GAANNNNTTC
>EA442405.1 Sequence 46 from patent US 7338656
GACNNNNGTC
>EA442402.1 Sequence 42 from patent US 7338656
CAYNNNNRTG
>EA442401.1 Sequence 41 from patent US 7338656
GAGTCNNNNN
>EA442395.1 Sequence 33 from patent US 7338656
GATNNNNATC
>EA433822.1 Sequence 8 from patent US 7335492
TAACCGCGGT
>EA433770.1 Sequence 41 from patent US 7335484
CAATTAAAGA
>EA433758.1 Sequence 28 from patent US 7335484
CCTAGCGTTG
>EA433757.1 Sequence 27 from patent US 7335484
GGCTGCAAAC
>EA433756.1 Sequence 26 from patent US 7335484
TGCCAGTGGA
>EA433755.1 Sequence 25 from patent US 7335484
TGTTCGCCAG
>EA433754.1 Sequence 24 from patent US 7335484
AAGCGACCGA
>EA433695.1 Sequence 122 from patent US 7335476
MAMMATGNHS
>EA433060.1 Sequence 36 from patent US 7332590
GCCCCCTTCC
>EA433059.1 Sequence 35 from patent US 7332590
CAGCTGTCCC
>EA433058.1 Sequence 34 from patent US 7332590
GATCTCTTGG
>EA433057.1 Sequence 33 from patent US 7332590
TTTCCTCTCA
>EA433056.1 Sequence 32 from patent US 7332590
GATGTGCACG
>EA433055.1 Sequence 31 from patent US 7332590
CCCTTGAGGA
>EA433054.1 Sequence 30 from patent US 7332590
GCCCCTGCTG
>EA433053.1 Sequence 29 from patent US 7332590
AAAGCACAAG
>EA433052.1 Sequence 28 from patent US 7332590
CTTCCTTGCC
>EA433051.1 Sequence 27 from patent US 7332590
GACATCAAGT
>EA433050.1 Sequence 26 from patent US 7332590
TGGGGAGAGG
>EA433049.1 Sequence 25 from patent US 7332590
CTCCTCACCT
>EA433048.1 Sequence 24 from patent US 7332590
CTAAGACTTC
>EA433047.1 Sequence 23 from patent US 7332590
TGTCCTGGTT
>EA433046.1 Sequence 22 from patent US 7332590
CCTGGGAAGT
>EA433045.1 Sequence 21 from patent US 7332590
GTTGTGGTTA
>EA433044.1 Sequence 20 from patent US 7332590
CTCCCCCAAA
>EA433043.1 Sequence 19 from patent US 7332590
CTCCCCCAAG
>EA433042.1 Sequence 18 from patent US 7332590
GAAATAAAGC
>EA433041.1 Sequence 17 from patent US 7332590
AAGGGAGCAC
>EA433040.1 Sequence 16 from patent US 7332590
GTTCACATTA
>EA433039.1 Sequence 15 from patent US 7332590
ATGGGATGGC
>EA433038.1 Sequence 14 from patent US 7332590
CGCAGCGGGT
>EA433037.1 Sequence 13 from patent US 7332590
CAAACTAACC
>EA433036.1 Sequence 12 from patent US 7332590
GGGCATCTCT
>EA433035.1 Sequence 11 from patent US 7332590
CTCCCAGCCA
>EA433034.1 Sequence 10 from patent US 7332590
CTGACCTGTG
>EA433033.1 Sequence 9 from patent US 7332590
CCAGGGGAGA
>EA433032.1 Sequence 8 from patent US 7332590
AGAACAAAAC
>EA433031.1 Sequence 7 from patent US 7332590
GCTTGAATAA
>EA433030.1 Sequence 6 from patent US 7332590
AAGGAGCAAG
>EA433029.1 Sequence 5 from patent US 7332590
TGCCGTTTTG
>EA433028.1 Sequence 4 from patent US 7332590
ACCTTTACTG
>EA433027.1 Sequence 3 from patent US 7332590
GGTGGTGTCT
>EA433026.1 Sequence 2 from patent US 7332590
CAATAAATGT
>EA433025.1 Sequence 1 from patent US 7332590
AACGACCTCG
>EA433024.1 Sequence 72 from patent US 7332589
TGGAGACTTC
>EA433023.1 Sequence 71 from patent US 7332589
CCCAAGGTAT
>EA433022.1 Sequence 70 from patent US 7332589
CCCAAGCTTC
>EA432026.1 Sequence 3 from patent US 7332331
GAAAGGAGGT
>EA426434.1 Sequence 89 from patent US 7332169
CGCGAGCTCG
>EA426215.1 Sequence 19 from patent US 7329798
GCCGGCTCCA
>EA426214.1 Sequence 18 from patent US 7329798
GGCCCGTCCA
>EA426183.1 Sequence 8 from patent US 7329765
AATTAATCAT
>EA425987.1 Sequence 7 from patent US 7329733
TCTTTCCTCC
>EA425049.1 Sequence 1 from patent US 7329515
TTTTTTTTTT
>DJ336610.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
ACAACCAGCC
>DJ336609.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
ACAATCAGCC
>DJ336608.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
ACACTCAGCC
>DJ336607.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
ACTCTCAGCC
>DJ336606.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
AGTCTCAGCC
>DJ336605.1 Polynucleotides Capable of Target-Dependent Circularization and Topological Linkage
TGTCTCAGCC
>DJ336217.1 Pharmaceutical composition
CGAAGAAGCG
>DJ334745.1 GENETIC ANALYSIS BY SEQUENCE-SPECIFIC SORTING
CCCTTAGCTG
>DJ334175.1 AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
AGCGGCCGCT
>DJ334062.1 Covalent Tethering of Functional Groups to Proteins
GCCACCATGG
>DJ332532.1 TB Resistance Assay
TCGGCACTGG
>DJ332531.1 TB Resistance Assay
ACCCACAAGC
>DJ332530.1 TB Resistance Assay
CGCTGTCGGG
>DJ332529.1 TB Resistance Assay
CAGAACAACC
>DJ332528.1 TB Resistance Assay
CATGGACCAG
>DJ332527.1 TB Resistance Assay
GAGCCAATTC
>DJ332526.1 TB Resistance Assay
CGAGATGATA
>DJ332525.1 TB Resistance Assay
CGAGACGATA
>DJ332524.1 TB Resistance Assay
CACCACCGGC
>DJ332523.1 TB Resistance Assay
TGCCGCTGGT
>DJ332512.1 TB Resistance Assay
CCAGTGCCGA
>DJ332511.1 TB Resistance Assay
GCTTGTGGGT
>DJ332510.1 TB Resistance Assay
CCCGACAGCG
>DJ332509.1 TB Resistance Assay
GGTTGTTCTG
>DJ332508.1 TB Resistance Assay
CTGGTCCATG
>DJ332507.1 TB Resistance Assay
GAATTGGCTC
>DJ332506.1 TB Resistance Assay
TATCATCTCG
>DJ332505.1 TB Resistance Assay
TATCGTCTCG
>DJ332504.1 TB Resistance Assay
GCCGGTGGTG
>DJ332503.1 TB Resistance Assay
ACCAGCGGCA
>DJ331396.1 CELLULAR MEMBRANE PROTEIN ASSAY
RCCACCATGG
>DJ330566.1 Direct Nucleic Acid Detection in Bodily Fluids
CGCGCCGAGG
>DJ330035.1 RECOMBINANT HUMAN METAPNEUMOVIRUS AND ITS USE
GGGGCAAATA
>DJ328714.1 METHYLATED GENE BIOMARKERS FOR DETECTING CANCER
ATGTGAAGAG
>DJ327829.1 Nucleic Acids and Corresponding Proteins Named 158P1D7 Useful in the Treatment and Detection of Bladder and Other Cancers
GATCCTCGGC
>DJ327695.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
TAGTCATGCG
>DJ327694.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
TGGTCGTGCG
>DJ327693.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
TAGCCATGCT
>DJ327692.1 GENETIC DIAGNOSIS USING MULTIPLE SEQUENCE VARIANT ANALYSIS
AAGTTATGAG
>DJ326563.1 Nucleic Acid Cleaving Agent
GTTGCGGGAT
>DJ326561.1 Nucleic Acid Cleaving Agent
GGTCGGGACC
>DJ326560.1 Nucleic Acid Cleaving Agent
CGAAAACGGT
>DJ127304.1 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER
GATCCTCGGC
>DJ129001.1 Primer set to detect Lactococcus lactis subsp. cremoris FC strain, and detection method and quantitative method of Lactococcus lactis subsp. cremoris FC strain using said primer set
GCGGTTGAGG
>DJ128257.1 Nucleotide sequence sensor system based on transcriptional mechanism
GTCGCAAGTT
>DJ121771.1 Nucleic Acid Based Modulators of Gene Expression
GCCGTTAGGC
>DJ100702.1 Nucleic Acid Based Modulators of Gene Expression
CTTCTCATCT
>DI011060.1 Compositions and methods for the treatment anddiagnosis of breast cancer
GGTACTAAGG
>DI010840.1 Groups of genes expressed in human monocytes and human macrophages
TGTGTTGAGA
>DI010359.1 Groups of genes expressed in human monocytes and human macrophages
AGCCCTACAA
>DI010238.1 Groups of genes expressed in human monocytes and human macrophages
CATCTAAACT
>DI008325.1 Immunostimulatory Nucleic Acids
ACAACGTTGA
>DI008253.1 Groups of genes expressed in human monocytes and human macrophages
TTGGTGAAGG
>DI004196.1 Nanostructures Containing PNA Joining and Functional Elements
GTGTGTCCTT
>DI004174.1 Nanostructures Containing PNA Joining and Functional Elements
CGGGTACGGT
>DI004173.1 Nanostructures Containing PNA Joining and Functional Elements
TTGTCGATTG
>DI004130.1 Nanostructures Containing PNA Joining and Functional Elements
GGGTGCAGGT
>DI004115.1 Nanostructures Containing PNA Joining and Functional Elements
TTTTGCGAAC
>DI004113.1 Nanostructures Containing PNA Joining and Functional Elements
TCTGTATTGG
>DI004108.1 Nanostructures Containing PNA Joining and Functional Elements
GGGGTTCGTA
>DI053998.1 ZINC FINGER DOMAIN LIBRARIES
GAGGTGGGAG
>DI053883.1 Groups of genes expressed in human monocytes and human macrophages
AGGGCTTCCA
>DI021186.1 Gene group expressed in human dendritic cells
TCAGGGCTGA
>DI021160.1 METHOD FOR AMPLIFYING SPECIFIC NUCLEIC ACID SEQUENCES
CCCTGGGCAG
>DI006374.1 ZINC FINGER DOMAIN LIBRARIES
GCTGGGGACT
>DI006361.1 Groups of genes expressed in human monocytes and human macrophages
GGATTTGGCC
>DI053687.1 Groups of genes expressed in human monocytes and human macrophages
ACCATTCTGC
>DI053612.1 Gene group expressed in human dendritic cells
TATATTTTCT
>DI038373.1 CLASSIFICATION OF THE KOREAN GINSUNG BY RADP ANALYSIS
AATCGGGCTG
>DI038231.1 Immunostimulatory Nucleic Acids
TCGATGTCGA
>DI020951.1 Groups of genes expressed in human monocytes and human macrophages
GTATGGGCCC
>DI020948.1 Gene group expressed in human dendritic cells
CACTACTCAC
>DI020821.1 Compositions and methods for the treatment and diagnosis of breast cancer
AGTAGTTGCC
>DI004078.1 Nanostructures Containing PNA Joining and Functional Elements
CCAAGTTCAC
>DI004068.1 Nanostructures Containing PNA Joining and Functional Elements
CACACAGGAA
>DI004015.1 Nanostructures Containing PNA Joining and Functional Elements
GTCTTACTGA
>DI004011.1 Nanostructures Containing PNA Joining and Functional Elements
CCCCAAGCAT
>DI035995.1 Compositions and methods for the treatment and diagnosis of breast cancer
TGGTAAAGGG
>DI035964.1 Groups of genes expressed in human monocytes and human macrophages
AATAGAAATT
>DI035963.1 ZINC FINGER DOMAIN LIBRARIES
GATGGGGTTT
>DI035936.1 Groups of genes expressed in human monocytes and human macrophages
GGGCTGGGGT
>DI030820.1 Gene group expressed in human dendritic cells
CCAGAACAGA
>DI030785.1 Groups of genes expressed in human monocytes and human macrophages
TCAGTTTGGA
>DI028420.1 Groups of genes expressed in human monocytes and human macrophages
GGTTGGGGGC
>DI025715.1 Groups of genes expressed in human monocytes and human macrophages
GAGGGAGTTT
>DI025681.1 CELLS FOR DRUG DISCOVERY
GCGGTGGCTC
>DI023339.1 Gene group expressed in human dendritic cells
AGGAGATGCT
>DI020645.1 ZINC FINGER DOMAIN LIBRARIES
AGGGAGGGAG
>DI020612.1 Groups of genes expressed in human monocytes and human macrophages
GACGACACGA
>DI020607.1 Gene group expressed in human dendritic cells
AGCAAACTGA
>DI020521.1 Groups of genes expressed in human monocytes and human macrophages
CCCATCGTCC
>DI020299.1 Gene group expressed in human dendritic cells
ATGGAAGTCT
>DI020260.1 ZINC FINGER DOMAIN LIBRARIES
TGGGGAGATT
>DI020205.1 Groups of genes expressed in human monocytes and human macrophages
GAGGGAGTCC
>DI019986.1 ZINC FINGER DOMAIN LIBRARIES
GTGGGGAAAA
>DI019895.1 Groups of genes expressed in human monocytes and human macrophages
TGGCCCCACC
>DI019843.1 ZINC FINGER DOMAIN LIBRARIES
GACATCGAGC
>DI019675.1 DNA-PROTEIN FUSIONS AND USES THEREOF
TAGCGGATGC
>DI019604.1 ZINC FINGER DOMAIN LIBRARIES
GGAAGAGAGG
>DI019583.1 Gene group expressed in human dendritic cells
GTCCCCCCAA
>DI019480.1 Novel high-throughput system for functional genomics usingunidirectional antisense cDNA library
ACCTCGGCCG
>DI019404.1 Groups of genes expressed in human monocytes and human macrophages
ACCTTTACTG
>DI019391.1 Groups of genes expressed in human monocytes and human macrophages
CTGTACTTGT
>DI019300.1 Gene group expressed in human dendritic cells
GGAGGCAGGA
>DI018939.1 Groups of genes expressed in human monocytes and human macrophages
GTGCGCTGAG
>DI018937.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNNNGCC
>DI018927.1 Groups of genes expressed in human monocytes and human macrophages
AGGCTACGGA
>DJ089908.1 PHARMACEUTICAL COMPOSITION
CCAAGAAGCC
>DJ087237.1 High Titer Recombinant Influenza Viruses for Vaccines and Gene Therapy
GGGAGCAAAA
>DJ086500.1 Compounds for Targeting
CCCGGGTAAA
>DI166634.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
GGGGGCCCCC
>DI166471.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
CCCCCGGGGG
>DI166454.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGTTTT
>DI166357.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGCGACGTT
>DI166318.1 SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TCGTCGACGA
>DI163784.1 Anticancer agents comprising minus strand RNA viruses
CTTTCACCCT
>DI162028.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
TCNAACNTTC
>DI161183.1 The Satt228 marker tightly linked Ti locus controlling presenceand absence of the Soybean kunitz tripysin inhibitor protein
ACACTCTGCC
>DI161008.1 Identification of restore fertility gene using RAPD marker inonion
TCAGGGAGGT
>DI160261.1 Antibodies and Molecules Derivedtherefrom that Bind to STEAP-1 Proteins
GATCCTCGGC
>DI160225.1 Aptamers to the Human IL-12 Cytokine Family and Their Use asAutoimmune Disease Therapeutics
AACGTTCGAG
>DI158856.1 METHOD OF DETECTING ncRNA
TTCACTGTGA
>DI158547.1 Method for production of minus-strand RNA virus vectorsusing a promoter containing a cytomegalovirus enhancer anda chicken beta actin promoter
CTTTCACCCT
>DI158050.1 METHOD OF DETECTING ncRNA
CACGGTACGA
>DI157930.1 METHOD OF DETECTING ncRNA
TGTGCTGCTA
>DI157904.1 Method for producing virus vectors
AGGGTGAATG
>DI157464.1 METHOD OF DETECTING ncRNA
TACTACCTCA
>DI157462.1 METHOD OF DETECTING ncRNA
CATTGCACTG
>DI157456.1 METHOD OF DETECTING ncRNA
ATTACTTGAA
>DI157258.1 METHOD OF DETECTING ncRNA
CGTGCTGCTA
>DI157105.1 METHOD OF DETECTING ncRNA
TACTACCTCA
>DI156838.1 METHOD OF DETECTING ncRNA
AGACAGTGTT
>DI156755.1 Method for production of minus-strand RNA virus vectorsusing a promoter containing a cytomegalovirus enhancer anda chicken beta actin promoter
AGGGTGAATG
>DI156697.1 METHOD OF DETECTING ncRNA
TAGGCCAGTT
>DI156554.1 METHOD OF DETECTING ncRNA
TGCCTGCTGT
>DI156523.1 Method for production of minus-strand RNA virus vectorsusing a promoter containing a cytomegalovirus enhancer anda chicken beta actin promoter
AGGGTCAAAG
>DI156446.1 METHOD OF DETECTING ncRNA
TACGCGTATA
>DI156331.1 METHOD OF DETECTING ncRNA
CTGCGGCACT
>DI156197.1 Gastrointestinal Proliferative Factor and uses thereof
TCGAGTTAAC
>DI156178.1 Method for producing virus vectors
AGGGTGAAAG
>DI156035.1 METHOD OF DETECTING ncRNA
CTTCATCTCA
>DI154358.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CTATCTGACG
>DI153798.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CGTTCTCTGT
>DI153634.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DI152902.1 Gene therapy for tumors using a minus-strand RNA virus vectorencoding an immune stimulatory cytokine
CTTTCACCCT
>DI152607.1 Gene therapy for tumors using a minus-strand RNA virus vectorencoding an immune stimulatory cytokine
AGGGTGAATG
>DI152285.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CGTTCTCTGT
>DI152269.1 Gene therapy for tumors using a minus-strand RNA virus vectorencoding an immune stimulatory cytokine
AGGGTCAAAG
>DI151941.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
CAGAGCTCTG
>DI151200.1 NOVEL VECTORS AND USE THEREOF
GGNNNNNTTA
>DI150620.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
CGGCGGGGAA
>DI139789.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI139107.1 Height-related gene
GAGCTGCCTC
>DI139094.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI139025.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI138989.1 Mycoplasma gallisepticum Formulation
CCGCAGCCAA
>DI138812.1 ALBUMIN-FUSED KUNITZ DOMAIN PEPTIDES
CTCTTCNNNN
>DI137981.1 Methods of storing, aligning, and retrieving haplotype data
GTTCTGTGAT
>DI137756.1 Methods of storing, aligning, and retrieving haplotype data
CTACTGCGAT
>DI137539.1 Methods of storing, aligning, and retrieving haplotype data
GTTCTGTGAT
>DI137423.1 PACKAGED VIRUS-LIKE PARTICLES
GACGATCGTC
>DI136967.1 TRANSFORMANT AND METHOD OF PRODUCING POLYESTERS WITH IT
TACTCTAGAG
>DI136338.1 Newcastle disease virus infectious clones, vaccines anddiagnostic assays
CGCGAGCTCG
>DI136311.1 Methods of storing, aligning, and retrieving haplotype data
GAACTGTAGG
>DI136253.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CGTTCTCTGT
>DI136242.1 SELECTION OF PROTEINS USING RNA-PROTEINFUSIONS
GGAGGACGAA
>DI136038.1 Ribozyme-encoding paramyxovirus vectors and their use
AGGGTGAAAG
>DI135850.1 Height-related gene
GAGCTGCCTC
>DI135842.1 Methods of storing, aligning, and retrieving haplotype data
GATCTGTAGG
>DI135831.1 Methods of storing, aligning, and retrieving haplotype data
GTTTTGCGAT
>DI135366.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI134843.1 Methods of storing, aligning, and retrieving haplotype data
ATTCTCTGGT
>DI134634.1 Methods of storing, aligning, and retrieving haplotype data
CTCTGGCCAT
>DI134511.1 Methods of storing, aligning, and retrieving haplotype data
GTCCTGCGAT
>DI134418.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CGTTCTCTGT
>DI134104.1 Methods of storing, aligning, and retrieving haplotype data
GTCCTGCGAT
>DI133644.1 Methods of storing, aligning, and retrieving haplotype data
GATCAGCCAT
>DI133590.1 Methods of storing, aligning, and retrieving haplotype data
GTCTGGCGAT
>DI133086.1 Methods of storing, aligning, and retrieving haplotype data
GTTCTCTGAT
>DI132976.1 Methods of storing, aligning, and retrieving haplotype data
ATTCTGTAGT
>DI132800.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI132696.1 Methods of storing, aligning, and retrieving haplotype data
CTTCCCTGGT
>DI132559.1 Methods of storing, aligning, and retrieving haplotype data
GATCGGCGAT
>DI132548.1 Ribozyme-encoding paramyxovirus vectors and their use
AGGGTCAAAG
>DI132135.1 Novel Mannheimia sp. and Process for Preparing Succinic AcidEmploying the Same
TCTAGAAGCT
>DI131921.1 Methods of storing, aligning, and retrieving haplotype data
ATACTCTGGT
>DI131842.1 TARGETS FOR TUMOR GROWTH INHIBITION
TGGCCAATAA
>DI131835.1 Methods of storing, aligning, and retrieving haplotype data
GTTCGCTGGT
>DI131813.1 Methods of storing, aligning, and retrieving haplotype data
ATTCCGCTAT
>DI131637.1 Methods of storing, aligning, and retrieving haplotype data
GTTCTCTGAT
>DI131291.1 Methods of storing, aligning, and retrieving haplotype data
GTTCTGCGAT
>DI131180.1 Disease associated protein
CCTCGTGCCG
>DI131044.1 Methods of storing, aligning, and retrieving haplotype data
GTTCGGTAGT
>DI130840.1 Methods of storing, aligning, and retrieving haplotype data
GATCTGCGAT
>DI130256.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI130250.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
TCAACGTTGA
>DI130236.1 Mycoplasma gallisepticum Formulation
CCCGTCAGCA
>DI129971.1 Methods of storing, aligning, and retrieving haplotype data
GATCTGCGAT
>DI129677.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI129536.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
TCAAGCTTGA
>DI129510.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI129332.1 Methods of storing, aligning, and retrieving haplotype data
GTTCGGCGAT
>DI129018.1 Methods of storing, aligning, and retrieving haplotype data
GTTCGGCGAT
>DI127779.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI127563.1 Methods of storing, aligning, and retrieving haplotype data
ATTCTGTAGT
>DI127359.1 Methods of transducing a gene into T cells
CTTTCACCCT
>DI126762.1 Ribozyme-encoding paramyxovirus vectors and their use
CTTTCACCCT
>DI126588.1 Methods of storing, aligning, and retrieving haplotype data
ATCTTGCGAT
>DI125053.1 ALBUMIN-FUSED KUNITZ DOMAIN PEPTIDES
GACNNNNGTC
>DI125045.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
CTGACGTTCT
>DI124998.1 IMMUNOSTIMULATORY NUCLEIC ACIDS
TTTGACGTTT
>DI124756.1 Methods of storing, aligning, and retrieving haplotype data
GTCTGGCGAT
>DI124553.1 RHEUMATOID ARTHRITIS GENE AND METHOD FOR DIAGNOSING RHEUMATOIDARTHRITIS
ATGAAGACCT
>DI123464.1 PRODUCTION OF OMEGA FATTY ACIDS IN OLEAGINOUS YEASTS
MAMMATGNHS
>DI123005.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGAAAAACTT
>DI122875.1 Recombinant Influenza Vectors with A PolII Promoter and Ribozymesfor Vaccines and Gene Therapy
GGGAGCAAAA
>DI122783.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGGGTGAATG
>DI122531.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGAAAAACYY
>DI121934.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
CTTTCACCCT
>DI121628.1 A MINUS STRAND RNA VIRUS VECTOR CARRING A GENE IN WHICHA MUTAGENIC REGION HAS BEEN ALTERED
AGGGTCAAAG
>DI121531.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
GCCTCGTGCG
>DI121283.1 A METHOD OF ANALYSING A MARKER NUCLEIC ACID MOLECULE
CTAACTGGGG
>DI121125.1 Variant of Rumen Bacteria and Process for Preparing Succinic AcidEmploying the Same
TCTAGAAGCT
>DI120819.1 PNA MONOMER AND PRECURSOR
TCTTCTAGTG
>DI120818.1 A composition containing a photoacid generator monomer, asubstrate coated with the composition, method for synthesizing acompound on a substrate using the composition and a microarrayproduced by the method
GGAGTAGTCT
>DI120681.1 PNA MONOMER AND PRECURSOR
CTCGTTTCCA
>DI120629.1 PNA MONOMER AND PRECURSOR
CTCATTTCCA
>DI120402.1 PNA MONOMER AND PRECURSOR
GTGCTCCTCC
>DI120351.1 METHOD FOR INHIBITING IRES-DEPENDENT TRANSLATION BY USING ANOLIGO DNA
CCGTCACCGG
>DI120319.1 PNA MONOMER AND PRECURSOR
CCCTACTGTG
>DI120297.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
GCCTCGTGCG
>DI120178.1 A composition containing a photoacid generator monomer, asubstrate coated with the composition, method for synthesizing acompound on a substrate using the composition and a microarrayproduced by the method
CCTCGTCAGA
>DI120096.1 METHOD FOR INHIBITING IRES-DEPENDENT TRANSLATION BY USING ANOLIGO DNA
CGCGTTACGA
>DI120073.1 PNA MONOMER AND PRECURSOR
ACCAGCGGCA
>DI119901.1 PNA MONOMER AND PRECURSOR
GTGCATGATG
>DI119733.1 PNA MONOMER AND PRECURSOR
TCGTGTCGTA
>DI119653.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
GTAGACCCGT
>DI119586.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
CTCACCTCTG
>DI119548.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
CTGCTGGGAC
>DI119516.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
TGCGCCCTTC
>DI119503.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
GGTGACGCAG
>DI119387.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
CAGAGCTCTG
>DI119225.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
TGGGGGACTC
>DI119052.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
TTTGCCCGGA
>DI118780.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
GGAGGGTGTT
>DI118623.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
CCTTGACGCA
>DI118460.1 Control of plant viruses with extracts of endemic strain,Pseudomonas fluorescens Gpf01[KCCM10642P]
GTCCACACGG
>DI118403.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
CAGAGCTCTG
>DI116018.1 MelanA-Peptide Analogue-Carrier-Conjugates
GACGATCGTC
>DI115181.1 Control of plant viruses with its extract of endemic strain,Serratia sp. Gsm01
TGGGGGACTC
>DI113634.1 Control of plant viruses with its extract of endemic strain,Serratia sp. Gsm01
GGAGGGTGTT
>DI112099.1 Control of plant viruses with its extract of endemic strain,Serratia sp. Gsm01
CCTTGACGCA
>DI112093.1 Control of plant viruses with its extract of endemic strain,Serratia sp. Gsm01
GTCCACACGG
>DI111359.1 Control of plant viruses with its extract of endemic strain,Serratia sp. Gsm01
TTTGCCCGGA
>DI108824.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
TCGCGTCGTT
>DI108792.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
TCGTCGACGA
>DI108687.1 VIRTUAL REPRESENTATIONS OF NUCLEOTIDE SEQUENCES
AGACAGTCAT
>DI108363.1 C-CLASS OLIGONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORYPOTENCY
TCGACGTCGA
>DI107997.1 VIRTUAL REPRESENTATIONS OF NUCLEOTIDE SEQUENCES
ACGTCAGTCA
>DI107719.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CGGCCCACGT
>DI107436.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
ACGGCGTCAC
>DI107434.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CCTGGTGGTT
>DI107427.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GAATGCGAGG
>DI107306.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CTAGGGGCTG
>DI107023.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
TGGGCTCGCT
>DI106986.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
ATGGCCTTAC
>DI106909.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CGGTGGCGAA
>DI106903.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
TTCCATGCCT
>DI106889.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CACAACGGGT
>DI106811.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GCGAACCTCC
>DI106798.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GCGAACCTCG
>DI106767.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GTGGCCGCGC
>DI106682.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GCGGCCCTCT
>DI106681.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GAGCCAGAAG
>DI106629.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GGTGGTTTCC
>DI106496.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
CTCTCCAGGC
>DI106488.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
ACATCCTGCG
>DI106480.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
ATCTAGGGAC
>DI106363.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
GTATGGGGCT
>DI106136.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
ACGGCAGTGG
>DI106118.1 SEQUENCE CHARACTERIZED AMPLIFIED REGION MARKERS FORDISCRIMINATION OF ARTEMISIA HERB
AGCGGCTAGG
>DI104407.1 Senock, A New Kind of Grass
GGTGACGCAG
>DI104233.1 Molecular marker associated with CMV resistance and use thereof
GTCCCGACGA
>DI102510.1 Achaete-Scute Like-2 Polypeptides and Encoding NucleicAcids and Methods for the Diagnosis and Treatment of Tumor
CTGGCCAAGA
>DI101976.1 GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS
CCCGGGATGA
>DI101519.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
TGGAGGTCAA
>DI101431.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
CGAATGTAAT
>DI101414.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGAATCTCC
>DI101386.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
GGAGGCTCAG
>DI101380.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATTGCACCCA
>DI101227.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGACGATAT
>DI101220.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGAGCCAGT
>DI101152.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGGTGAGAT
>DI101092.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
CTGACAGGGT
>DI100983.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGACTTTGG
>DI100836.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
CTTTGGTCAT
>DI100711.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
TTTTCGTCAT
>DI100698.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
GAAGCGTAAT
>DI100693.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGAAAGGCT
>DI100676.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATGACAGCAT
>DI100615.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
GCCCGGTAAT
>DI100594.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
ATTTCGTAAT
>DI100577.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
GATTCGTAAT
>DI100539.1 METHODS FOR DEVELOPING ANIMAL MODELS
TCCTGCTGCC
>DI100333.1 Promoters having a modified transcription efficiency and derivedfrom methyl-trophic yeast
TCCAGATCAT
>DI099986.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CTTCGCACGC
>DI099970.1 Method for breeding a hybrid pepper using interspecifichybridization
CGCCCGCAGT
>DI099125.1 Method to Inhibit Cell Growth Using Oligonucleotides
GGGTTAGGTT
>DI099095.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
GGGAGGGGTG
>DI099020.1 A vector with an altered tropism of protease dependency
CTTTCACCCT
>DI098816.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CCAGCGCTAG
>DI098614.1 Method for identification and analysis of specific moleculesusing single strand nucleic acid ligands
CACCCCTCCC
>DI097275.1 title
GGTTTAAACC
>DI097257.1 Covalent Tethering of Functional Groups to Proteins
GCCACCATGG
>DI096405.1 A method for discriminating between apricot and mume, and SCARmarker primer therefor
TCAGAGCGCC
>DI096209.1 Method for identification and analysis of specific moleculesusing molecular beacons
CTTCGCACGC
>DI096187.1 Method for identification and analysis of specific moleculesusing molecular beacons
CCAGCGCTAG
>DI096115.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
CGNNNNCGCG
>DI095959.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
NNCGCGNNCG
>DI095899.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
NNNCGCGNNN
>DI095736.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
NNNNCGNNNN
>DI095368.1 Immunostimulatory sequence oligonucleotidesand methods of using the same
NNNCGNNNCG
>DI094906.1 PNA MONOMER AND PRECURSOR
GTGCATGATG
>DI094376.1 PNA MONOMER AND PRECURSOR
CTCGTTTCCA
>DI094250.1 PNA MONOMER AND PRECURSOR
ACCAGCGGCA
>DI094029.1 PNA MONOMER AND PRECURSOR
TCTTCTAGTG
>DI093683.1 PNA MONOMER AND PRECURSOR
TCGTGTCGTA
>DI093427.1 PNA MONOMER AND PRECURSOR
CCCTACTGTG
>DI093395.1 PNA MONOMER AND PRECURSOR
CTCATTTCCA
>DI093014.1 ZINC FINGER DOMAIN LIBRARIES
GAGTGGGAAA
>DI092831.1 Groups of genes expressed in human monocytes and human macrophages
TGTTCATCAT
>DI092828.1 Groups of genes expressed in human monocytes and human macrophages
AAGGTGGAGG
>DI092809.1 Groups of genes expressed in human monocytes and human macrophages
AGTTTCTTGT
>DI092752.1 Groups of genes expressed in human monocytes and human macrophages
GTTCACATTA
>DI092744.1 Groups of genes expressed in human monocytes and human macrophages
CACAAACGGT
>DI092564.1 Compositions and methods for the treatment anddiagnosis of breast cancer
TGGATTGGTC
>DI092105.1 Gene group expressed in human dendritic cells
CCCAAGCTAG
>DI092042.1 Groups of genes expressed in human monocytes and human macrophages
GCGGTTGTGG
>DI091804.1 Compositions and methods for the treatment and diagnosis of breast cancer
AGTCTATGCG
>DI091803.1 POLYMORPHIC LOCI THAT DIFFERENTIATE ESCHERICHIA COLI 0157:H7 FROMOTHER STRAINS
CAGGGAAGAT
>DI091780.1 Gene group expressed in human dendritic cells
CACAAAAAGA
>DI091749.1 Immunostimulatory Nucleic Acids
GCAATATTGC
>DI091740.1 Gene group expressed in human dendritic cells
CCTGGGGTAA
>DI091729.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TGACNGTTCG
>DI091706.1 Groups of genes expressed in human monocytes and human macrophages
TGCACCACAG
>DI091695.1 Gene group expressed in human dendritic cells
ATACCTGGAT
>DI091503.1 Groups of genes expressed in human monocytes and human macrophages
AGGGAGGGGC
>DI091470.1 Gene group expressed in human dendritic cells
ATGAGCTGAC
>DI091459.1 ZINC FINGER DOMAIN LIBRARIES
GCTGGGGACT
>DI091180.1 ZINC FINGER DOMAIN LIBRARIES
AAAAGAAAAA
>DI091142.1 Groups of genes expressed in human monocytes and human macrophages
GCGACCGTCA
>DI091022.1 ZINC FINGER DOMAIN LIBRARIES
GGGGGCGGTT
>DI090953.1 Groups of genes expressed in human monocytes and human macrophages
CCCTGAGGCC
>DI090898.1 Oligonucleotide for detection and identification of Mycobacteria
AAGGAGCACC
>DI090746.1 Groups of genes expressed in human monocytes and human macrophages
CCAGTGGCCC
>DI090713.1 Groups of genes expressed in human monocytes and human macrophages
GTGAAGGCAG
>DI090705.1 Gene group expressed in human dendritic cells
AAGTACTTCA
>DI090470.1 Groups of genes expressed in human monocytes and human macrophages
ACATCATCGA
>DI090315.1 Gene group expressed in human dendritic cells
TTGGCCAGGC
>DI090289.1 Gene group expressed in human dendritic cells
CCCCCTGGAT
>DI090158.1 Gene group expressed in human dendritic cells
TTGCTGCCAG
>DI090076.1 Groups of genes expressed in human monocytes and human macrophages
GCCGGCCGGA
>DI089997.1 ZINC FINGER DOMAIN LIBRARIES
GCAGCTGCTT
>DI089988.1 Groups of genes expressed in human monocytes and human macrophages
AACGGGGCCC
>DI089833.1 Groups of genes expressed in human monocytes and human macrophages
AGTGCACGTG
>DI089832.1 Pharmaceutical composition for promoting recovery from stressand novel Tricholoma matsutake strain
GACTAGCCTC
>DI089744.1 Gene group expressed in human dendritic cells
GAGGGTGCCA
>DI089735.1 Immunostimulatory Nucleic Acids
ATTTTATCGT
>DI089669.1 Groups of genes expressed in human monocytes and human macrophages
GCTTTATTTG
>DI089655.1 AMPLIFICATION OF NUCLEIC ACID FRAGMENTSUSING NICKING AGENTS
GGATCNNNNN
>DI089625.1 Groups of genes expressed in human monocytes and human macrophages
CACCTAATTG
>DI089574.1 Groups of genes expressed in human monocytes and human macrophages
CTCCCCTGCC
>DI089504.1 Gene group expressed in human dendritic cells
TTGTAATCGT
>DI089391.1 Groups of genes expressed in human monocytes and human macrophages
GCCGAGGAAG
>DI089234.1 Gene group expressed in human dendritic cells
CAGGATGACG
>DI089123.1 Groups of genes expressed in human monocytes and human macrophages
AAGTTGCTAT
>DI088978.1 Novel Polypeptidies and DNAs
AGCGGCCGCG
>DI088972.1 Groups of genes expressed in human monocytes and human macrophages
CGCTGGTTCC
>DI088932.1 Groups of genes expressed in human monocytes and human macrophages
CGCACAATCA
>DI088904.1 ZINC FINGER DOMAIN LIBRARIES
GGTGATGCTC
>DI088824.1 ZINC FINGER DOMAIN LIBRARIES
GAAGCGGAGG
>DI088790.1 Groups of genes expressed in human monocytes and human macrophages
GGGGCTTCTG
>DI088642.1 Gene group expressed in human dendritic cells
ATCCGGACCC
>DI088628.1 Groups of genes expressed in human monocytes and human macrophages
GTTGTGGTTA
>DI088569.1 Gene group expressed in human dendritic cells
TGTACCTGTA
>DI088549.1 Groups of genes expressed in human monocytes and human macrophages
AAAACATTCT
>DI088522.1 Gene group expressed in human dendritic cells
GAAGCAGGAC
>DI088381.1 Gene group expressed in human dendritic cells
GTGACCACGG
>DI088305.1 Groups of genes expressed in human monocytes and human macrophages
CTTGACATAC
>DI088089.1 Immunostimulatory Nucleic Acids
TCAANGTTGA
>DI088070.1 Gene group expressed in human dendritic cells
TACATTCTGT
>DI088018.1 Gene group expressed in human dendritic cells
CCCACAACCT
>DI087824.1 Groups of genes expressed in human monocytes and human macrophages
TGAAAACTAC
>DI087519.1 CLASSIFICATION OF THE KOREAN GINSUNG BY RADP ANALYSIS
GACCGCTTGT
>DI087496.1 Immunostimulatory Nucleic Acids
CTGACGTCAT
>DI087486.1 Gene group expressed in human dendritic cells
AATTAAATTA
>DI087390.1 Groups of genes expressed in human monocytes and human macrophages
ATGGCTGGTA
>DI087220.1 Gene group expressed in human dendritic cells
GCGACAGCTC
>DI087140.1 Gene group expressed in human dendritic cells
TATATTGATT
>DI087087.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TTAACGTTCG
>DI087040.1 TRANSFORMATION SYSTEMS FOR THE YEAST CANDIDA UTILISAND THE EXPRESSION OF HETEROLOGOUS GENES THEREWITH
CCGGATCCGG
>DI087035.1 Groups of genes expressed in human monocytes and human macrophages
GGGGAAATCG
>DI087018.1 Groups of genes expressed in human monocytes and human macrophages
TTGGTCCTCT
>DI086884.1 Compositions and methods for the treatment anddiagnosis of breast cancer
TCTGTCCACA
>DI086843.1 Gene group expressed in human dendritic cells
ACTACAAATA
>DI086744.1 DNA sequences comprising gene transcription regulatory qualities and
GAGNNNNCCC
>DI086563.1 Groups of genes expressed in human monocytes and human macrophages
CCTTGTCCTC
>DI086521.1 Groups of genes expressed in human monocytes and human macrophages
CCAGAACAGA
>DI086493.1 Gene group expressed in human dendritic cells
CCATTGCACT
>DI086414.1 Groups of genes expressed in human monocytes and human macrophages
GATAGGATAA
>DI086383.1 Groups of genes expressed in human monocytes and human macrophages
GCATCCCTCC
>DI086380.1 Compositions and methods for the therapy and diagnosisof breast cancer
CTATCCATGG
>DI086230.1 Groups of genes expressed in human monocytes and human macrophages
TCACCTTAGG
>DI086216.1 Gene group expressed in human dendritic cells
GGAGGTGGGG
>DI086191.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNNNCCC
>DI086154.1 Groups of genes expressed in human monocytes and human macrophages
TGTCCCAGCC
>DI086108.1 ZINC FINGER DOMAIN LIBRARIES
TGGGAGGATC
>DI086102.1 CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME
TGATCGTTCG
>DI085927.1 DNA sequences comprising gene transcription regulatory qualities and
AGGNNNNCCC
